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ABSTRACT 
Commercial sows experience a high incidence of prenatal loss and substantial 
variation in birthweight among piglets in a litter. These outcomes negatively impact 
efficiency and profitability in the swine industry and are hypothesized to result from 
insufficient endometrial support and placental development during pregnancy. This 
study examined how glucose and fructose are synthesized, transported, and metabolized 
at the uterine-placental interface of pigs to support development and growth of the 
placenta and embryo/fetus. 
Total tissue mRNA expression and mRNA or protein cellular localization for 
glucose transporters and polyol pathway enzymes were determined in endometrial 
and/or placental tissues collected from gilts throughout the estrous cycle and pregnancy. 
SLC2A1 is the most abundant glucose transporter in the endometrium and is expressed 
by luminal (LE) and glandular epithelia (GE) throughout pregnancy. SLC2A3 is 
expressed by trophectoderm/chorion throughout pregnancy. SLC2A5, a fructose 
transporter, is expressed by LE and chorion after Day 30 of gestation. SLC2A8, a 
glucose and fructose transporter, is expressed by LE, GE, and select fetal tissues during 
the peri-implantation period of pregnancy. SLC2A1 mRNA and SLC2A8 protein are 
upregulated in the uterine epithelia in response to E2 and P4. 
The conversion of glucose to fructose involves aldose reductase (AKR1B1) and 
sorbitol dehydrogenase (SORD). AKR1B1 is expressed by uterine LE during the peri-
implantation period, then by chorion after Day 20. SORD is expressed initially by 
iii 
uterine LE, GE, and trophectoderm, but is barely detectable in the endometrium by Day 
20. Ketohexokinase (KHK), which phosphorylates fructose, is expressed by
trophectoderm/chorion throughout pregnancy, especially in the tall columnar cells and 
areolae. 
These results establish the presence of the molecular components for hexose 
sugar transport, conversion of glucose to fructose, and fructose utilization at the uterine-
placental interface of pigs. The shift in expression of AKR1B1 and SORD from uterine 
LE to chorion during pregnancy suggests that the free-floating conceptuses are supported 
by fructose synthesized and secreted into the uterine lumen by uterine LE. After 
placentation is initiated, the chorion becomes self-sufficient for fructose synthesis and 
transport to the conceptus.  With this knowledge, future studies can be designed to 
manipulate the availability and transport of hexose sugars across the uterine-placental 
interface to decrease prenatal loss and variability in birth weights within litters, leading 
to increased efficiency and profitability for the swine industry. 
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CHAPTER I  
INTRODUCTION 
 
Modern commercial sows have a high incidence of prenatal loss, and individual 
piglet birthweight varies greatly within a litter, especially with increasing litter size (van 
der Lende et al., 2001). While sows ovulate 20 to 30 oocytes, only 9 to 15 piglets are 
delivered at term, and this is due to embryonic/fetal losses at multiple time points during 
pregnancy. Embryonic/fetal losses occur during four periods of pregnancy, including: 1) 
the peri-implantation period, prior to Day 16 of pregnancy; 2) between Days 35 to 40; 3) 
mid-gestation from Days 55 to 75; and, 4) just prior to farrowing (van der Lende and van 
Rens, 2003). These time points coincide with major changes in placental growth and 
development, therefore, fetal loss may be in part due to insufficient physical and 
biochemical development of the interface between endometrial and placental tissues or 
endometrial development early in pregnancy (Wilson et al., 2001; Vallet et al., 2002).   
The large variability in birthweights within a single litter is attributed to 
intrauterine growth restriction resulting in runt piglets that are only one-half or one-third 
the size of their largest littermates (Widdowson, 1971). This reduced bodyweight 
correlates with reduced survival and growth of the runt piglets, making them less cost 
efficient than larger piglets as they are never able to fully compensate for the intrauterine 
growth restriction (Ritacco et al., 1997; Tilley et al., 2007). Differences in embryonic 
development in early pregnancy are noticeable during trophectoderm elongation (Geisert 
et al., 1982a). Insufficient trophectoderm elongation directly affects placental 
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development leading to detrimental alterations of the maternal/conceptus interface of 
small as compared to large fetuses (Vallet and Freking, 2007). While there is evidence 
that manipulating the maternal diet can reduce variation in birthweight, and improve 
fetal survivability, advancements in the basic understanding of nutrient transport and 
metabolism in the endometrium and placenta of pregnant pigs is necessary for further 
development of strategies to improve placental development and birth weights of piglets 
for increased economic profitability and sustainability of the swine industry (Wu et al., 
2013; De Vos et al., 2014). 
Glucose and fructose are abundant hexose sugars in porcine endometria and 
conceptuses (embryo/fetus and associated placenta). Fructose plays a minor role as an 
energy source in the placenta and fetus, but fructose can be used as a substrate in a 
number of metabolic pathways that support conceptus development, including 
biosynthesis of glycosaminoglycans, phospholipids, and nucleic acids (White et al., 
1982). Recently, in vitro studies demonstrated that porcine trophectoderm cells utilize 
fructose through the hexosamine biosynthetic pathway to stimulate mechanistic target of 
rapamycin (MTOR) cell signaling and cell proliferation, and for the synthesis of 
hyaluronic acid, a significant glycosaminoglycan in the placenta (Kim et al., 2012).  
Fructose is detected in uterine flushings of pregnant gilts as early as Day 12 of 
pregnancy and is present in greater quantities than glucose in the allantoic fluid and fetal 
blood (Aherne et al., 1969; Zavy et al., 1982; Bazer et al., 1988). Additionally, fructose 
is undetectable in maternal blood of pregnant gilts and sows (Pere, 1995). Studies by 
White et al. demonstrated that fructose injected intraperitoneally into an in utero fetus 
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cannot cross the placenta or be converted into glucose, but glucose injected in the same 
manner can cross the placenta and be converted to fructose (White et al., 1979). Those 
results suggest that the placenta is the site of fructose production and it is hypothesized 
that fructose synthesis is a method for the fetus to sequester hexose sugars from the 
mother (Zavy et al., 1982). However, the cellular localization of fructose synthesis, the 
cellular use of fructose, and the transport system for both glucose and fructose in 
placental and endometrial tissues have not been defined in pigs.   
The long term research goal is to establish the roles of glucose and fructose in 
fetal and placental development in pigs, and to determine how they relate to birth weight 
and fetal survival. The short term goals of the research described in this dissertation were 
to: 1) identify and localize transporters for hexose sugars in cells of the endometria and 
placentae; 2) determine which cells synthesize fructose from glucose within endometria 
and placentae; and 3) determine which endometrial and placental cells utilize fructose.  
Our hypothesis was that glucose is transported to the placenta from maternal 
blood and that a fraction of the glucose is converted to fructose via the polyol pathway. 
Fructose can then be transported and utilized by the conceptus for synthesis of 
glycosaminoglycans via the hexosamine pathway and/or for actions as a metabolic 
regulator. While fructose is found in high concentrations in fetal blood and allantoic 
fluid, and the conceptus metabolizes fructose, the roles of specific endometrial and 
placental cell types in synthesizing and metabolizing fructose are unknown. 
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CHAPTER II 
LITERATURE REVIEW 
 
Estrous Cycle 
 Pigs are polyestrus, spontaneous ovulators with an approximately 21-day estrous 
cycle. The cycle begins with the onset of estrus, and ovulation of 15-30 oocytes takes 
place about 40 hours later. At this time the circulating concentration of progesterone is 
low, but as the corpora lutea (CL) develop, more progesterone is produced until serum 
levels reach peak quantities around Days 8 to 9 after ovulation. Progesterone levels are 
maintained until the luteolysin prostaglandin F2α (PGF) is secreted in pulses by the 
uterine luminal epithelium (LE) towards the utero-ovarian vein in response to pituitary 
oxytocin binding the oxytocin receptor in the LE on Day 15 or 16 of the estrous cycle 
(Moeljono et al., 1976; Mirando et al., 1995). The PGF is transported to the ovary and 
initiates luteolysis of the CL. This results in decreased serum progesterone levels, and 
the inhibition of progesterone on estrogen action is removed to allow for an ovulatory 
surge of luteinizing hormone to induce ovulation. Concentrations of estrogen in serum 
increase, as concentrations of progesterone decrease, and peak about two days before 
ovulation. During the estrous cycle, the uterus responds to increasing concentrations of 
progesterone to prepare for the arrival of embryos (Soede et al., 2011).    
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Pregnancy 
The early stages of embryonic development in pigs proceed in a manner similar 
to that of other mammalian species (Figure 2.1). The pig is a litter bearing species, 
therefore, multiple oocytes are transported down the oviduct after ovulation. Fertilization 
occurs within the oviduct, and the zygotes undergo the first cleavage division by 26 
hours after fertilization. Cleavage divisions continue, and at the 8-16 cell stage activation 
of the embryonic transcriptome occurs.  The developing embryos enter the uterus at 46 
to 56 hours post-fertilization, and form blastocysts. At this point the pluripotent 
blastomeres begin to differentiate into the inner cell mass (ICM) and trophectoderm to 
begin the cell lineages that will eventually become the embryo/fetus proper and the 
placental chorion, respectively, and are collectively termed the conceptus. Blastocysts 
hatch out of the zona pellucida on Days 6 to 7 as 0.5 to 1 mm spheres, and increase in 
size to 2 to 6 mm by Day 10 before undergoing a rapid morphological transition called 
elongation (Figure 2.2). The small spherical blastocysts grow into a long ovoid form (10 
to 15 mm) with the trophoblast and endoderm cells migrating toward the ICM to form 
the elongation zone. The tubular (15 mm by 50 mm) blastocysts then begin to increase in 
length and decrease in diameter due to the migration of trophectoderm and endoderm 
cells towards the ends of the blastocyst to produce the filamentous form (1 mm by 100-
200 mm). Pig conceptuses elongate at 30 to 40 mm/h during the transition from spherical 
to filamentous forms primarily due to this trophectoderm remodeling (Geisert et al., 
1982a; Mattson et al., 1990). The next phase of rapid growth is dependent on 
hyperplasia, and the filamentous conceptus grows to 800 to 1000 mm in length by Day 
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Figure 2.1 Pig embryo pre-implantation development 
Pig conceptus pre-implantation development begins with the cleavage stages and the 
development of the blastocyst. The blastocyst hatches from the zona pellucida and 
begins to elongate from a small sphere, to a large sphere, to a tubular form, and then to a 
filamentous form. Reprinted with permission from Bazer and Johnson, 2014. 
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Figure 2.2 Elongation of the pig embryo 
Pig embryo elongation is proposed to begin with the (A) proliferating trophectoderm and 
endoderm cells migrating toward the inner cell mass (ICM) to form the elongation zone 
along the same plane as the ICM along the length of the blastocyst (B). The 
trophectoderm and endoderm cells then migrate towards the tips of the tubular blastocyst 
(C), which reduces the diameter of the blastocyst to eventually develop the filamentous 
form that can has the maximal surface area for interaction with the uterine luminal 
epithelium. Reprinted with permission from Bazer and Johnson, 2014. 
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18 of pregnancy. During the early elongation period, the conceptus remains free-floating 
and dependent on the uterus for nutrients. Conceptus elongation provides increased 
surface area for  nutrient exchange between the conceptus and uterus and to ensure that 
estrogens from the conceptus inhibit luteolysis (Dhindsa and Dziuk, 1968). Development 
of conceptuses within a litter does not happen uniformly as can been seen by the 
presence of multiple morphological stages at any given time point in a single uterus 
(Anderson, 1978).  
After the blastocyst hatches from the zona pellucida, gastrulation, or formation of 
three distinct germ layers, ectoderm, mesoderm, and endoderm, begins. The ICM first 
differentiates into the hypoblast or the primitive endoderm (ventral to the blastocyst 
cavity, layered against the trophectoderm) and the epiblast (dorsal to the blastocyst 
cavity). At Day 9 of pregnancy, the trophectoderm overlaying the epiblast (Rauber’s 
layer) gradually disintegrates allowing the epiblast to be exposed to the uterine 
environment and to form the embryonic disc, which will differentiate into the three 
distinct germ layers. By Day 11, the mesoderm and endoderm begin to form, and then 
the remaining epiblast cells differentiate into neural or ectoderm cells (Figure 2.3). The 
endoderm cells begin to replace the hypoblast cells that line the epiblast and the 
mesoderm cells localize as an intermediate mesenchymal layer between the epithelial 
endodermal and ectodermal cell layers. Eventually, the extra-embryonic mesoderm will 
fuse with the primitive endoderm, the ectoderm, and the trophectoderm to give rise to 
the yolk sac, amnion, and chorion, respectively, as seen in Figure 2.4 (Perry, 1981; 
Blomberg et al., 2008; Oestrup et al., 2009). 
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Figure 2.3 Development of the extraembryonic membranes 
By Day 11, the embryonic disc has formed, while the mesoderm and endoderm are 
developing (A, B). The trophoblast and mesoderm fold around the embryo to create the 
amnion (C) as the endoderm develops into the yolk sac, and the chorion is formed from 
the trophoblast and the mesoderm (D). By Day 15, the allantoic cavity has formed (E) 
and will continue to enlarge as pregnancy progresses . Reprinted with permission from 
Perry, 1981. 
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Figure 2.4 Extraembryonic membranes at Day 18 of pregnancy 
By Day 18, the amnion completely surrounds the embryo, the allantois has formed and is 
enlarging to eventually surround the amnion and the embryo, and the yolk sac provides 
nutrients to the embryo. As placentation proceeds, the yolk sac will recede and the 
allantois will take over its function in nutrient support for the fetus. Reprinted with 
permission from Perry, 1981. 
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As conceptuses undergo these morphological changes, they also produce and 
secrete estrogen as well as a multitude of other cytokines and growth factors (Geisert et 
al., 1982b; La Bonnardiere et al., 1991). Many of these factors then act in a paracrine  
manner, or in an autocrine manner of the trophectoderm, to begin cross-talk between the 
conceptus and uterus that is necessary for successful implantation. 
 
Maternal Recognition of Pregnancy 
 In the pig, conceptus trophectoderm secretes estrogen as the signal for maternal 
recognition of pregnancy (Bazer and Thatcher, 1977). As outlined in the endocrine-
exocrine theory, estrogen secretion by the trophectoderm between Days 11 to 12 acts to 
redirect secretion of prostaglandin F2α (PGF) into the uterine lumen, where it is 
sequestered and/or metabolized in order to prevent luteolysis (Bazer and Thatcher, 1977; 
Pusateri et al., 1990). This exocrine secretion of PGF is in contrast to the endocrine 
secretion that would occur in a normal estrous cycle without the influence of estrogen. 
Maintenance of the CL is necessary because it produces progesterone, the hormone of 
pregnancy, which is an essential regulator of uterine functions required for conceptus 
development, implantation, placentation, and the sustainability of pregnancy. 
Pseudopregnancy can be achieved in the pig with injection of exogenous 17β-estradiol 
on Days 11 to 15 of the estrous cycle as the estrogen results in PGF secretion into the 
uterine lumen and continued maintenance of the corpus luteum for a period of time that 
is equal to, or slightly longer than, the normal period of gestation for pigs of 114 days 
(Frank et al., 1977).   
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Progesterone and Estrogen Receptors in the Uterine Endometrium 
 Progesterone, from the CL, and estrogen, from the conceptus trophectoderm, 
mediate their effects on the uterine endometrium through their respective steroid 
hormone receptors. Expression of these receptors is temporally and spatially variable 
during the estrous cycle and early pregnancy and allows for the tight control of 
downstream targets necessary to either maintain a successful pregnancy, or prepare the 
endometrium for another cycle. Progesterone receptor B (PGRB) protein is expressed in 
the uterine LE, GE, stroma, and myometrium through Day 7 of the estrous cycle and 
pregnancy. During both the estrous cycle and pregnancy, prolonged progesterone 
exposure leads to undetectable levels of PGRB in the uterine LE by Day 10 and in the 
GE by Day 12, but stromal and myometrial cells continue to express PGRB (Geisert et 
al., 1994). Progesterone receptor A (PGRA) protein has been detected by Western Blot 
in endometria between Days 0 to 10 of the estrous cycle and pregnancy (Geisert et al., 
1994). 
 Estrogen receptor (ER) protein localizes to the uterine LE and GE from Days 0 to 
12 of the estrous cycle and pregnancy with decreased expression in the LE and GE from 
Days 5 to 10, and then increased expression between Days 12 and 15 (Ross et al., 2010). 
Stromal expression of ER is highest at Day 0, decreases by Day 5, and remains low 
throughout pregnancy, or increases by Day 18 in the estrous cycle (Geisert et al., 1993). 
ER continues to be expressed in the deep glands through Day 71 of pregnancy with 
detectable myometrial expression observed from Days 10 through 32 of pregnancy 
(Knapczyk-Stwora et al., 2011).  
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Implantation 
 Implantation involves complex interactions between a developmentally 
competent conceptus and a receptive uterus (Carson et al., 2000; Burghardt et al., 2002; 
Lessey, 2002). The phases of the implantation cascade are defined as: (1) shedding of 
the zona pellucida and elongation of the conceptus trophectoderm; (2) pre-contact and 
blastocyst orientation; (3) apposition of trophectoderm to uterine LE; and, (4) adhesion 
of the apical surface of the trophectoderm to the apical surface of the uterine LE (Figure 
2.5) (Guillomot, 1995). In the pig, the implantation event is truncated as compared to 
rodents or humans. That is, after a prolonged pre-attachment period, the conceptus 
undergoes orientation, apposition, and adhesion, but does not invade through the uterine 
LE (Dantzer, 1985). The implantation cascade requires the loss of anti-adhesive mucin 
in the glycocalyx of the uterine LE that sterically inhibits attachment of trophectoderm to 
uterine LE. This critical event is temporally associated with loss of PGR in the uterine 
LE (Bowen et al., 1996; Aplin, 1999). Removal of the large anti-adhesive molecules 
allows smaller carbohydrate molecules, such as selectins and galectins, on the uterine LE 
to be accessible to the conceptus trophectoderm for initial attachment at Day 13 of 
pregnancy (Kimber et al., 1995; Farmer et al., 2008). The low stability contact is then 
replaced by a more stable and comprehensive collection of adhesive interactions 
between integrins and the extracellular matrix (ECM) that are maintained throughout 
implantation (Burghardt et al., 1997; Johnson et al., 2001; Lessey, 2002). 
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Figure 2.5 Adhesion cascade for implantation 
The implantation cascade begins with the blastocyst hatching from the zona pellucida 
and undergoing the elongation process. During this time, the uterine LE is responding to 
progesterone to downregulate MUC1 and allow for the initial contact between the 
conceptus and LE through carbohydrate-lectin interactions. These low stability contacts 
are then replaced by the more stable integrin-extracellular matrix protein interactions 
that are maintained throughout implantation. 
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Placentation 
 The pig develops a diffuse, epitheliochorial type placenta to support the growth 
of each individual fetus. This placentation is characterized as being superficial, non-  
invasive, and having a uterine LE that remains intact. The uterine lamina propria (termed 
the stroma) underlies the uterine LE to provide structural support and includes 
fibroblasts, immune cells, and vasculature (endothelial and smooth muscle cells). In the 
uterus, the LE, GE, and lamina propria are called the endometrium.  Outside the 
endometrium is the myometrium, which contains both inner circular and outer 
longitudinal layers of smooth muscle. Within the endometrium, invaginations of the LE 
form tubular compartments, the endometrial glands, which are lined with GE that form a 
lumen that empties into the uterine lumen and, eventually, into areolae (Fig. 2.6). These 
areolae are pockets of invaginated chorionic epithelia (CE) that form over the mouths of 
endometrial glands and are surrounded by a specialized microvasculature (Friess et al., 
1981). Underlying the chorion, both in areolar and inter-areolar areas, is the allantoic 
stroma, which contains fibroblasts and cells of the vasculature. Underlying the allantoic 
stroma is the allantoic epithelium, which lines the allantoic sac (Figure 2.6). 
 Areolae form from Days 18 to 30 of pregnancy and the placenta of each piglet 
will contain about 2,500 areolae (Knight et al., 1977; Leiser and Dantzer, 1994). 
Secretions from the uterine glands, called histotroph, fill the lumen of the areolae and are 
then transported through the chorion by fluid phase pinocytosis to the fetal vasculature 
for use by the placenta and fetus (Renegar et al., 1982; Song et al., 2010). The CE that 
 16 
 
   
Figure 2.6 The fetal environment 
As pregnancy progresses, the fetus resides within the fluid-filled amnion, which is 
contained inside the allantoic cavity. The allantoic cavity is surrounded by the allantoic 
membrane and allantoic stroma, which supports the chorion that is interdigitated with the 
uterine luminal epithelium. At this interface, areolae form over the mouths of glands and 
are surrounded by a specialized microvasculature. Reprinted with permission from Song 
et al., 2010. 
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composes the areola contains tall columnar cells with long microvilli that are optimal for 
transporting histotroph. 
Filamentous conceptuses space out along the uterine horns in order that each 
conceptus has its own segment of uterine endometrium for implantation/placentation. 
There is minimal overlap between conceptuses and the areas where the trophoblastic tips 
do overlap undergo necrosis. There is complete attachment between the uterine LE and 
trophectoderm by Day 24 of pregnancy. The two adhered epithelia then begin to fold 
around Day 30 to increase the surface area for nutrient transport and this folding 
becomes more extensive as gestation progresses (Friess et al., 1980; Vallet and Freking, 
2007). The epitheliochorial placenta allows for both histotrophic and hemotrophic 
support for the developing conceptus. Histotrophic support comes from the GE and is 
transported through the areolae. Hemotrophic support includes any transport from the 
maternal blood to the placental blood that occurs in non-areolar regions, across the two 
adhered epithelia (LE and CE). As pregnancy progresses, the two adhered epithelia and 
underlying connective tissue become thinner to decrease the distance between the 
maternal and placental capillaries to as little as 2 microns (Friess et al., 1980). The 
maternal and fetal capillaries are arranged in a cross-countercurrent manner on opposite 
sides of the adhered epithelia. If the fetal side of the placenta is “up”, then maternal 
blood enters at the top of the folds and exits at the bottom. In contrast, the placental 
blood enters at the bottom of the folds and exits at the top (Leiser and Dantzer, 1988). 
This arrangement allows for optimum transport of nutrients, especially those dependent 
on concentration gradients, from mother to fetus. The chorion has two different cell 
 18 
 
types. Tall columnar cells are found at the tops of folds, while short cuboidal cells are at 
the bottoms. The two cell types differ in their transcriptome and may play different roles 
in both nutrient transport and fold development (Vallet et al., 2014). 
 After rapid expansion by the chorion and allantois between Days 18 to 30 of 
pregnancy, they fuse during Days 30 to 60. The placenta grows exponentially through 
this time until about Day 70 of pregnancy when placental development is completed in 
terms of placental weight, surface area, and numbers of areolae (Knight et al., 1977). 
There continues to be angiogenesis and increases in capillary bed volume until 
parturition to support the exponential growth of the fetus in the last 40 days of gestation 
(Ullrey et al., 1965; Knight et al., 1977).  
 
Fetal Growth 
 From Days 15 to 30 of pregnancy, the fetal organs first develop from the three 
germ layers, endoderm, mesoderm, and ectoderm. As pregnancy progresses, the organs 
expand in size and weight, but the timing of this expansion is dependent on the organ. 
The heart, brain, and liver increase exponentially in weight from Days 51 to 114, while 
lungs and spleen stop enlarging by Day 93 (Ullrey et al., 1965). The bones begin to 
calcify around Day 30. This represents the time point before which fetuses that are not 
viable are reabsorbed, while after Day 30, they often result in stillborn mummified 
fetuses. Overall fetal weight increases exponentially during the last third of pregnancy 
and this necessitates the increased movement of nutrients through the placenta (Ullrey et 
al., 1965; McPherson et al., 2004). 
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Allantoic and Amniotic Fluids 
 The allantoic cavity is surrounded by the allantoic epithelium and an extensive 
vasculature that empties into the umbilical artery. The urachus connects the fetal bladder 
to the allantois allowing for waste from the fetus to be moved into the allantoic cavity 
(Patten, 1948). Allantoic fluid is a hypotonic solution composed of electrolytes, sugars, 
proteins, and water that are of maternal and fetal origin, and provide a nutrient reservoir 
for the fetus (Aherne et al., 1969; Wu et al., 1995). These components are all moved 
across the allantoic epithelium most likely in a sodium concentration dependent manner. 
Allantoic fluid is dynamic during pregnancy in terms of changes in both volume and 
composition. The initial increase in volume from Days 18 to 30 promotes the expansion 
of the allantois, its apposition with the chorion, and contact with the maternal 
endometrium. The allantoic fluid volume then decreases until Day 45, again increases 
until Day 58, and then decreases until parturition (Knight et al., 1977; Goldstein et al., 
1980). As the allantoic fluid volume rises, so does the total amounts of glucose and 
fructose sequestered in allantoic fluid, indicating that the movement of these sugars may 
be sodium-dependent as is transport of water into the allantoic sac.  
 The amnion is the fluid-filled sac immediately surrounding the fetus. Suspension 
in the amnion protects the growing fetus from mechanical injury and allows the fetus to 
grow symmetrically without pressure points that would lead to abnormal development 
(Patten, 1948). Additionally, the amnion serves as a nutrient reservoir containing amino 
acids, sugars, and electrolytes that the fetus may drink during gestation (Aherne et al., 
1969; Wu et al., 1995). 
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Fructose in the Conceptus 
 
Sheep 
 Fructose has long been detected in the fetal fluids of ruminants, pigs, and, in 
trace amounts in humans, but the methods used left doubt as to whether the sugar that 
was being described was actually fructose. By 1946, Cole and Hitchcock used a 
modified version of the Seliwanoff technique to definitively detect up to 1 mg/ml 
fructose in the umbilical blood of sheep fetuses between Days 107 and 141 of pregnancy 
(Cole and Hitchcock, 1946). They also determined that fetal blood fructose levels fall 
rapidly within 24 hours of birth. Around the same time, Bacon and Bell reported the 
presence of both glucose and fructose in the blood of fetal sheep late in pregnancy and 
found greater quantities of fructose  than glucose (Bacon and Bell, 1948). This explained 
the conundrum that total fetal blood sugar concentration was higher than the mother’s 
blood sugar concentration. The glucose concentrations were lower in the fetal blood than 
in the maternal blood and the rest of the sugar, in the fetus, was fructose.  
 Barklay et al. then determined fructose quantities in the amniotic and allantoic 
fluids of sheep. Fructose present in amniotic and allantoic fluids was found in larger 
quantities than glucose and levels peaked from Days 110 to 130 of pregnancy in both 
fluids before decreasing substantially just before parturition (Barklay et al., 1949). There 
was concern that the anaesthetic being given to the ewes was altering their blood glucose 
levels and, therefore, giving inaccurate results about the differences between maternal 
and fetal concentrations of glucose in blood. Hitchcock performed a study that accounted 
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for this concern and concluded that the maternal and fetal concentrations of glucose in 
blood were less differential than previously thought and that there was a constant loss of 
glucose from maternal blood to the fetal blood through the placenta (Hitchcock, 1949). 
 Since the levels of fructose in the maternal blood were undetectable to barely 
detectable, the question arose as to where the fructose originated. Huggett et al. 
approached this question by administering intravenous glucose into ewes that were 115 
days pregnant and recording both the maternal and fetal blood glucose concentrations. 
After glucose was administered, there was an immediate rise and peak in maternal blood 
glucose levels, which then slowly decreased over the course of 3 to 4 hours. There was a 
concurrent, although less drastic peak in the fetal glucose levels with a similar decrease 
over time. But, surprisingly, the fetal fructose levels rose slowly, peaked about 3 hours 
after glucose administration, and slowly fell back to original levels over the course of 3 
to 6 hours. The placenta was determined to be the site of fructose production in an 
experiment using twin lambs at Day 135 of pregnancy, where one lamb was detached 
from the placenta, one remained attached, and both were given glucose through the 
umbilical cord. In the attached lamb, circulatory fructose increased, but not in the 
detached lamb. Blood collected from the umbilical veins and arteries of multiple lambs 
also indicated that fructose levels were greater in umbilical veins. Taken together, these 
data implicate the placenta as the site of fructose production, and glucose as the substrate 
from which fructose is produced in the sheep (Huggett et al., 1951).    
 It was next determined that fructose production remains constant regardless of 
fetal blood glucose levels, however, the rate of glucose transport across the placenta 
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increases with increasing maternal blood glucose levels (Alexander et al., 1955b). When 
radioactive glucose was administered intravenously to ewes, both radioactive glucose 
and fructose were detected in the fetus; and it was demonstrated that glucose can be 
transported from the ewe to the fetus and from the fetus to the ewe, whereas fructose 
could not be transported back to the maternal blood (Alexander et al., 1955a). 
 McGowan et al. found that oxidation of fructose only accounted for 16% of the 
total fetal CO2 production, which indicates that glucose, not fructose, is utilized as the 
major energy source in the sheep fetus (McGowan et al., 1995). 
 
Pigs 
 The literature contains fewer studies concerning fructose in the pregnant pig, but 
the first report of fructose in the blood of fetal pigs was made by Goodwin in 1956 when 
he collected blood from piglets just after birth (Goodwin, 1956). Also of note in that 
article was the report of appreciable fructose in fetal blood of oxen, goats, horses, and 
whales, which are all animals with epitheliochorial or synepitheliochorial placentae. In 
contrast, animals with endotheliochorial and hemochorial placentae such as dogs, cats, 
ferrets, guinea pigs, and rabbits had little to no detectable fructose in the fetal blood 
(Goodwin, 1956). 
 In fetal pigs, as seen in fetal lambs, blood fructose levels drop quickly after birth 
with fructose being non-detectable by 24 hours. Interestingly, although the neonatal pig 
excretes fructose through the urine, it is very sensitive to decreases in blood glucose 
levels and easily develops hypothermia within hours of birth in a starved state. 
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Therefore, any ability that the fetus may have had in utero to utilize fructose is rapidly 
lost after parturition (Goodwin, 1957; Curtis et al., 1966; Aherne et al., 1969).  
 Aherne et al. determined that fructose levels were substantially higher than 
glucose levels in the fetal blood, amniotic fluid, and allantoic fluid from Days 82 to 112 
of pregnancy. Concentrations of fructose in fetal blood decreased over this time period, 
while it peaked at both Days 82 and 110 in amniotic and allantoic fluids (Aherne et al., 
1969). There were detectable concentrations of fructose in the maternal blood, but they 
were less than 1% of the concentrations of fructose in fetal blood. Interestingly, the 
concentrations of fructose in the umbilical artery and vein were equal in this study, 
which would not be expected if the placenta was the site of fructose production. A more 
recent study by Pere also found that concentrations of fructose in the umbilical artery 
and vein are equal, and that fructose is undetectable in maternal blood (Aherne et al., 
1969; Pere, 1995). 
Fructokinase activity, the enzyme that phosphorylates fructose to produce 
fructose-1-phosphate, was also measured in the liver, intestine, and placenta by Aherne 
et al. and enzyme activity was greater in the liver and intestine than the placenta through 
all days studied (Aherne et al., 1969). 
To determine if glucose was a precursor for fructose in the fetal pig, White et al. 
injected radio-labeled glucose or fructose intraperitoneally into fetal pigs at 
approximately Day 60 of pregnancy. Results showed that glucose could be converted 
into fructose, but fructose was not converted into glucose. Also, the radio-labeled 
carbons from the glucose appeared in the maternal blood, but the radio-labeled carbons 
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from fructose did not. Therefore, glucose was able to cross the placenta from fetal to 
maternal blood, but fructose did not (White et al., 1979).  
White et al. then asked the question: what is the role of fructose in the fetal pig? 
Again in utero fetal pigs were injected intraperitoneally with radio-labeled fructose at 
about Day 60 of pregnancy. After 240 min, the fetal pigs were sacrificed and nucleic 
acids were extracted from skeletal muscle and liver. Both skeletal muscle and liver had 
radiolabeled carbons incorporated in the nucleic acids indicating that fructose was being 
used for synthesis of nucleic acids (White et al., 1982). 
Recent studies using isolated porcine trophectoderm cells have identified new 
roles for fructose in stimulating cell proliferation and mRNA translation via activation of 
the mechanistic target of rapamycin (MTOR) cell signaling pathway. Additionally, 
fructose is also metabolized via the hexosamine pathway, which is responsible for 
glycosaminoglycan synthesis, and specifically, hyaluronic acid, an abundant component 
of the placental stroma (Kim et al., 2012). 
In addition to being present in fetal fluids, fructose is also found in the uterine 
flushings of gilts approximately 48 hours after onset of estrus, and in quantities that were 
similar to the amount of glucose. Fructose was undetectable by 4 days post-estrus and 
remained undetectable for the remainder of the estrous cycle (Haynes and Lamming, 
1967; Zavy et al., 1982). In contrast, the uterine flushings from pregnant gilts contained 
detectable fructose as early as Day 14, and the total recoverable fructose increased 
through Day 18 of pregnancy (Zavy et al., 1982; Bazer et al., 1991).  
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Hexose Sugar Transport 
 There are five main roles for soluble sugars in most organisms, including: 1) a 
source of carbon skeletons for biosynthesis of many compounds; 2) transient energy 
storage; 3) a driver of osmotic processes; 4) signal transduction; and, 5) molecule 
transport. In these roles, sugars are essential for growth, development, and maintenance 
of cells, tissues, organs, and whole organisms. Sugars are either synthesized within 
special cells or collected from the environment, but with either route of sugar 
acquisition, there must be a mechanism for transporting the hydrophilic sugars through 
cell membranes. 
 The study of sugar transport began with Cori’s studies of intestinal sugar 
absorption, which provided the first evidence for catalyzed transport by showing that the 
rate of absorption differed depending on the sugar, the transport mechanism could be 
saturated, and there was competition between glucose and galactose for transporters 
(Cori, 1925, 1926). Sistrom showed that sugars can be transported against a 
concentration gradient. This led to the question of how, energetically, this could be 
achieved (Sistrom, 1958). The evidence for an active transport mechanism for sugars 
was presented by Crane who described the sodium/glucose cotransport hypothesis, in 
which the sodium gradient is actually the important driving factor and that the gradient is 
maintained by the sodium/potassium pump (Crane, 1962, 1965). In 1965, the first 
purification of a plasma membrane protein that facilitated nutrient transport was 
published by Fox and Kennedy and described the M (membrane) protein, a component 
of the β-galactoside transport system in Escherichia coli (Fox and Kennedy, 1965). The 
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first evidence of a proton co-transport mechanism in a eukaryotic cell, using the lactose 
transport system, was published in 1970 (Komor and Tanner, 1974). Taken together 
these findings are the basis for our understanding of sugar transport where either sugar 
or sodium concentration gradients drive the movement of sugar molecules from one 
compartment to another through proteins located in the plasma membranes.  
There are three mechanisms for transporting hexose sugars in mammals and all 
require plasma membrane transporter proteins. The first mechanism uses the 
concentration gradient of the sugar and this is facilitated by members of the GLUT 
family (gene name: solute carrier family 2A; SLC2A) of integral membrane proteins. The 
second mechanism involves sodium-glucose co-transporters that depend on the sodium-
potassium ATPase pump to maintain a sodium gradient to drive glucose transport and 
this is facilitated by members of the sodium-glucose transporter family (SGLT; gene 
name: SLC5A). The third, and relatively newly discovered, mechanism has not been 
fully defined but uses the SWEET (Sugars Will Eventually be Exported Transporters) 
transporter of which only one has been defined in mammals. 
 The GLUT transport family (gene name SLC2A) is a subfamily of the major 
facilitator superfamily (MFS) and consists of 14 members (GLUT1-12, H+/myo-inositol 
transporter [HMIT], GLUT14; SLC2A1-14) that have a homologous 12-transmembrane 
domain structure that creates a pore in the plasma membrane (Figure 2.7)(Bell et al., 
1993). While family members have common structural features, they vary greatly in 
kinetic characteristics, substrate specificity, tissue/cell localization, and regulation. The 
family is divided into three classes with Class I including the traditional glucose  
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Figure 2.7 GLUT transporter structure 
GLUT transporters are composed of 12 transmembrane spanning helices with both 
termini on the cytoplasmic side. Modifications at different locations give rise to different 
members of the family. Reprinted with permission from Bell et al., 1993. 
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transporters GLUT1-4, Class II includes the fructose transporters GLUT5, 7, 9, and 11, 
and Class III includes GLUT6, 8, 10, 12, 13, and 14 (Bell et al., 1993). Differences in 
affinities for molecules in part come from certain amino acid or motif changes. For 
example, affinity for fructose is seen within Class II of the family due to the lack of the 
QLS motif in the seventh transmembrane domain on the extracellular side. The 
nomenclature for the GLUT family was defined so that the numbering scheme used for 
GLUTs is identical to that used for SLC2A, as in GLUT1 is the protein and SLC2A1 is 
the corresponding gene. The only exception to this is the HMIT protein, which 
corresponds to the SLC2A13 gene (Joost et al., 2002). 
The sodium-glucose transporter family (SGLT; gene name SLC5A) is a 
subfamily of the sodium solute symporter family (SSF) that consists of 12 members that 
transport sugars, myo-inositol, iodide, short-chain fatty acids, and choline. All members 
code for 60-80 kDa proteins that contain 580-718 amino acids and have 14-15 
transmembrane helices (Wright et al., 2004). SGLT1, SGLT2, SGLT4, and SGLT5 have 
been determined to specifically transport glucose. All function as sodium symporters, 
but there are some differences in mechanism. For instance, SGLT1 couples transport of 
one glucose molecule to two sodium molecules, while SGLT2 couples one glucose with 
one sodium molecule. This explains differences in rate of transport between the two 
isoforms. There is only one post-translational modification found on these proteins, an 
N-linked glycosylation (Wright et al., 2011). SGLT1 and SGLT2, in particular, have 
been extensively described in the literature as being active in the apical membrane of 
absorptive epithelia in the intestine and kidney. For this transporter family the 
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protein/gene nomenclature is identical for SGLT1/SLC5A1 and SGLT2/SLC5A2, but not 
for SGLT4/SLC5A9 and SGLT5/SLC5A10 (Joost et al., 2002). 
 The SWEET transporters are smaller than the SLC2A and SLC5A transporters in 
that they only have seven trans-membrane spanning domains, but they are able to 
mediate both cellular uptake and efflux. SWEET transporters have an extracellular N-
terminus and a long cytosolic C-terminus, which has multiple phosphorylation sites. The 
sequence of the C-terminus is not well conserved among isoforms or species and has 
been hypothesized to function in transmission of signals or as a hub for binding of 
regulatory components (Chen et al., 2015). These transporters have a low affinity for 
multiple mono- and di-saccharides. The low affinity results in high capacity, so these 
transporters are most efficient when sugar concentrations are high.  SWEET transporters 
were originally discovered in plants, but have now been found in animals including one 
transporter in humans (Feng and Frommer, 2015).  
 
Glucose Transporter Characteristics 
 
SLC2A1/GLUT1 
GLUT1 is the most studied transporter of the GLUT family and was the first to 
be isolated and cloned (Mueckler and Thorens, 2013). GLUT1 is responsible for the 
basal level of glucose uptake into most cells and transports glucose with a Km=3 mM. 
Additionally, GLUT1 can transport galactose, mannose, and glucosamine.  
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SLC2A1 mRNA is ubiquitously expressed throughout the body in multiple 
species and is upregulated in many cancers (Nishimura and Naito, 2005). In the human 
placenta, SLC2A1 mRNA is more abundantly expressed than in any other tissues studied 
(Nishimura and Naito, 2005). GLUT1 has been reported in both the apical and basal 
membranes of the syncytiotrophoblast, the cytotrophoblast, and endothelial cells of the 
human placenta (Jansson et al., 1993; Korgun et al., 2005). Rat and mouse uteri also 
express GLUT1 protein in the LE, stroma, and decidua (Korgun et al., 2001; Frolova and 
Moley, 2011b). GLUT1 is detectable in the oocyte through the blastocyst stage in both 
the inner cell mass and trophectoderm in mice and cattle (Aghayan et al., 1992; Augustin 
et al., 2001). The SLC2A1 homozygous knock out is embryonic lethal in mice. 
GLUT1 expression in the syncytiotrophoblast of placentae of women is 
upregulated in women with diabetes (Gaither et al., 1999; Jansson et al., 1999). SLC2A1 
mRNA levels are positively correlated with increasing maternal age (Sciullo et al., 
1997).  GLUT1 protein is detected in lactating mammary epithelial cells in cattle with 
the highest levels observed early in lactation, and levels decreasing to barely detectable 
in non-lactating mammary epithelia (Zhao and Keating, 2007a). 
In the sheep, SLC2A1 mRNA is abundant in the endometrial LE and GE during 
early pregnancy with a peak in expression occurring during the period of maternal 
recognition of pregnancy. The protein follows the same profile and is observed in the 
uterine LE/GE as well as the trophectoderm and endoderm. SLC2A1 is upregulated by 
progesterone and that effect is enhanced by interferon tau at the mRNA and protein 
levels in uterine LE and superficial GE of sheep (Gao et al., 2009a).  
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SLC2A2/GLUT2 
 GLUT2 protein is mainly located in enterocytes, hepatocytes, pancreatic β-cells, 
and the epithelial cells of proximal tubules across multiple species and is responsible for 
the transport of glucose, fructose, galactose, mannose, and glucosamine across the 
basolateral and/or apical plasma membranes of cells. SLC2A2 mRNA is abundant in the 
human liver, kidney and small intestine, but not in placenta or uterus (von Wolff et al., 
2003; Nishimura and Naito, 2005). GLUT2 is located in trophectoderm in mouse 
blastocysts, but not in the uterus (Aghayan et al., 1992; Frolova and Moley, 2011a). 
Bovine embryos express SLC2A2 in the trophectoderm as it elongates (Augustin et al., 
2001).  
 
SLC2A3/GLUT3 and SLC2A14/GLUT14 
GLUT3 and GLUT14 are pseudogenes that share 95% homology. While there is 
a region of approximately 100 nucleotides in the gene transcript for SLC2A3, but not 
SLC2A14, most studies have not differentiated between the two genes. SLC2A3 mRNA 
is found in many organs in humans (Nishimura and Naito, 2005) and is particularly 
abundant in neurons and other tissues that require rapid transport of large amounts of 
glucose, as it is a high affinity, high capacity transporter for glucose with a Km=1.5 mM, 
although it can also transport galactose, mannose, and xylose (Gould et al., 1991; 
Mueckler and Thorens, 2013). SLC2A3 has been reported as non-detectable or lowly 
expressed in human placenta mainly due to samples being taken late in pregnancy, while 
recent reports indicate that GLUT3 is found at higher levels early in pregnancy in the 
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extravillous trophoblast cells while invasion is occurring and before a direct connection 
with the maternal blood has been established (Jansson et al., 1993; Hahn et al., 2001; 
Brown et al., 2011). GLUT3 expression is higher in placentae of human intrauterine 
growth restricted (IUGR) fetuses (Janzen et al., 2013). SLC2A3 expression begins at the 
morulae stage in bovine embryos and continues to be expressed in the trophectoderm 
(Augustin et al., 2001). Homozygous knockout of SLC2A3 in mice is embryonic lethal at 
the neurulation stage, but the heterozygous knockout survives and displays late gestation 
fetal growth restriction (Ganguly et al., 2007).  
In sheep, SLC2A3 mRNA is expressed in the conceptus trophectoderm and 
endoderm early in pregnancy, but has not been studied beyond Day 18 of pregnancy 
(Gao et al., 2009a).  
 
SLC2A4/GLUT4 
GLUT4 is required for systemic glucose homeostasis and is primarily located in 
skeletal muscle and adipose tissue, although some other tissues, including placenta and 
uterus express GLUT4 (Nishimura and Naito, 2005; Thorens and Mueckler, 2010). 
Insulin signaling, in response to high blood glucose, induces the translocation of GLUT4 
from an intracellular compartment to the plasma membrane where it can actively 
transport glucose (Km=2-10 mM) into cells from the blood (Bryant et al., 2002). 
Compared to other SLC2A family members, SLC2A4 mRNA is lowly expressed in the 
endometrial stroma of humans, rats, and mice (Korgun et al., 2001; Frolova and Moley, 
2011b). GLUT4 null mice survive past birth and display only perturbations in glucose 
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and lipid metabolism, indicating that GLUT4 is not required for embryonic development 
(Charron and Katz, 1998). 
In cattle, SLC2A4 mRNA is lowly expressed in the blastocyst, while in sheep, 
SLC2A4 mRNA is lowly detectable in most cell types of the endometrium with protein 
expression in the uterine LE, GE, and trophectoderm (Augustin et al., 2001; Gao et al., 
2009a). SLC2A4 is not regulated by progesterone, but interferon tau has a suppressive 
effect on mRNA in uteri of sheep during early pregnancy (Gao et al., 2009a). 
 
SLC2A5/GLUT5 
 GLUT5 is the only GLUT family member that will only transport fructose 
(Km=6mM), not glucose or galactose, and has been mainly studied for its role in 
transporting fructose across the apical membrane of enterocytes. SL2A5 mRNA is 
expressed at high levels in bone marrow, kidney, small intestine, and testes of the 
human, but not in endometrium (von Wolff et al., 2003; Nishimura and Naito, 2005). 
SLC2A5 is expressed in bovine embryos (Augustin 2001). Sperm have high SLC2A5 
expression in multiple species, including humans, mice, cattle, and pigs (Burant et al., 
1992; Angulo et al., 1998; Sancho et al., 2007). GLUT5 is upregulated in enterocytes in 
response to high fructose concentrations in the intestinal lumen. Some cancer cells 
overexpress GLUT5, specifically in tumors found in brain, breast, liver, uterus, and 
testes, and fructose uptake is increased in those tumors (Godoy et al., 2006).  
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SLC2A7/GLUT7 
 GLUT7 is highly homologous with GLUT5 in terms of amino acid sequence, 
although it is capable of transporting both glucose and fructose. SLC2A7 mRNA is only 
detected in the small intestine and testes in humans (Nishimura and Naito, 2005). 
GLUT7 protein has been detected in the apical membrane of enterocytes (Cheeseman, 
2008). 
 
SLC2A8/GLUT8 (GLUTX1) 
GLUT8 has a high affinity for glucose (Km=2 mM), but can also transport 
fructose and galactose. GLUT8 localizes to the plasma membrane in some cells, but 
GLUT8 also contains a specific di-leucine motif in the N-terminus that is conserved 
across species and believed to be responsible for the transporter localizing to late 
endosomes, lysosomes, and endoplasmic reticulum (Ibberson et al., 2000; Augustin et 
al., 2005; DeBosch et al., 2014a). GLUT8 is hypothesized to have a role in providing 
glucose for glycosylation of proteins in the endoplasmic reticulum. Multiple splice 
variants have been defined for SLC2A8 and not all of them have a role in sugar transport 
since some are truncated and do not have the traditional motifs necessary for transport 
(Romero et al., 2009). SLC2A8 mRNA is expressed in human tissues with particular 
abundance in the liver, spleen, lung, brown adipose tissue, placenta, and testes 
(Nishimura and Naito, 2005). SLC2A8 is upregulated in the brain in response to the  
ovarian hormones estrogen and progesterone (Harrell et al., 2014). SLC2A8 is 
ubiquitously expressed throughout the stages of oocyte and embryo development in 
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cattle (Augustin et al., 2001). GLUT8 protein expression is found in the mouse 
endometrium during the period of implantation of the blastocyst and decidualization of 
the uterine stroma and localizes to both the basolateral and apical surfaces of the uterine 
LE and GE (Kim and Moley, 2009). The mating of two heterozygous SLC2A8 mice 
results in lower numbers of SLC2A8 null pups than would be expected by Mendelian 
genetics, which indicates that while the knockout is not embryonic lethal, it does a play 
some role in embryonic development (Augustin, 2010). 
 
SLC2A9/GLUT9 
SLC2A9 was first identified through bioinformatics by searching the human 
genome for sequences similar to those that code for SLC2A1 and SLC2A5. The main 
difference between SLC2A9 and other members of the SLC2A family is a longer 
cytoplasmic amino terminus (Phay et al., 2000). GLUT9 is a high capacity uric acid 
transporter (Km=0.6 mM) that helps maintain uric acid homeostasis in multiple tissues 
(DeBosch et al., 2014b). SLC2A9 mRNA is most abundant in the kidney proximal tubule 
and liver hepatocytes, but has also been localized to the basolateral and apical surfaces 
of enterocytes where it is responsible for the clearance of uric acid from the blood 
(Augustin et al., 2004; DeBosch et al., 2014b).  
 
SLC2A11/GLUT11 
 GLUT11 exhibits a high degree of similarity to GLUT5, but can transport both 
glucose and fructose. SLC2A11 mRNA is abundantly expressed in the human kidney, 
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pancreas, and placenta (Nishimura and Naito, 2005; Scheepers et al., 2005). 
Interestingly, mice and rats do not have the SLC2A11 gene.  
 
SLC2A12/GLUT12 
GLUT12 transports glucose and fructose, but it has some unique characteristics. 
First, GLUT12 is insulin-sensitive in muscle and adipose tissue and may work in concert 
with GLUT4 for glucose uptake in those tissues. Second, GLUT12 sugar transport is 
influenced by protons and Na+ ions, and there is a “sodium leak” associated with these 
transporters even when sugar is not present, although exactly how these ions 
mechanistically work with GLUT12 is still unknown. Therefore, GLUT12 appears to 
have characteristics of both the GLUT and SGLT glucose transporter families (Pujol-
Gimenez et al., 2015). SLC2A12 mRNA is ubiquitously expressed in human tissues and 
GLUT12 protein has been localized to cardiac muscle, skeletal muscle, adipose tissue, 
and mammary glands (Nishimura and Naito, 2005). GLUT12 protein has also been 
localized to human trophoblast cells from first trimester placentae and villous stromal 
cells from term placentae (Gude et al., 2003; Gude et al., 2005). 
 
SLC2A13/HMIT 
 HMIT is an H+/myo-inositol co-transporter and does not transport glucose. 
SLC2A13 mRNA is abundantly expressed in human brain, but is also detectable in 
adipose tissue, placenta and uterus (Uldry and Thorens, 2004; Nishimura and Naito, 
2005).  
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SLC5A1/SGLT1 
 SGLT1 is a high affinity transporter that has an apparent coupling stoichiometry 
of two sodium ions to one sugar molecule with a Km=0.5 mM (Turner and Moran, 1982). 
This transporter was the first of the family to be cloned and was determined to have no 
homology with other sugar transporters in the GLUT family (Hediger et al., 1987). 
SGLT1 is abundant in the apical membrane of enterocytes, but is also found in the 
kidney, heart, brain, testes, and pancreas. There is low expression of SLC5A1 mRNA in 
human uterus and placenta (Nishimura and Naito, 2005). SLC5A1 is also expressed 
throughout the stages of embryo development, but is most abundant in the oocyte 
(Augustin et al., 2001). 
 In sheep, SLC5A1 mRNA and protein are expressed in the uterine LE and GE 
during early pregnancy and this expression is upregulated by progesterone (Gao et al., 
2009a). 
 SGLT1 protein is expressed in bovine mammary glands and is more abundant in 
lactating glands than non-lactating glands (Zhao and Keating, 2007a). Additionally, 
SGLT1 is expressed in human mammary epithelial cells during lactation (Obermeier et 
al., 2000). SGLT1 may be necessary for providing sugars to the cell for energy and 
molecule production or may be necessary for secretion of milk products. 
 SGLT1 null mice survive to weaning, but die within 2 days post-weaning on a 
normal diet with loss of glucose in the feces and urine. However, these mice survive if 
given a diet with no free monosaccharides or disaccharides. SGLT1 null mouse models 
have been used to demonstrate that SGLT1 is necessary for large uptake of glucose from 
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the intestinal lumen. In addition to overall uptake by enterocytes, SGLT1 in the apical 
membrane of the enteroendocrine L-cells and K-cells stimulates production and 
secretion of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic 
peptide (GIP), which in turn enter the systemic blood and act to increase the pancreatic 
production of insulin (Gorboulev et al., 2012). SGLT1 is also necessary for reabsorption 
of glucose in the kidney, specifically in the straight descending portion of the proximal 
tubule (Gorboulev et al., 2012).  
 Mutations in the human SLC5A1 gene can occur and result in the glucose-
galactose malabsorption syndrome where SGLT1 does not function properly to absorb 
glucose in the intestine or kidney, but fetuses develop normally and symptoms are not 
seen until after birth (Wright et al., 2011; Raja and Kinne, 2012). 
 SGLT1 can be transcriptionally and post-transcriptionally regulated by 
regulatory solute carrier protein (RSC1) to increase SGLT1 in response to a glucose-rich 
diet (Filatova et al., 2009). Protein kinases A and C can stimulate the trafficking of 
SGLT1 to the plasma membrane, and this can occur either through phosphorylation of 
the transporter, or independently of phosphorylation (Raja et al., 2012). 
 
SLC5A2/SGLT2 
 SGLT2 is a low affinity glucose transporter that has an apparent coupling 
stoichiometry of one sodium ion to one sugar molecule with a Km=6 mM (Turner and 
Moran, 1982). SGLT2 was originally isolated from the kidney and SLC5A2 mRNA is 
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abundant in that organ with low to non-detectable expression in other human organs 
(Nishimura and Naito, 2005). 
 
SLC5A9/SGLT4 
 SGLT4 is a sodium/glucose co-transporter that has been localized in intestine, 
kidney, liver, lung, uterus, and pancreas of multiple species (Wright et al., 2004). 
 
SLC5A10/SGLT5 
 SGLT5 is a sodium/glucose co-transporter that has been localized to the kidney 
cortex. SLC5A10 mRNA is abundant in the kidney, but is very low in other human 
tissues (Nishimura and Naito, 2005). 
 
Regulation of Transporters 
 Glucose transport can be regulated by a variety of factors including hormones, 
substrate concentration, and oxidative stress. Growth hormone stimulates the uptake of 
glucose by villous tissue of the placenta during late pregnancy in women, but has no 
effect in early pregnancy (Ericsson et al., 2005a). Corticotropin releasing hormone can 
increase GLUT1 expression and decrease GLUT3 expression. Since CRH is produced 
by the human placenta, this represents a paracrine/autocrine regulation of glucose 
transport (Goland et al., 1993; Gao et al., 2012).  
 The literature on the effects of insulin on glucose uptake in human pregnancy is 
variable. Insulin has very little effect on glucose transport by placental samples at term, 
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but glucose transport in villous fragments of placentae can be stimulated with insulin 
early in pregnancy (Challier et al., 1986; Ericsson et al., 2005b). GLUT4 and GLUT12, 
two insulin-sensitive GLUT isoforms, are found in placentae from humans early in 
pregnancy, but not late, and may be responsible for insulin sensitivity (Gude et al., 2003; 
Ericsson et al., 2005b).  
The steroid hormones progesterone and estrogen regulate glucose transporters in 
multiple species and tissues. Progesterone upregulates GLUT1 protein in the epithelial 
cells of the mouse uterus as well as mouse and human endometrial stromal cells (Frolova 
et al., 2009). Estradiol upregulates glucose utilization in the rat uterus (Smith and 
Gorski, 1968). Indeed, GLUT1 protein in the uterus is increased within 4-6 h after 
estrogen administration (Welch and Gorski, 1999). In the sheep, progesterone 
upregulates GLUT1 protein in uterine LE and superficial GE with the increase being 
augmented by the cytokine interferon tau (Gao et al., 2009a). Progesterone and 
interferon tau also increased the localization of GLUT4 protein to the uterine LE. 
SGLT1 protein was upregulated by progesterone in the uterine LE of sheep, but 
interferon tau had a suppressive effect (Gao et al., 2009a). 
 Maternal nutrition can regulate glucose transporter expression. In a mouse model 
of maternal obesity where dams were fed diets composed of high amounts of sugar, 
placental trophoblast cells from obese dams showed increased expression of GLUT1 and 
GLUT3 proteins compared to the controls (Rosario et al., 2015). In intrauterine growth 
restriction models, GLUT8 protein is decreased in whole sheep placentae (Limesand et 
al., 2004), as is GLUT3 protein in whole rat placentae (Lesage et al., 2002). GLUT3 is 
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also upregulated in human pregnancies with intrauterine growth restricted fetuses in 
trophoblast cells at term (Janzen et al., 2013). While the effects of maternal diet on 
placental glucose transporters are varied, mainly due to differences in maternal diet in 
the models or the uncontrolled diet in human studies, the consistency between studies is 
that glucose transporters can be affected by nutrient availability. 
 Under hypoxic conditions, SLC2A1 and SLC2A3 transcription is increased 
through the HIF-1 pathway and there is a decreased amount of transcript degradation in 
placental tissues from humans and mice (Iyer et al., 1998; Baumann et al., 2002).  
 
Sugar Transport in the Intestine 
 In the small intestine, polarized enterocytes absorb sugars from the intestinal 
lumen, and deliver them into the vasculature in order to provide these sugars to the rest 
of the body. When luminal glucose concentrations are high, and a large disparity 
between luminal and blood concentrations exists, such as after a meal, sodium transport 
through SGLT1 causes apical membrane depolarization, which stimulates Ca2+ entry and 
allows GLUT2 to be rapidly trafficked to the apical surface of enterocytes. GLUT2 
facilitates glucose transport at a rate 3-5 times greater than SGLT1 (Raja et al., 2012). 
GLUT2 is also located basolaterally in enterocytes to facilitate the transport of glucose 
and fructose through the basal membrane and into the circulation (Uldry and Thorens, 
2004). After a meal, insulin binding to its enterocyte receptor rapidly traffics GLUT2 out 
of the apical membrane (Hahn et al., 2001). SGLT1 is continuously localized to the 
apical surface to maximize sugar absorbance from the lumen as luminal concentrations 
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decrease. The sodium concentration gradient that drives glucose transport by SGLT1 is 
created and maintained by the Na-K-ATPase primary active transport system in the basal 
membrane (Schultz and Curran, 1970). Fructose is transported through the apical surface 
of enterocytes using mainly GLUT5 and GLUT2, although GLUT7 and GLUT9 may 
also play a role. Fructose is transported through the basolateral surface using GLUT2 
(Uldry and Thorens, 2004).  
 
Sugar Transport in the Kidney 
 In the kidney, sugar transport is necessary to retrieve sugars from the filtrate 
generated in the glomerulus so that they can be returned to the peritubular blood and not 
lost through the urine. The early and late proximal tubules have different glucose 
transport characteristics. The early proximal tubule has high-capacity, low affinity 
glucose transport mainly facilitated by SGLT2 in the apical membrane, while the late 
proximal tubule uses the higher affinity SGLT1 to move glucose against the 
concentration gradient that is increasing with movement down the tubule (Balen et al., 
2008; Sabolic et al., 2012). GLUT2 is located basolaterally in the renal epithelia to 
transport glucose out of the cells and into the blood.   
 
Water Transport by Sugar Transporters 
 In addition to transport of sugars, members of both the GLUT and SGLT families 
also transport water molecules. For each sugar molecule transported by SGLT1, there 
are 260 molecules of water transported (Loo et al., 1996). GLUT transporters are also 
 43 
 
capable of transporting water, but with only 35 molecules of water translocated per sugar 
molecule (Zeuthen et al., 2007). The total volume of water moved by GLUT transporters 
is probably greater than that by SGLT1 due to the great volume of sugar molecules being 
moved by the GLUTs. GLUT1 and GLUT3 are also capable of moving water (Tomioka, 
2012). Water transported by co-transporters such as SGLT1 and GLUT2 can be moved 
with or against an osmotic gradient (Zeuthen, 2010). These transporters may play a role 
in the dynamic fluid volume changes that are seen in pig conceptuses during pregnancy 
(Knight et al., 1977). 
 
Fructose Synthesis and Metabolism 
 
The Polyol Pathway 
 Fructose can be synthesized from glucose via the polyol pathway, which is also 
known as the sorbitol-aldose reductase pathway. This pathway has mostly been studied 
for its role in pathological complications associated with the metabolic disorder diabetes 
mellitus, although it is active in the normal liver, kidney, and male reproductive tract 
(Kobayashi et al., 2002; Pruneda et al., 2006; Alexiou et al., 2009; Pastel et al., 2012). 
 The polyol pathway is a minor metabolic pathway for glucose that is activated 
when intracellular concentrations of glucose are high. In the first, and rate limiting step, 
aldose reductase uses NADPH as a co-factor to reduce glucose to its alcohol, sorbitol. 
Sorbitol is then metabolized to fructose by the enzyme sorbitol dehydrogenase using the 
co-factor NAD+. Sorbitol is a polyhydroxylated, strongly hydrophilic alcohol that does 
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not readily diffuse through membranes and can act as an osmotic regulator. A transport 
system for sorbitol has not been elucidated in animals, although in plants there are 
specific plasma membrane transporters for sorbitol movement. Therefore, it is 
hypothesized that, in animals, sorbitol is either converted to another metabolite in the 
cell in which it is synthesized or it accumulates in cells. Sorbitol accumulation is often 
toxic to cells. Sorbitol has been hypothesized to be synthesized in the placentae of sheep, 
cattle, and humans due to greater concentrations in the uterine vein than in the uterine 
artery (Teng et al., 2002; Brusati et al., 2005).  
 In the liver, aldose reductase and sorbitol dehydrogenase in hepatocytes catalyze 
the conversion of glucose, from blood, into fructose that is used to produce fatty acids 
(Lanaspa et al., 2013). In the kidney, these enzymes localize to epithelia of the renal 
tubules (Corder et al., 1977; Zopf et al., 2009). Aldose reductase has been localized to 
the uterine LE from Days 12 to 15 of pregnancy in pigs (Seo et al., 2014). Sorbitol 
dehydrogenase, also known as ketose reductase, has been localized to the trophectoderm 
of bovine placenta (Rama et al., 1973). Overall, the polyol pathway is not a major 
metabolic pathway nor has it been well studied, but the pig epitheliochorial placenta is a 
potential site for the polyol pathway to have a major metabolic role.   
 
Metabolism 
 Fructose metabolism begins with phosphorylation, which can occur at multiple 
carbons on the fructose molecule. Phosphorylation of fructose results in it being 
sequestered in the cell and requires ATP to donate the phosphate group. Hexokinase 
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adds a phosphate group to the 6-carbon to produce fructose-6-phosphate (F-6-P). 
Ketohexokinase (KHK; also known as fructokinase) adds a phosphate group to the 1-
carbon to produce fructose-1-phosphate (F-1-P) and cannot act on glucose. Fructose-3-
phosphate can also be produced (Feinman and Fine, 2013). 
 Aldolase B and triosekinase catalyze the cleavage of F-1-P into 
dihydroxyacetone phosphate and glyceraldehyde-3-phosphate. These two substrates can 
either enter into the glycolytic pathway for use in the TCA cycle, the gluconeogenic 
pathway, or triglyceride synthesis. Dihydroxyacetone phosphate and glyceraldehyde-3-
phosphate enter into the glycolytic pathway below the step where phosphofructokinase 
converts fructose-6-phosphate into fructose-1,6,-bisphosphate, which is the main 
regulation point in glycolysis. Therefore, fructose is not regulated as tightly as glucose, 
which results in greater lipogenesis when fructose levels are high. The metabolic 
pathway used depends on the cell type (Feinman and Fine, 2013). In the liver, fructose is 
used for glycogen and triglyceride synthesis, while in sperm, fructose is utilized as the 
main energy source (Aalbers et al., 1961). 
 F-1-P can also regulate glucose metabolism by binding glucokinase regulatory 
protein (GKRP) and allowing glucokinase to be released, then translocate to the 
cytoplasm from the nucleus (Brown et al., 1997). This release of inhibition on  
glucokinase increases the amount of glucose that can enter the cell and be sequestered. 
 
Ketohexokinase (KHK) 
KHK has two isoforms, A and C (Hayward and Bonthron, 1998). KHK-C is 
 46 
 
expressed in small intestine, liver, and kidney and has a Km=0.8. KHK-A is more 
ubiquitously expressed throughout tissues and has a Km=8.0. High amounts of KHK 
activity result in ATP depletion because one molecule of ATP is necessary to 
phosphorylate each fructose molecule. This results in increased levels of uric acid, which 
can induce oxidative stress in vascular smooth muscle and endothelial cells (Corry et al., 
2008; Lanaspa et al., 2012). Additionally, cytokines, chemokines, and transcription 
factors such as IL-1β, IL-6, MCP-1, and NFκB can be activated in a KHK-dependent 
manner in renal proximal tubule cells (Cirillo et al., 2009; Lanaspa et al., 2014).  
 KHK has greater expression in liver hepatocytes than in any other tissue 
(Adelman et al., 1967). This is hypothesized to be because the liver is removing fructose 
from the portal blood, especially after a meal. KHK has been detected in uteri of mice 
and placentae of humans, but the cellular localization is unknown (Funari et al., 2005; 
Diggle et al., 2009). 
 
Summary 
The pig has a diffuse, fructogenic, epitheliochorial type placenta that develops to 
support the growth of each individual fetus after the conceptus has undergone elongation 
and implantation. Elongation requires vast morphological remodeling of the blastocyst, 
which temporally overlaps with attachment of the trophectoderm to the uterine LE in a 
truncated implantation process where the trophectoderm never invades the uterine LE. 
During these events, the conceptus trophectoderm also secretes estrogen, the maternal 
recognition of pregnancy signal, to maintain the CL, progesterone production, and, 
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therefore, pregnancy. The placenta utilizes both histotrophic and hemotrophic support, 
which contain sugars, amino acids, proteins, and electrolytes, to provide for the 
developing fetus until the end of gestation. 
Sugars are essential for growth, development, and maintenance of cells and 
tissues, including those that compose the endometrium and conceptus.  Sugars are 
mainly transported either in a sodium-dependent manner by the SGLT family or by 
facilitated diffusion by the GLUT family of transporter proteins. Different members of 
these two families localize to different cell types throughout the body and are regulated 
by a variety of factors. GLUT1, GLUT3, and SGLT1 have been the most studied in the 
reproductive tract during pregnancy and can be regulated by the steroid hormones 
estrogen and progesterone. 
Concentrations of fructose are substantially higher than those for glucose in fetal 
blood, amniotic fluid, allantoic fluid, and uterine flushings during pregnancy in the pig, 
although the roles of fructose have not been fully elucidated. The polyol pathway is a 
minor metabolic pathway for glucose that converts glucose into fructose. Our hypothesis 
is that glucose is transported to the placenta from maternal blood and that a fraction of 
the glucose is converted to fructose via the polyol pathway. Fructose can then be 
transported and utilized by the conceptus via pathways such as the hexosamine pathway 
or for production of fatty acids and lipids. The studies described in this dissertation were 
aimed at defining the transport mechanisms for glucose and fructose as well as 
identification of tissues which synthesize and utilize fructose at the uterine-placental 
interface during pregnancy in pigs.  
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CHAPTER III 
APPROPRIATE REFERENCE GENE SELECTION FOR QPCR DEMONSTRATES 
THAT PORCINE PLACENTA EXPRESSES SLC7A3 AND INDUCES 
ENDOMETRIAL SLC5A1 EXPRESSION 
 
Introduction 
Dynamic changes occur in the porcine endometrium and the developing placenta 
that allow for the exchange of gases, micronutrients (including glucose and amino 
acids), and macromolecules (proteins) necessary for the growth and development of the 
conceptus (embryo/fetus and associated extraembryonic membranes). Our long-term 
goal is to understand interactions between the uterus and placenta that provide the 
necessary support for embryonic/fetal development; however, these vast structural, 
metabolic, and angiogenic changes can alter the expression of genes that are often 
considered stable reference genes for qPCR in less dynamic tissues. The aims of this 
study were to identify genes that are stable across the estrous cycle and pregnancy to be 
used as reference genes for qPCR, and then use them to examine mRNA expression of 
select glucose and amino acid transporters in the porcine endometrium and placenta. A 
comparison was made between the mRNA profiles from qPCR and in situ hybridization 
to verify that the reference genes were appropriate for future use in porcine endometrial 
and placental tissues. 
 After entering the uterus on Days 4 to 5 post-fertilization, pig blastocysts remain 
free-floating within the uterine lumen for an extended period of time that allows them to 
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elongate prior to attaching to the uterine wall and implanting between Days 13 and 25 of 
pregnancy (Bazer and Johnson, 2014). The conceptus undergoes major structural 
remodeling during this period as it elongates from a 10 mm spherical blastocyst to a 
1000 mm long filamentous blastocyst in order to maximize the surface area for 
attachment to the uterine endometrium for exchange of molecules (Geisert et al., 1982a; 
Bazer and Johnson, 2014). Additionally, the conceptus secretes multiple factors at this 
time, including interferons, growth factors, and estrogens, the maternal recognition of 
pregnancy signal in the pig (Bazer and Thatcher, 1977; Mirando et al., 1990; Johnson et 
al., 2009). Many of the changes incurred in the endometrium early in pregnancy can be 
attributed to estrogens and cytokines secreted by the conceptus, which regulate 
transcription of multiple genes, including those for glucose transporters, osteopontin, 
growth factors, and interferon-stimulated genes in the endometrium (White et al., 2005; 
Joyce et al., 2007; Ka et al., 2007; Bazer and Johnson, 2014). Progesterone, the hormone 
of pregnancy, is also present in high concentrations in blood and can affect gene 
expression in both the placenta and endometrium (Bailey et al., 2010b; Mathew et al., 
2011). 
This rapid growth and remodeling of the conceptus requires a substantial amount 
of nutrient support from the endometrium (Geisert et al., 1982b). In order to support the 
conceptus as it attaches to the uterine luminal epithelium (LE) for implantation, the 
endometrium undergoes substantial cellular restructuring to increase angiogenesis and 
nutrient transport. Pigs develop a true epitheliochorial placenta where the apical surface 
of the uterine LE attaches to the apical surface of the conceptus trophectoderm and this 
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interface is maintained throughout pregnancy (Dantzer, 1985). There is never invasion of 
the maternal endometrium by the conceptus and multiple cell layers separate the 
maternal and placental circulations (Wislocki and Dempsey, 1946; Friess et al., 1980).  
The placenta exponentially increases in weight from Day 20 to approximately 
Day 70 of pregnancy and angiogenesis continues to increase capillary bed volume until 
the end of gestation at 114 days (Michael et al., 1983; Freking et al., 2007). The placenta 
is responsible for nutrient, ion, gas, and waste transport between the mother and fetus, 
and is dynamic in terms of metabolism and structure. The interface between the maternal 
LE and the conceptus chorion (outer placental epithelium) begins folding around Day 25 
and continues to remodel throughout pregnancy in order to increase surface area 
available for transport of nutrients and gases (Dantzer and Leiser, 1994; Vallet et al., 
2009). Also, between Days 25 and 30, the endometrial glandular epithelia (GE) become 
more active in the synthesis and secretion of histotroph (composed of proteins, 
carbohydrates, sugars, lipids, and ions that nourish and sustain the conceptus) that is 
transported to placental areolae that form over the uterine gland openings for absorption 
of histotroph into the placenta (Friess et al., 1981; Bailey et al., 2010c).  
Significant amounts of glucose are transported across the pig placental 
membranes either by facilitated diffusion solute carrier family 2A (SLC2A) transporters, 
which move glucose down its concentration gradient, or by sodium-dependent solute 
carrier family 5A (SLC5A) transporters, which move glucose using the sodium gradient 
maintained by the sodium-potassium ATPase pump. The two most studied sodium-
glucose co-transporters are SLC5A1 and SLC5A2. SLC5A1 mRNA is expressed on the 
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luminal surface of large intestine, small intestine, and stomach of mice (Yoshikawa et 
al., 2011) and by the uterine LE and GE of the ovine endometrium (Gao et al., 2009a). 
Amino acids, particularly arginine, profoundly impact conceptus development in 
pigs (Wu et al., 2013). Similar to glucose, amino acids are also delivered across cellular 
membranes, but use a subfamily of the solute carrier 7 (SLC7) cationic amino acid 
transporter proteins. The four known transporter proteins for cationic amino acids 
include SLC7A1, SLC7A2A, SLC7A2B, and SLC7A3. Cationic amino acids are 
transported into cells for protein synthesis, and arginine is also converted into nitric 
oxide by nitric oxide synthase 2, and polyamines by arginase and ornithine 
decarboxylase (Fotiadis et al., 2013). 
Quantitative PCR is an efficient, sensitive, and reliable method for estimating 
expression of gene transcripts. However, qPCR depends on finding stable endogenous 
genes to use as a reference in order to minimize problems arising from RNA extraction 
or cDNA synthesis efficiency (Lanoix et al., 2012; Kozera and Rapacz, 2013). Reference 
genes that have been used widely include glyceraldehydes-3-phosphate dehydrogenase 
(GAPDH), β-actin (ACTB), and 18S rRNA, but these genes are involved in many major 
cellular processes and are not stable in all tissues (Kuijk et al., 2007; Mamo et al., 2007). 
Beta-2-microglobulin (B2M), a commonly used reference gene, has been shown to 
increase in the pig endometrium in response to interferons secreted by conceptuses 
(Joyce et al., 2008). Jalali et al. determined that ACTB and TUBA1B proteins increase 
from Days 9 to 12 of pregnancy, which may indicate changes in expression of mRNAs 
for those genes (Jalali et al., 2015). Use of either an inappropriate or an individual 
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reference gene can lead to inaccurate interpretation of target gene expression 
(Vandesompele et al., 2002a). A few studies have determined stable reference genes for 
short periods of time or individual days during the estrous cycle and pregnancy in the pig 
(Kuijk et al., 2007; Wang et al., 2011), but not throughout pregnancy. Studying gene 
expression throughout the estrous cycle and pregnancy is important for understanding 
both normal and pathological pregnancies, which in the pig, a livestock species, can lead 
to increased production and profit.    
 In this study, we identified a trio of genes with stable expression across the 
estrous cycle (Days 5 to 15) and pregnancy (Days 9 to 85) for which their geometric 
mean serves as an acceptable endogenous reference for analysis of qPCR gene 
expression profiles from pig endometrial tissues.  Further, we identified the geometric 
mean of a second trio of genes that can serve as an acceptable endogenous reference for 
qPCR in placental tissues. Lastly, we compared the mRNA localization by in situ 
hybridization to the results of mRNA quantification from qPCR across the estrous cycle 
and pregnancy for a glucose transporter, SLC5A1, and an amino acid transporter, 
SLC7A3, to determine if the chosen qPCR reference genes were appropriate. 
 
Materials and Methods 
 
Animals and Tissue Collection 
Sexually mature, 8-month-old crossbred gilts were observed daily for estrus (Day 
0) and exhibited at least two estrous cycles of normal duration (18 to 21 days) before 
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being used in these studies. All experimental and surgical procedures were in 
compliance with the Guide for Care and Use of Agricultural Animals in Teaching and 
Research and approved by the Institutional Animal Care and Use Committee of Texas 
A&M University.  
To evaluate gene expression in normal endometrial and placental tissues, gilts 
were detected in estrus, and then assigned randomly to either cyclic or pregnant status. 
Gilts in the pregnant group were bred naturally to boars with proven fertility. Then, gilts 
were ovariohysterectomized on either Day 5, 9, 11, 12, 13, 15 or 17 of the estrous cycle 
or Day 9, 11, 12, 13, 14, 15, 17, 20, 25, 30, 40, 60, or 85 of pregnancy (n = 3 or 4 
gilts/day/status). Conceptuses and several cross-sections of uterus and placenta from the 
middle of each uterine horn (~1 cm) were fixed in fresh 4% paraformaldehyde in PBS 
(pH 7.2) and embedded in Paraplast-Plus (Oxford Laboratory, St. Louis, MO). 
Additionally, endometrium was physically dissected from the myometrium, snap-frozen 
in liquid nitrogen, and stored at -80°C for RNA extraction. Chorioallantoic tissue was 
physically dissected from uterine tissues and frozen in a similar manner. For Day 60 
placenta, areolae were carefully dissected from inter-areolar chorioallantois and both 
tissue compartments were immediately subjected to procedures to assess arginine 
transport. 
To evaluate effects of estrogen (E2) and E2-induced pseudopregnancy on uterine 
SLC5A1 gene expression, gilts were detected in estrus (Day 0) and assigned randomly to 
receive daily intramuscular injections of 5 mg 17β-estradiol benzoate in 5ml corn oil 
(Sigma-Aldrich, St. Louis, MO; n = 4) or 5ml corn oil alone (CO; n = 4) on Days 11, 12, 
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13, and 14 of the estrous cycle (Joyce et al., 2007).  All gilts were ovariohysterectomized 
on Day 15 of pseudopregnancy. Tissues were collected as described above. 
To evaluate effects of long-term progesterone (P4) treatment without the 
influence of other ovarian hormones on uterine SLC5A1 gene expression, gilts were 
ovariectomized on Day 12 of the estrous cycle and assigned randomly to receive daily 4 
ml intramuscular injections of either P4 (200 mg in corn-oil; CO) or CO alone on Days 
12 through 39 post-estrus (n=3/treatment) (Bailey et al., 2010c).  All gilts were 
hysterectomized on Day 40 post-estrus and tissues collected as above. 
 
RNA Extraction and cDNA Synthesis 
Total RNA from endometrial and placental tissues was isolated using Trizol 
reagent (Life Technologies, Carlsbad, CA, USA) according to manufacturer’s 
instructions (Appendix B). RNA yield and purity were determined using a Nanodrop 
spectrophotometer (Thermo Scientific, Waltham, MA, USA). First strand cDNA was 
synthesized from 5µg of total RNA using Superscript III First Strand Kit (Life 
Technologies) following the manufacturer’s instructions (Appendix B). The cDNA was 
subjected to a 1:5 dilution with nuclease-free water and stored at -20°C.  
 
Gene Selection and Primer Design 
Ten candidate reference genes were selected (ACTB, B2M, GAPDH, HPRT1, 
PPIA, RPL7, SDHA, TBP, TUBA1B, YWHAZ) based on common usage in endometrial, 
placental, and other pig tissues (Table 3.1). Primers for reference genes not present in the  
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Gene 
Name 
Genbank 
Reference 
Sequence 
Sequence Product 
Length 
Reference 
ACTB XM_003124280 5’-TCCCTGGAGAAGAGCTACGA-3’ 
5’-TGT TGG CGT AGA GGT CCT TC-3’ 
187 Designed 
B2M NM_213978 5’-TTCACACCGCTCCAGTAG-3’ 
5’-CCAGATACATAGCAGTTCAGG-3’ 
166 (Kuijk et 
al., 2007) 
GAPDH NM_001206359 5’-GGTGAAGGTCGGAGTGAACG-3’ 
5’-TGACTGTGCCGTGGAATTTG-3’ 
173 Designed 
HPRT1 NM_001032376 5’-GGACTTGAATCATGTTTGTG-3’ 
5’-CAGATGTTTCCAAACTCAAC-3’ 
91 (Kuijk et 
al., 2007) 
PPIA NM_214353 5’-CCAACACAAACGGTTCCCAG-3’ 
5’-GCCATCCAACCACTCAGTCT-3’ 
59 Designed 
RPL7 NM_001113217 5’-AAGCCAAGCACTATCACAAGGAATACA-3’ 
5’-TGCAACACCTTTCTGACCTTTGG-3’ 
171 (Seo et al., 
2012) 
SDHA XM_003362140 5’-CTACAAGGGGCAGGTTCTGA-3’ 
5’-AAGACAACGAGGTCCAGGAG-3’ 
141 (Nygard et 
al., 2007) 
SLC5A1 
(qPCR) 
NM_001164021.1 5’-GGCTGGACGGAAGTATGGTGT-3’ 
5’-ACAACCACCCAAATCAGAGC-3’ 
158 Designed 
SLC5A1 
(ISH) 
NM_001164021.1 5’-TCTCATGAGCTCCCTGACCT-3’ 
5’-GAGACGACCAGGACGATGAT-3’ 
468 Designed 
SLC7A3 
(qPCR) 
NM_001130973.1 5’-CACTCAACTCCATCCCCACT-3’ 
5’-CTGTGGCTGTCTCCAGATGA-3’ 
206 Designed 
SLC7A3 
(ISH) 
NM_001130973.1 5’-CTGGAGGATTTGTGCCATTT-3’ 
5’-AAAGAGGAATGCCATGAACG-3’ 
479 Designed 
SLC16A6 XM_005674551.1 5’ –AGGAGTTTGGGTATGGCAGAAA-3’ 
5’ –ACTTACTCCCTGGGTTGACATC-3’ 
143 Designed 
TBP XM_003361418 5’-AACAGTTCAGTAGTTATGAGCCAGA-3’ 
5’-AGATGTTCTCAAACGCTTCG-3’ 
153 (Nygard et 
al., 2007) 
TUBA1B NM_001044544 5’-GCTGCCAATAACTATGCCCG-3’ 
5’-ACCAAGAAGCCCTGAAGACC-3’ 
116 Designed 
YWHAZ XM_001927228 5’-TGATGATAAGAAAGGGATTGTGG-3’ 
5’-GTTCAGCAATGGCTTCATCA-3’ 
203 (Nygard et 
al., 2007) 
 
Table 3.1 Primer information for qPCR and in situ hybridization analyses 
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literature and for SLC16A6, SLC5A1, and SLC7A3 were designed using Genbank 
sequences inserted into Primer3Plus software (Untergasser et al., 2007). Primers were 
submitted to NCBI BLAST to test for specificity against the known pig genome. All 
primer sequences and product lengths are presented in Table 3.1. 
 
Quantitative PCR 
All qPCR reactions were performed in triplicate, in 10 µl reactions using 
PerfeCta SYBR Green Mastermix (Quanta Biosciences, Gaithersburg, MD, USA) and 
2.5 mM of each specific primer, on a Roche 480 Lightcycler (Roche) with 
approximately 75 ng of cDNA per reaction (Appendix B). The PCR program began with 
5 min at 95°C followed by 40 cycles of 95°C denaturation for 10 sec and 60°C 
annealing/extension for 30 sec. A dissociation curve was produced with every run after 
the 40th cycle to verify a single gene-specific peak. Additionally, qPCR products were 
run in a 2.5% agarose electrophoresis gel to confirm primer specificity. Standard curves 
with 4-fold serial dilutions of pooled cDNA samples were run to determine primer 
efficiencies. All primer slopes were -3.30 to -3.48 with efficiencies of 97-100%. 
 
Gene Stability 
Analysis of the stability of candidate reference genes was performed using 
NormFinder and GeNorm algorithms.  
 
 
 57 
 
In situ Hybridization Analysis 
Cell-specific expression of mRNAs in sections (5 µm) of porcine endometria and 
placentae were determined using radioactive in situ hybridization analysis as described 
previously (Johnson et al., 1999)(Appendix B). Briefly, partial cDNAs for porcine 
SLC5A1 and SLC7A3 mRNAs were cloned beginning with PCR amplification using total 
RNA from Day 15 pregnant porcine endometrial tissues by specific primers (Table 3.1). 
PCR amplification was conducted as follows: 1) 95°C for 5 min; 2) 95°C for 45 sec, 
60°C for 30 sec, and 72°C for 1 min for 35 cycles; and 3) 72°C for 10 min. The partial 
cDNAs of the correct predicted size were cloned into a pCRII plasmid using a T/A 
Cloning Kit (Life Technologies) and the sequence of each verified using an ABI PRISM 
Dye Terminator Cycle Sequencing Kit and ABI PRISM automated DNA sequencer 
(Perkin-Elmer Applied Biosystems). 
Radiolabeled antisense or sense cRNA probes were generated by in vitro 
transcription using linearized plasmid templates, RNA polymerases, and [α-35S]-UTP.  
Deparaffinized, rehydrated, and deproteinated uterine tissue sections (5µm thick) were 
hybridized with radiolabeled antisense or sense cRNA probes.  After hybridization, 
washing, and ribonuclease A digestion, slides were dipped in NTB-2 liquid photographic 
emulsion (Kodak, Rochester, NY), and exposed at 4C for seven to ten days.  Slides 
were developed in Kodak D-19 developer, counterstained with Gill’s hematoxylin 
(Fisher Scientific, Fairlawn, NJ), and then dehydrated through a graded series of alcohol 
to xylene.  Coverslips were affixed with Permount (Fisher Scientific, Fairlawn, NJ).  
Digital images of representative fields recorded under brightfield or darkfield 
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illumination were evaluated using an Axioplan 2 microscope (Carl Zeiss, Thornwood, 
NY) interfaced with an Axioplan HR digital camera and Axiovision 4.3 software.  
Photographic plates were assembled using Adobe Photoshop (version 6.0, Adobe 
Systems Inc., San Jose, CA). 
 
Arginine Transport in Placenta 
 Arginine transport in pig placenta was determined using L-[U-14C]-arginine 
(American Radiolabeled Chemicals, St. Louis, MO) as described previously for 
branched-chain amino acids (Self et al., 2004). Placental samples (~200 mg of areolar or 
inter-areolar chorioallantois; n=4 placentae) were washed three times in oxygenated 
(95% O2/5% CO2, v/v) Krebs-Henseleit bicarbonate (KHB) buffer containing 20 mM 
HEPES (pH 7.4) and 5 mM glucose. Samples were then incubated at 37°C for 5 min in 1 
ml of oxygenated KHB buffer plus 20 mM HEPES, 2 mM glutamate, 5 mM glucose, 0.5 
mM arginine, 0.05 µCi L-[U-14C]-arginine, and 0.05 µCi [3H] inulin. After a 5 min 
incubation, the tissues were rinsed thoroughly with fresh KHB buffer and solubilized in 
0.5 ml Soluene 350. The 14C and 3H radioactivities were measured using a dual-channel 
counting program in a Packard 1900 liquid scintillation counter (Meriden, CT). The 
specific activity of L-[U-14C]-arginine was used to calculate arginine uptake by the 
placentae.  
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Statistical Analyses 
For all qPCR data, fold changes were determined using the 2-ΔΔCt Method with 
raw Ct values normalized to either B2M or the geometric mean of TBP, SDHA, and 
ACTB for endometrial tissue and the geometric mean of TBP, HPRT1, and TUBA1B for 
placental tissue (Livak and Schmittgen, 2001). The qPCR data for normal tissues were 
analyzed for effect of day, pregnancy status, and their interaction for Days 9, 11, 13, 15 
and 17 by 2-way ANOVA via the General Linear Models (GLM) procedures of the 
Statistical Analysis System (SAS Institute, Cary, NC) with the least significant 
difference (LSD) multiple testing method. The qPCR data were also subjected to a 
sliding time window linear regression analysis to determine if there was an effect of day 
of gestation on the gene expression for the genes of interest throughout pregnancy (Days 
9 to 85). The sliding time windows of the analysis were designed to detect effect of day 
on gene expression during three biologically relevant periods of time: the beginning, the 
middle, and the end of the study period. Each window analyzed contained a minimum of 
three days. Some windows contained greater than three days as long as the regression 
model showed a non-decreased performance in terms of the r2 and the p-value of the F-
statistics.  
The data from the hormone therapy studies were analyzed by Students t-test. The 
arginine transport data were subjected to a least-squares regression analysis (ANOVA) 
using the GLM procedures of the Statistical Analysis System. All data are presented as 
mean±standard error with significance at p<0.05. 
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Results 
 
Primer Specificity and Efficiency 
Ten genes were chosen as candidate reference genes based on their previous 
published use in pig tissues and their involvement in diverse cellular processes. The first 
step to determining stable reference genes was to ensure that the selected genes were 
expressed in the pig endometrium and placenta and that the primers were both specific 
and efficient for the pig genes. The ten selected genes (beta-actin, ACTB; beta-2-
microglobulin, B2M; glyceraldehydes-3-phosphate dehydrogenase, GAPDH; 
hypoxanthine phosphoribosyl transferase 1, HPRT1; peptidylprolyl isomerase A, PPIA; 
ribosomal protein L7, RPL7; succinate dehydrogenase complex protein A, SDHA; 
TATA-box binding protein, TBP; alpha tubulin 1B, TUBA1B; tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein zeta, YWHAZ) were 
expressed in endometrial and placental tissues with the expected amplicon size as seen 
with agarose gel electrophoresis (Figure 3.1). The presence of only one band in the 
agarose gel and a single peak in the dissociation curves confirmed amplification 
specificity of the primers. Standard curves were generated to determine amplification 
efficiencies, which ranged from 97-100%.  
 
Gene Stability Analyses 
Raw Cq values from endometrial tissues of pregnant and cyclic gilts were used to 
determine optimal stability with both NormFinder and GeNorm algorithms (Table 3.2). 
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Figure 3.1 PCR of candidate reference genes 
Agarose gels (2.5%) showing PCR products for candidate reference genes from 
endometrial or placental tissues. Amplicons were of expected sizes (ACTB 187bp, B2M 
166bp, GAPDH 173bp, HPRT1 91bp, PPIA 59bp, RPL7 171bp, SDHA 141bp, TBP 
153bp, TUBA1B 116bp, YWHAZ 203bp). Legend: Endometrium (E); Placenta (P). 
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Raw Cq values for placental tissues were analyzed separately (Table 3.3). For this 
particular set of data, NormFinder is the more appropriate algorithm because it takes into 
consideration both intra- and inter-day sources of variation. TBP was the most stable 
gene for both analyses, and both tissues, with YWHAZ being the least stable gene overall 
(Table 3.2, endometrium; Table 3.3, placenta). The genes ranked differently in degree of 
stability between endometrial and placental tissues. They also ranked differently 
between the two algorithms. For endometrial tissue, SDHA and TUBA1B ranked in the 
top half of genes, while GAPDH and B2M ranked in the bottom half (Table 3.2). For 
placental tissue, HPRT1 and RPL7 ranked in the top half, while GAPDH and B2M 
ranked in the bottom half for stability (Table 3.3). 
The acceptable standard for calculation of normalization factors includes a 
geometric mean of the top three most stable genes (Vandesompele et al., 2002b; Gu et 
al., 2011). Therefore, the candidate genes were ranked by combining the ranks from the 
two algorithms for each tissue type. For endometrial tissue, the geometric mean of TBP, 
SDHA, and ACTB is recommended, while the geometric mean of TBP, HPRT1, and 
TUBA1B are recommended for placenta (Table 3.4). 
 
Influence of Reference Gene Choice on Target Gene Expression 
As mentioned previously, the choice of reference gene can influence the 
conclusions that are made about the target gene. In order to demonstrate the benefit of 
normalizing with the most stable reference genes when analyzing gene expression in a 
specific tissue, the mRNA expression profile for the monocarboxylate transporter 
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Gene NormFinder 
Stability (±SE) 
GeNorm 
Stability 
ACTB 0.478±0.079 0.086 
B2M 0.627±0.093 0.108 
GAPDH 0.886±0.123 0.089 
HPRT1 0.616±0.092 0.080 
PPIA 1.027±0.139 0.084 
RPL7 0.584±0.089 0.079 
SDHA 0.556±0.086 0.074 
TBP 0.454±0.077 0.069 
TUBA1B 0.568±0.087 0.079 
YWHAZ 1.120±0.150 0.099 
 
Table 3.2 Stability values for candidate reference genes in endometrial tissue 
 
 
Gene 
 
NormFinder 
Stability (±SE) 
GeNorm 
Stability  
ACTB 0.380±0.071  0.058 
B2M 0.686±0.110 0.063 
GAPDH 0.552±0.092 0.053 
HPRT1 0.333±0.066 0.046 
PPIA 0.543±0.091 0.048 
RPL7 0.380±0.071 0.047 
SDHA 0.417±0.075 0.047 
TBP 0.225±0.058 0.043 
TUBA1B 0.373±0.070 0.050 
YWHAZ 1.081±0.166 0.073 
 
Table 3.3 Stability values for candidate reference genes in placental tissue 
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Rank 
 
Endometrium Placenta  
1 TBP TBP 
2 SDHA HPRT1 
3 ACTB TUBA1B 
4 TUBA1B RPL7 
5 HPRT1 SDHA 
6 RPL7 PPIA 
7 PPIA ACTB 
8 GAPDH GAPDH 
9 B2M B2M 
10 YWHAZ YWHAZ 
 
Table 3.4 Recommended ranking of candidate reference genes for endometrial and 
placental tissue 
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SLC16A6 in endometrial tissue was determined via qPCR and normalized using the 
geometric mean of TBP, SDHA, and ACTB or the single gene, B2M (Figure 3.2). The 
data normalized to the trio of genes indicates little difference in SLC16A6 gene 
expression between the estrous cycle and pregnancy from Days 5 to 20 with the greatest 
expression occurring on Day 17 of the estrous cycle. The data normalized to only B2M 
indicates that the gene has significantly higher expression in pregnant gilts than cycling 
gilts on Days 15 and 17 (Figure 3.2b; p<0.05). In the pig, this is a critical period of 
pregnancy because maternal recognition of pregnancy has recently occurred, while 
elongation and attachment are proceeding. The conclusions drawn from these two 
profiles would be opposites. In Figure 3.2b, expression of SLC16A6 mRNA is higher 
during pregnancy than the estrous cycle, but this expression is being influenced by the 
reference gene, B2M, which is also higher during pregnancy than the estrous cycle.  
From Figure 3.2a, the conclusion would be that the conceptus has no influence on 
expression of mRNA for this gene in the endometrium during the peri-implantation 
period, while Figure 3.2b indicates that the conceptus, possibly conceptus secreted 
estrogens or cytokines, could be increasing gene expression in the endometrium.   
 
Expression of SLC5A1 mRNA in Porcine Endometria and Placentae 
Analysis by qPCR, using the geometric mean of TBP, SDHA, and ACTB for 
normalization, determined that SLC5A1 mRNA increased between Days 5 and 9, then 
decreased between Days 9 and 11 in endometria from both the estrous cycle and 
pregnancy (Fig. 3.3a). In contrast, there was a significant increase in the expression of 
 66 
 
 
Figure 3.2 Expression of SLC16A6 mRNA in endometrial tissues normalized using 
optimal and suboptimal reference genes 
Expression of SL16A5 mRNA across the estrous cycle and pregnancy in endometria 
normalized to the geometric mean of TBP, ACTB, and SDHA (A) or to B2M (B). 
Relative mRNA expression values are expressed as a ratio to Day 5 of the estrous cycle. 
Differing superscript letters indicate significant differences (p<0.05). Values are 
presented as mean±SEM. 
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SLC5A1 mRNA between Days 11 and 13 of pregnancy, and SLC5A1 mRNA was more 
abundant in the endometria from Day 13 pregnant as compared to Day 13 cyclic gilts 
(Fig. 3.3a; p<0.001). After Day 13, expression of SLC5A1 mRNA decreased and 
remained lowly abundant with no changes in expression for the duration of pregnancy 
(Fig. 3.3a; p>0.05; r2=0.173).  
Analysis by qPCR using the geometric mean of TBP, HPRT1, and TUBA1B for 
normalization determined that expression of SLC5A1 mRNA was unchanged in placental 
tissue from Days 30 to 85 of pregnancy expression (Fig. 3.3b; p>0.05; r2=0.008).  
In situ hybridization analysis localized SLC5A1 mRNA to uterine LE and GE of both 
cyclic and pregnant gilts as well as the placental chorion and areolae (Fig. 3.3c).  
SLC5A1 was expressed in the uterine LE and GE of both cyclic and pregnant gilts on 
Day 9, and then appeared to decrease in those cells between Days 9 and 12 of the estrous 
cycle (Fig. 3.3). In contrast to the estrous cycle, expression of SLC5A1 mRNA appeared 
to further increase in the uterine LE between Days 9 and 12 of pregnancy (Fig. 3.3c). 
Expression of SLC5A1 mRNA then appeared to decrease to background levels in uterine 
LE and GE between Days 13 and 14 of gestation and remained at that level for the 
duration of gestation (Fig. 3.3c).   
 Results of qPCR analysis indicated that expression of SLC5A1 mRNA was 
greater in endometria of pseudopregnant as compared to cyclic gilts (p<0.01) and 
expression was unaffected by long-term P4 treatment (Fig. 3.4a,b; p>0.05). In situ 
hybridization analysis localized SLC5A1 mRNA to uterine LE of Day 15 
pseudopregnant, but not cyclic gilts, suggesting that E2 induces SLC5A1 mRNA in  
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Figure 3.3 Expression SLC5A1 mRNA in endometria and placentae 
Expression of SLC5A1 mRNA was higher in endometria (A) from pregnant than cyclic 
gilts on Day 13 (p<0.05), but placental expression of SLC5A1 mRNA (B) showed no 
change from Days 30 to 85 (p>0.05). Corresponding bright-field and dark-field images 
from in situ hybridization (C) reveal expression of SLC5A1 mRNA in uterine LE and 
GE at Day 9 of the estrous cycle and pregnancy and only in uterine LE by Day 12 of 
pregnancy. The D20 sense panel is the negative control. Width of field is 870 µm. 
Legend: LE, luminal epithelium; GE, glandular epithelium; Tr, trophectoderm; CE, 
chorion. 
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Figure 3.4 Estradiol induces expression of SLC5A1 mRNA in uterine LE 
SLC5A1 mRNA expression is higher in endometria from E2-treated as compared to 
control gilts (A; p<0.05), but was not different in endometria from P4-treated compared 
to control gilts (B; p>0.05). Corresponding bright-field and dark-field images from in 
situ hybridization (C) depict SLC5A1 mRNA expression increases in the uterine LE and 
GE in response to E2, while P4 treatment had no detectable effect on gene expression. 
The D20 Sense panel in Figure 3.3 is the negative control. Legend: LE, luminal 
epithelium. 
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uterine LE (Fig. 3.4c).  Long-term P4 treatment of ovariectomized gilts did not induce 
expression of SLC5A1 mRNA in the endometrium (Fig. 3.4c).   
Expression of SLC7A3 mRNA in Porcine Endometria and Placentae 
 Analysis by qPCR, using the geometric mean of TBP, SDHA, and ACTB for 
normalization, determined that SLC7A3 mRNA was not detectable in endometrial tissues 
at any day of the estrous cycle and pregnancy (data not shown). 
 Analysis by qPCR, using the geometric mean of TBP, HPRT1, and TUBA1B for 
normalization, determined that SLC7A3 mRNA expression in placental tissue increased 
from Days 30 to 40 (p<0.001; r2=0.999) and then expression remained unchanged 
through Day 85 of pregnancy (Fig. 3.5a; p>0.05; r2=0.086). In situ hybridization 
analyses localized SLC7A3 mRNA to the chorion (Fig. 3.5b). SLC7A3 mRNA was not 
detectable in trophectoderm through Day 20, but was detectable in the chorion by Day 
25 of gestation.  The hybridization signal for SLC7A3 mRNA expression appeared to 
increase in placental tissues through Day 85, and was present in both the chorionic 
epithelia of areolae and non-areolar regions of placentae with distinctly higher 
expression in the tall columnar cells at the tops of uterine folds (Fig. 3.5b).  SLC7A3 
mRNA was not detected in endometria from any day of the estrous cycle or pregnancy 
(Fig. 3.5b).  
 Radiolabeled arginine was transported from culture medium into the 
chorioallantoic cells of Day 60 pig placentae (Fig. 3.5c).  As predicted from results of in  
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Figure 3.5 Expression of SLC7A3 mRNA and arginine transport in placentae 
Expression of SLC7A3 mRNA in placenta (A) increases from Days 30 to 40 of 
pregnancy (p<0.001; r2=0.999) and then remains unchanged through Day 85 of 
pregnancy (p>0.05; r2=0.086). Corresponding bright-field and dark-field images from in 
situ hybridization (B) depict SLC7A3 mRNA localization to the trophectoderm, CE, and 
areolae. There is no difference in arginine transport between areolar and inter-areolar 
regions (C; p>0.05). The D60P Sense panel is the in situ hybridization negative control. 
Legend: LE, luminal epithelium; Tr, trophectoderm; CE, chorion.  
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situ hybridization analyses to determine cell-specific localization of SLC7A3 mRNA, no 
significant difference in arginine transport was found between areolae and inter-areolar 
regions of the chorioallantois (Fig. 3.5c; p<0.05). 
 
Discussion 
Gene expression analysis applied over the duration of the estrous cycle and 
pregnancy is a useful tool for studying the myriad of changes that occur in both the 
maternal endometrium and fetal placenta. In the pig, protein analysis is restricted by the 
availability of commercial antibodies that cross-react with pig proteins, making gene 
expression analysis by qPCR one of the main tools for documenting changes in gene 
expression. Care must be given to determine which genes are reliable and optimal for 
selection as reference genes in order to provide the most accurate data (Peters et al., 
2004).  
A serious issue with measuring gene expression over the duration of pregnancy is 
the potential gene regulation of traditional reference genes because the pig endometrium 
and placenta undergo temporal remodeling as they develop throughout pregnancy. 
Another consideration, specifically for the use of B2M or any other immune-related 
gene, is that pregnancy influences changes in the maternal immune system so that it will 
not reject the fetal allograft. In the epitheliochorial placenta of the pig, this can be seen 
in the down regulation of MHC class I molecules at the maternal/fetal interface 
(Huddleston and Schust, 2004; Joyce et al., 2008). This example shows that the 
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physiology of the tissue being analyzed should be considered when choosing reference 
genes. 
Previous studies have identified optimal reference genes for use in pig tissues, 
including: TBP, ACTB, HPRT1, YWHAZ, HSPCB (Nygard et al., 2007; Gu et al., 2011), 
but these studies did not include endometrium and placenta. Martinez-Giner et al. 
concluded that TBP, SDHA, and UBC were optimal reference genes in pig endometrium 
across pregnancy, but endometrial tissue from non-pregnant gilts during the estrous 
cycle was not considered in the analysis (Martinez-Giner et al., 2013). The present 
results agree with Martinez-Giner et al. in that TBP and SDHA were also found to be the 
most stable reference genes when tissues from non-pregnant cycling gilts were included 
in the analyses. The ability to compare tissue from pregnant and cycling gilts is 
important for understanding gene expression during establishment of pregnancy in pigs.   
The ribosomal protein 18S is often used as a reference gene, but it was excluded 
in the present study because of the disadvantages that ribosomal genes can have when 
used as reference genes. First, rRNA genes have a much higher abundance than most 
target genes and this imbalance can negatively impact the accuracy of the qPCR analysis 
(Vandesompele et al., 2002b). Second, regulation of rRNA synthesis is different than for  
mRNA, as it is transcribed by RNA polymerase I (Radonic et al., 2004). Ribosomal 
protein RPL7 was included in this analysis, but was not found to be optimal, most likely 
due to the issues noted.   
In order to provide evidence that the reference genes chosen were appropriate, 
both qPCR and in situ hybridization were performed for two genes over the duration of 
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the estrous cycle and pregnancy in the pig. SLC5A1 mRNA expression from the qPCR 
analyses closely followed the results from in situ hybridization analyses indicating that 
expression was high on both Day 9 of the estrous cycle and pregnancy, then decreased in 
the estrous cycle, while increasing and peaking on Day 15 of pregnancy. The data from 
the pseudopregnant model further confirmed the biological significance of this peak by 
determining that it was induced by E2, the maternal recognition of pregnancy signal. In 
the pig, the corpora lutea can be maintained without any conceptuses when injections of 
exogenous E2 are administered during Days 11 to 14 of the estrous cycle to mimic 
secretion of estrogen by the conceptus. This psuedopregnant state provides an 
opportunity to determine the effects of E2 on the endometrium independent of other 
conceptus-secreted factors.  SLC7A3 mRNA expression also followed a similar pattern 
between the two techniques with increasing expression in the chorion as pregnancy 
progressed and the areolar development most likely driving the increase seen in 
placental tissue from Days 30 to 40 of pregnancy. 
In addition to being models for determining the appropriateness of reference 
genes for qPCR, SLC5A1 and SLC7A3 also have biologically significant roles at the 
uterine-placental interface in the pig. Pig embryos enter the uterus, develop into 
blastocysts, and then shed the zona pellucida. The presumptive placental membranes 
(trophectoderm and endoderm) elongate at a rate of 30-45 mm/h from a 10 mm 
blastocyst to a 150-200 mm long filamentous form, after which further elongation occurs 
until conceptuses are 800-1,000 mm in length by Day 16 of pregnancy.  This process 
provides maximum surface area for contact between trophectoderm and uterine LE to 
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facilitate the uptake of nutrients from uterine LE and uterine GE (Bazer and Johnson, 
2014). Significant energy is required to drive those extreme morphological changes in 
the conceptus.  Glucose is essential to conceptus survival, growth, and development, and 
substantial amounts of glucose are transported across the placental membranes of pigs 
(White et al., 1979; Ramsay et al., 1984; Pere, 2003).  Although little is known about the 
role(s) of sodium-dependent glucose transporters in uterine physiology, SLC5A1 mRNA 
and protein are present in ovine uterine LE and GE during the peri-implantation period, 
making SLC5A1 a potential candidate for glucose transport into the uterine lumen 
during conceptus elongation in pigs (Gao et al., 2009a). 
Messenger RNA for the sodium-dependent glucose transporter SLC5A1 was 
localized to the uterine LE coinciding with conceptus elongation, pregnancy recognition, 
and early attachment of conceptuses to the uterine wall for implantation.  SLC5A1 
mRNA expression was greatest in uterine LE on Days 12 and 13 of pregnancy, then 
decreased precipitously to undetectable levels by Day 14, suggesting that a paracrine 
factor(s) from the conceptus regulates expression of SLC5A1 mRNA. Pig conceptuses 
secrete E2 on Days 11 and 12 to signal initiation of pregnancy to the uterus.  Conceptus 
E2 also induces or upregulates expression of a number of endometrial growth factors and 
cytokines as components of histotroph that are released by uterine LE and GE into the 
uterine lumen to support development of free-floating conceptuses (Geisert et al., 1982c; 
Johnson et al., 2009). In this study, results from Day 15 psuedopregnant pigs provide 
strong evidence that E2 increases expression of SLC5A1 mRNA in uterine LE.  We 
hypothesize that as porcine conceptuses begin to elongate, an energy-dependent event, 
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they secrete E2 that increases the number of SLC5A1 transporters in uterine LE, thereby 
increasing potential transport of glucose into the uterine lumen to nourish free-floating 
conceptuses.  Accordingly, recoverable glucose in uterine flushings increases between 
Days 12 and 14 of pregnancy in Large White and Meishan gilts (Bazer et al., 1991). 
 Another hallmark of pregnancy in pigs is epitheliochorial placentation.  Porcine 
placental trophectoderm/chorion directly attaches to uterine LE, and these epithelia serve 
as the conduit for maternal hemotrophic and histotrophic support for conceptus growth 
and development. The formidable barrier to nutrient transport presented by two adhered 
epithelial cell layers separating uterine and placental vasculatures must be overcome in 
both the inter-areolar regions of placental attachment and in areolae that form only over 
the openings of uterine glands to maintain sufficient hemotrophic and histotrophic 
nutrition, respectively (Bazer and Johnson, 2014). Results from the present study 
provide evidence that both the inter-areolar and areolar chorion at the uterine-placental 
interface express SLC7A3, a transporter capable of moving arginine, and other amino 
acids, to the placental vasculature for transport to the embryo/fetus.  
 We reported an abundance of ornithine and arginine in the allantoic fluids of pigs 
at levels never before reported in any other biological fluid (Wu et al., 1995). On Days 
45 and 60 of gestation, ornithine and arginine account for 34-36% of total free α-amino 
acids in allantoic fluid, and arginine increased 4.5 fold between Days 30 and 45 of 
pregnancy (Wu et al., 1995).  The potential for arginine to positively influence conceptus 
development is profound as arginine is a precursor for synthesis of ornithine, 
polyamines, proline, glutamine, creatine, agmatine, NO, and proteins.  Further, arginine-
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derived ornithine serves as a precursor for synthesis of polyamines and proline in 
porcine maternal and conceptus tissues where proline and ornithine play an important 
role in polyamine synthesis (Wu and Morris, 1998; Wu et al., 2013). This biochemical 
potential has been realized in real-world application where arginine supplementation of 
the diet of pregnant gilts between Days 30 and 114 of pregnancy significantly increased 
litter birth-weight and the number of live-born piglets (Mateo et al., 2007), and a number 
of studies have provided additional support for a beneficial role for arginine 
supplementation in reducing embryonic deaths in gestating pigs (Berard and Bee, 2010; 
Wu et al., 2013).  Although the importance of placental arginine to pregnancy success in 
pigs is well established, little is known about how arginine is transported across the 
placental chorion for access to the placental vasculature, tissues for metabolism, and 
routes for diffusion through the allantois for storage in allantoic fluid before being taken 
up again into the circulation of the conceptus. This study identifies SLC7A3 as an 
excellent candidate for arginine transport across the placental chorion of pigs.  
 The mRNA for the cationic amino acid transporter SLC7A3 was localized to the 
chorionic epithelium coinciding with increased abundance of arginine in porcine 
allantoic fluid (Wu et al., 1995).  In situ hybridization and qPCR analyses demonstrated 
that SLC7A3 mRNA significantly increases between Days 30 and Day 60 in the chorion 
and support a role for SLC7A3 transport of amino acids across the placenta.  Further, 
when chorioallantois from Day 60 of pregnancy was isolated and areolae separated from 
inter-areolar regions of placentation, both areolae and inter-areolar tissues exhibited a 
comparable ability to transport radioactive arginine across cell membranes and into the 
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cells of the tissues.  We hypothesize that as the attachment phase of implantation in pigs 
is completed and mature placentation proceeds between Days 25 and 40 of pregnancy, 
the number of SLC7A3 transporters increase in the placental chorionic epithelium for 
transport of arginine across the chorioallantois and into the fetal-placental vasculature 
and/or allantoic fluid.  This enables arginine to be used immediately to support 
development and growth of the conceptus, but particularly the fetus during the second 
and third trimesters of gestation in gilts.  However, the allantois serves as a reservoir for 
storage of nutrients such as amino acids, glucose, and fructose that are available for 
subsequent uptake into the placental circulation as needed to support development and 
growth of the conceptus. 
In conclusion, these data would recommend use of TBP as an acceptable stable 
reference gene for qPCR in pig endometrial and placental tissues. The geometric mean 
of TBP, HPRT1, and TUBA1B is the optimal reference value for placental tissue, while 
the geometric mean of TBP, ACTB, and SDHA is optimal for endometrial tissue. 
YWHAZ, B2M, and GAPDH are not acceptable reference genes for pig endometrial or 
placental tissues. Additionally, using these recommended reference genes, this study has 
identified SLC5A1 and SLC7A3 as excellent candidate genes for glucose and arginine 
transport, respectively, during pregnancy to aid in growth and development of the 
porcine conceptus. 
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CHAPTER IV 
ESTROGEN AND PROGESTERONE REGULATE SLC2A FACILITATED 
GLUCOSE TRANSPORTER GENE EXPRESSION IN PORCINE ENDOMETRIA 
DURING PREGNANCY 
 
Introduction 
Glucose is an abundant hexose sugar that is transported through endometrial and 
placental tissues and utilized as a major energy substrate for growth and development of 
porcine conceptuses (embryo/fetus and associated extraembryonic membranes) during 
pregnancy (White et al., 1979; Pere, 2003). There is minimal gluconeogenesis in the 
placenta and fetus of pigs (Fowden et al., 1997). Therefore, glucose from maternal blood 
must be transported into the uterine lumen early in pregnancy where the free-floating 
conceptus can access the sugar and transport it across the trophectoderm. As 
implantation and placentation progress, the adherence of the uterine luminal epithelium 
(LE) to the placental chorion creates the uterine-placental interface of the 
epitheliochorial pig placenta that nutrients must traverse to reach the placental 
vasculature (Dantzer, 1984, 1985). 
Glucose can be transported by either facilitated diffusion transporters of the 
solute carrier 2A (SLC2A; GLUT) family or sodium-dependent transporters of the solute 
carrier 5A (SLC5A; SGLT) family. The pig primarily depends on a glucose 
concentration gradient to transport glucose as indicated by the concentrations of glucose 
in fetal blood that are 40-70% lower than concentrations of glucose in maternal blood 
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(Randall, 1977; Pere, 1995), therefore, this study focused on the SLC2A family of 
glucose transporters. There are 14 members of the SLC2A family (SLC2A1-14) 
responsible for transporting multiple sugars in addition to glucose. Different members of 
the family have differing affinities for glucose, some are regulated by insulin or steroid 
hormones, and all have a distinct tissue-specific expression (Augustin, 2010). SLC2A1 
is ubiquitously expressed throughout the body and is responsible for the basal glucose 
uptake into cells. SLC2A2 is a low affinity, high capacity glucose transporter often 
found in the basal plasma membrane of transporting epithelia. SLC2A3 is a high affinity, 
high capacity glucose transporter found in tissues such as the brain where glucose needs 
to be moved quickly and in large quantities. SLC2A4 is an insulin-sensitive glucose 
transporter mostly found in skeletal muscle and adipose tissues (Olson and Pessin, 1996; 
Zhao and Keating, 2007b). 
The transporters SLC2A1, SLC2A3, and SLC2A4 have been localized to 
endometrial or conceptus tissues of humans, mice, and sheep. SLC2A1 has been 
localized to human placental syncytiotrophoblasts and the LE, glandular epithelium 
(GE), and stroma of human and mouse endometrium (Jansson et al., 1993; Yamaguchi et 
al., 1996; von Wolff et al., 2003) ). SLC2A1 protein has also been detected in the LE 
and GE of the sheep endometrium during the estrous cycle and early pregnancy, as well 
as in the conceptus trophectoderm (Gao et al., 2009a). SLC2A3 has been detected in the 
stroma and decidua of human and mouse endometria in addition to the placenta 
(Yamaguchi et al., 1996; Hahn et al., 2001; Brown et al., 2011). SLC2A3 mRNA is 
expressed in the trophectoderm of sheep as early as Day 14 of pregnancy, but there is no 
 81 
 
endometrial expression detected through Day 20 (Gao et al., 2009a). SLC2A4 has been 
detected in LE, GE and stroma of human and mouse endometria as well as sheep uterine 
LE and GE throughout the estrous cycle and early pregnancy (von Wolff et al., 2003; 
Gao et al., 2009a). SLC2A2 has not been detected in either human or mouse endometria 
(von Wolff et al., 2003; Frolova and Moley, 2011b).  
Glucose transport from mother to conceptus can be influenced by several factors, 
including utero-placental blood flow, concentration gradients, surface area for exchange, 
placental metabolism, transporter expression, maternal hormones, and placental 
hormones. The true epitheliochorial placenta of the pig represents a significant barrier to 
nutrient transport because nutrients must traverse multiple cell layers between the 
maternal and fetal microvasculatures (Dantzer, 1985). This barrier to nutrient transport is 
overcome by folding of the adhered interface, comprised of the maternal uterine 
epithelia and placental chorion and underlying connective tissue, to increase surface 
area. Areolae, invaginations of the chorioallantois that receive and transport the 
secretions from uterine GE to the vasculature of the conceptus also develop (Friess et al., 
1981; Dantzer, 1984).  
Steroid hormone regulation of expression of SLC2A transporters has been 
described in the sheep where progesterone (P4) upregulates SLC2A1 protein in the 
uterine LE, but has no effect on expression of SLC2A4 protein (Gao et al., 2009a). 
Additionally, estrogen (E2) treatment increases glucose uptake and the expression of 
SLC2A1 protein in the rat uterus (Smith and Gorski, 1968; Welch and Gorski, 1999). 
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SLC2A1 protein is also upregulated in mouse uterine epithelia in response to P4 
(Frolova et al., 2009). 
While the glucose transporters SLC2A1, SLC2A2, SLC2A3, and SLC2A4 have 
been studied in the endometrial and placental tissues of non-pregnant and early pregnant 
humans, mice, and sheep, there is no information regarding the temporal and cell-
specific expression of these transporters in pig endometria and placentae or their 
regulation by steroid hormones. Therefore, this study aimed to quantify temporal and 
cell-specific changes in expression of glucose transporters throughout the estrous cycle 
and pregnancy in the pig and determine whether their expression is regulated by E2 
and/or P4, two important hormones of pregnancy in pigs. 
Material and Methods 
Animals and Tissue Collection 
Sexually mature, 8-month-old crossbred gilts were observed daily for estrus (Day 
0) and exhibited at least two estrus cycles of normal duration (18 to 21 days) before
being used in these studies.  All experimental and surgical procedures were in 
compliance with the Guide for Care and Use of Agricultural Animals in Teaching and 
Research and approved by the Institutional Animal Care and Use Committee of Texas 
A&M University. 
To evaluate the effects of pregnancy on expression of SLC2A1, SLC2A2, SLC2A3 
and SLC2A4 genes, gilts were assigned randomly to either cyclic or pregnant status. 
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Gilts in the pregnant group were bred naturally to boars with proven fertility. Cyclic gilts 
were ovariohysterectomized on either Day 5, 9, 11, 12, 13, 15 or 17 of the estrous cycle, 
while pregnant gilts were ovaiohysterectomized on either Day 9, 11, 12, 13, 15, 17, 20, 
25, 30, 35, 40, 50, 60, or 85 of pregnancy (n = 3 or 4 gilts/day/status). For uterine lumen 
fluid collection, the lumen of each uterine horn from Days 9 through 17 of the estrous 
cycle and pregnancy were flushed with 20 ml physiological saline. Pregnancy was 
confirmed in the mated gilts by the presence of morphologically normal conceptuses. 
Tissue sections (uterus or uterus with attached placenta ~1cm thick) from the middle of 
each uterine horn of all hysterectomized gilts were fixed in fresh 4% paraformaldehyde 
in PBS (pH 7.2) and embedded in Paraplast-Plus (Oxford Laboratory, St. Louis, MO). 
Additionally, endometrium was physically dissected from the myometrium, snap-frozen 
in liquid nitrogen, and stored at -80°C for RNA extraction. Chorioallantoic tissue was 
physically dissected from endometrium and frozen in a similar manner.  
 
Progesterone and Estrogen Models 
To evaluate effects of E2 and E2-induced pseudopregnancy on expression of 
SLC2A1, SLC2A2, SLC2A3, and SLC2A4 mRNAs in endometria, gilts were detected in 
estrus (Day 0) and assigned randomly to receive daily intramuscular injections of either 
estradiol benzoate (E2 in corn oil (E2); n = 4) or corn oil alone (CO; n = 4) on Days 11, 
12, 13, and 14 of the estrous cycle (Joyce et al., 2007).  All gilts were 
ovariohysterectomized on Day 15 of pseudopregnancy. Tissues were collected as 
described previously. 
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To evaluate effects of long-term P4 treatment, without ovarian hormones, on 
expression of SLC2A1, SLC2A2, SLC2A3 and SLC2A4 mRNAs in endometria, gilts were 
ovariectomized on Day 12 of the estrous cycle and assigned randomly to receive daily 
intramuscular injections of either CO (4 ml) or P4 (200 mg in 4 ml CO) on Days 12 
through 39 post-estrus (n = 3/treatment) (Bailey et al., 2010c).  All gilts were 
hysterectomized on Day 40 post-estrus and tissues collected as previously described. 
Concentrations of Glucose in Uterine Flushings 
Uterine flushings were purified by centrifugation at 3000 x g for 15 min at 4°C, 
and the supernatants aliquoted and stored at –80°C.  Uterine flushings (0.5 ml) were 
deproteinized with an equal volume of 1.5M HClO4 followed by addition of 0.25 ml of 2 
M K2CO3. Extracts were analyzed for glucose using a fluorometric method utilizing 
hexokinase and glucose-6-phosphate dehydrogenase as described previously (Bergmeyer 
et al., 1974). 
RNA Extraction, cDNA Synthesis, and Primer Design 
Total RNA was extracted from endometrial and chorioallantoic tissue samples 
using Trizol reagent (Life Technologies, Carlsbad, CA) according to the manufacturer’s 
recommendations (see Appendix B).  First strand cDNA was synthesized using a 
Superscript III First Strand Kit (Life Technologies, Carlsbad, CA) according to the 
manufacturer’s instructions (see Appendix B). First strand cDNA was diluted 10x for the 
qPCR reaction. Primers for qPCR and in situ hybridization were designed using NCBI
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Gene 
Name 
Method Gene ID Sequence Product 
Length 
SLC2A1 qPCR XM_005665507.1 F: 5'-TCCTTTACCCACATCCCACG-3'    
R: 5'-AAGGCAAGTGTCTAGGCAGG-3' 
82 
SLC2A1 ISH X17058 F: 5'-TGGCCTTCATATCTGCTGTG-3'    
R: 5'-AACAGCTCCAGGATGGTGAC-3' 
484 
SLC2A2 qPCR NM_001097417.1 F: 5'-CCCTGCTGCTTTAGCAATGG-3'   
R: 5'-TAAGGTCCACAGAAGTCCGC-3' 
96 
SLC2A3 qPCR XM_003355585.3 F: 5'-ATCTTGGTATGGCCACTCGG-3'   
R: 5'-GCAAGGCAATCCACTAAGGC-3' 
130 
SLC2A3 ISH NM_001009770.1 F: 5'-CCACACATGAGCCGTAAATG-3' 
R: 5'-TGAAGAGCCCAGTCTCCACT-3' 
477 
SLC2A4 qPCR NM_001128433.1 F: 5'-GAGAGCCAGTTCTCTCCACC-3'   
R: 5'-CTCCACCCTGGAAGTAACGG-3' 
88 
SLC2A4 ISH NM_001128433.1 F: 5'-CAACAGATAGGCTCCGAAGA-3' 
R: 5'-CACGTACATGGGCACCAG 
465 
ACTB qPCR XM_003124280.3 F: 5'-TCCCTGGAGAAGAGCTACGA-3' 
 R: 5'-TGTTGGCGTAGAGGTCCTTC-3' 
187 
HPRT1 qPCR DQ845175 F: 5'-GGACTTGAATCATGTTTGTG-3' 
 R: 5'-CAGATGTTTCCAAACTCAAC-3' 
91 
SDHA qPCR DQ845177 F: 5'-CTACAAGGGGCAGGTTCTGA-3'   
R: 5'-AAGACAACGAGGTCCAGGAG-3' 
141 
TBP qPCR DQ845178 F: 5’-AACAGTTCAGTAGTTATGAGCCAGA-3’ 
R: 5’-AGATGTTCTCAAACGCTTCG-3’ 
153 
TUBA1B qPCR NM_001044544.1 F: 5'-GCTGCCAATAACTATGCCCG-3'   
R: 5'-ACCAAGAAGCCCTGAAGACC-3' 
116 
Table 4.1 Primer information for SLC2A genes 
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Genbank sequences and Primer-BLAST (http://www.ncbi.nlm.nih.gov/). Primers were 
submitted to BLAST to test for specificity against the known porcine genome. Primer 
information is summarized in Table 4.1. 
 
Quantitative PCR 
Quantitative PCR assays were performed as previously described (Chapter III 
and Appendix B of this dissertation). Briefly, PerfeCta SYBR Green Mastermix 
(Quanta) was used in 10 µl reactions with 2.5 mM of each specific primer, on a Roche 
480 Lightcycler (Roche) with approximately 60 ng cDNA per reaction. The PCR 
program began with 5 min at 95°C followed by 40 cycles of 95°C denaturation for 10 
sec and 60°C annealing/extension for 30 sec. A melt curve was produced with every run 
to verify a single gene-specific peak. Standard curves with 2-fold serial dilutions were 
run to determine primer efficiencies. All primer correlation coefficients were greater 
than 0.95 and efficiencies were 95-102%. The geometric mean of TBP, SDHA, and 
ACTB was used to normalize endometrial tissue, while the geometric mean of TBP, 
HPRT1, and TUBA1B was used for chorioallantoic tissue.  
 
In situ Hybridization Analysis 
Cell-specific expression of mRNAs in sections of porcine endometria and 
placentae were determined by radioactive in situ hybridization analysis as described 
previously (Johnson et al., 1999)(Appendix B). Briefly, partial cDNAs for porcine 
SLC2A1, SLC2A2, SLC2A3 and SLC2A4 mRNAs were cloned beginning with PCR 
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amplification using total RNA from Day 15 pregnant porcine endometrial tissues using 
specific primers (Table 3.1). PCR amplification was conducted as follows: 1) 95°C for 5 
min; 2) 95°C for 45 sec, 60°C for 30 sec, and 72°C for 1 min for 35 cycles; and 3) 72°C 
for 10 min. The partial cDNAs of the correct predicted size were cloned into a pCRII 
plasmid using a T/A Cloning Kit (Life Technologies) and the sequence of each verified 
using an ABI PRISM Dye Terminator Cycle Sequencing Kit and ABI PRISM automated 
DNA sequencer (Perkin-Elmer Applied Biosystems). 
Radiolabeled antisense or sense cRNA probes were generated by in vitro 
transcription using linearized plasmid templates, RNA polymerases, and [α-35S]-UTP.  
Deparaffinized, rehydrated, and deproteinated uterine tissue sections (5 µm thick) were 
hybridized with radiolabeled antisense or sense cRNA probes.  After hybridization, 
washing, and ribonuclease A digestion, slides were dipped in NTB-2 liquid photographic 
emulsion (Kodak, Rochester, NY), and exposed at 4C for seven to ten days.  Slides 
were developed in Kodak D-19 developer, counterstained with Harris modified 
hematoxylin (Fisher Scientific, Fairlawn, NJ), dehydrated through a graded series of 
alcohol to Citrisolv (Fisher Scientific) and coverslips were affixed with Permount 
(Fisher Scientific). Slides were evaluated using an Axioplan 2 microscope (Carl Zeiss, 
Thornwood, NY) interfaced with an Axioplan HR digital camera and Axiovision 4.3 
software, and digital images of representative fields recorded under brightfield or 
darkfield illumination. Photographic plates were assembled using Adobe Photoshop 
(version 6.0, Adobe Systems Inc., San Jose, CA). 
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Statistical Analyses 
Data for concentrations of glucose were analyzed for effects of day, pregnancy 
status (cyclic or pregnant), and their interaction using a 2-way ANOVA via the General 
Linear Models (GLM) procedures of the Statistical Analysis System (SAS Institute, 
Cary, NC). For all qPCR data, fold changes were determined using the 2-ΔΔCt Method 
with raw Ct values normalized to the geometric mean of TBP, SDHA, and ACTB for 
endometrial tissue and the geometric mean of TBP, HPRT1, and TUBA1B for placental 
tissue. The qPCR data for normal tissues were analyzed for effects of day, pregnancy 
status, and their interaction for Days 9, 11, 13, 15 and 17 by 2-way ANOVA via the 
General Linear Models (GLM) procedures of the Statistical Analysis System (SAS 
Institute, Cary, NC) with the least significant difference (LSD) multiple testing method. 
The qPCR data were also subjected to a sliding time window linear regression analysis 
to determine if there was an effect of day of gestation on the gene expression for the 
genes of interest throughout pregnancy (Days 9 to 85). The sliding time windows of the 
analysis were designed to detect effect of day on gene expression during three 
biologically relevant periods of time: the beginning, the middle, and the end of the study 
period. Each window analyzed contained a minimum of three days. Some windows 
contained greater than three days as long as the regression model showed a non-
decreased performance in terms of the r2 and the p-value of the F-statistics.  
The data from the hormone therapy studies were analyzed using the Students t-
test. All data are presented as mean±standard error of the means with significance at 
p<0.05. 
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Results 
Glucose in Uterine Flushings 
Total recoverable glucose increased in the uterine flushings of both cyclic and 
pregnant gilts between Days 9 and 15 (Figure 4.1; p<0.05). This indicates that the free-
floating conceptus is exposed to increasing levels of glucose during development; 
however, there was no effect of pregnancy status, and no interaction between day and 
pregnancy status on total recoverable glucose (Figure 4.1; p>0.05). 
SLC2A1 mRNA Localizes to Uterine LE During Pregnancy 
and Is Upregulated by E2 and P4 
To determine the total endometrial expression of SLC2A1 mRNA, qPCR was 
used on tissue samples from Days 5 to 17 of the estrous cycle and Days 9 to 85 of 
pregnancy. Expression of SLC2A1 mRNA increased from Days 11 to 15 in endometrial 
tissue from cycling and pregnant gilts, but expression was more abundant in endometrial 
tissue from pregnant than cyclic gilts (Figure 4.2A; day x status, p<0.001). When 
endometrial expression of SLC2A1 mRNA from pregnant gilts was analyzed from Days 
9 to 85, there was an increase in expression from Days 9 to 17 (r2=0.864; p<0.05), and 
there was no change in expression of SLC2A1 between Days 17 and 25 (r2=0.108; 
p>0.05) or Days 30 and 85 (r2=0.578; p>0.05) of pregnancy. Expression of SLC2A1 
mRNA in the chorioallantois did not change between Days 30 and 85 of pregnancy 
(Figure 4.2B; r2=0.143; p>0.05). 
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Glucose increased in the uterine flushings from Day 9 through 15 during the estrous 
cycle and pregnancy (p<0.01). There was no interaction between Day and Status or 
effect of Status alone (p>0.05). Values are means ± SEM.   
 
 
 
 
 
 
 
 
 
Figure 4.1 Total recoverable glucose in porcine uterine flushings increased from 
Days 9 to 15 of the estrous cycle and pregnancy 
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Figure 4.2 Expression of SLC2A1 mRNA in endometria and placentae 
(A) Expression of SLC2A1 mRNA increased from Days 11 to 15 in endometrial tissue 
from cycling and pregnant gilts, and expression was more abundant in endometrial tissue 
from pregnant than cyclic gilts (day x status, p<0.001); (B) Expression of SLC2A1 
mRNA in placenta did not change between Days 30 and 85 (r2=0.143; p>0.05); (C) 
Exogenous E2 upregulated expression of SLC2A1 mRNA in endometria (p<0.05); (D) 
Exogenous P4 upregulated expression of SLC2A1 mRNA in endometria (p<0.05). 
Values presented are means±SEM and p<0.05 is significant. 
 
 
 92 
 
 
 
Figure 4.3 Cell-specific expression of SLC2A1 mRNA in endometria and placentae 
Corresponding bright-field and dark-field images from in situ hybridization show that SLC2A1 mRNA localizes predominantly 
to uterine LE during the estrous cycle and early pregnancy with some expression in the uterine GE and trophectoderm/chorion. 
Exogenous E2 induced expression of SLC2A1 mRNA in the LE, while exogenous P4 induced expression in the LE and GE. 
Width of field is 870 µm. The Day 20P Sense panel is the negative control. Legend: LE, luminal epithelium; GE, glandular 
epithelium; Tr, trophectoderm; CE, chorion. 
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Cell-specific expression of SLC2A1 mRNA was determined by in situ 
hybridization analysis of tissues from the estrous cycle and pregnancy. SLC2A1 mRNA 
localized to the uterine LE and GE on all days of the estrous cycle and pregnancy 
studied. On Day 15, expression of SLC2A1 mRNA appeared to be greater in uterine LE 
from pregnant gilts as compared to cyclic gilts (Figure 4.3). SLC2A1 mRNA was also 
detected in the conceptuses from Day 15 of pregnancy. From Days 25 to 85 of 
pregnancy, expression of SLC2A1 remained localized to the uterine LE with expression 
appearing to increase in the GE at Day 30, which then decreased by Day 85. Expression 
of SLC2A1 mRNA was also detected in the chorion, although at lower levels than in 
uterine LE (Figure 4.3). 
Endometria from gilts treated with exogenous E2 or P4 were analyzed for 
expression of SLC2A1 mRNA and its cell-specific localization. Expression of SLC2A1 
mRNA increased in uterine LE in response to E2 (Figure 4.2C; p<0.05), which was 
similar to the expression pattern in uterine tissues from Day 15 of pregnancy (Figure 
4.3). Endometrial expression of SLC2A1 mRNA increased in uterine LE and GE of gilts 
treated with exogenous P4 as compared to control gilts (p<0.05; Figure 4.2D and Figure 
4.3). 
 
SLC2A2 mRNA Is Expressed During Late Pregnancy 
Expression of SLC2A2 mRNA in endometria was low during the estrous cycle 
and early pregnancy compared to other SLC2A transporters studied with no significant 
effect of day or status during the peri-implantation period of pregnancy (Figure 4.4A; 
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p>0.05). However, expression of SLC2A2 mRNA increased in endometrium from Days 
9 to 85 of pregnancy (r2=0.774; p<0.001) and in the placenta from Days 30 to 85 of 
pregnancy (Figure 4.4B; r2=0.810; p<0.001). 
SLC2A2 mRNA was detected in the trophectoderm of Day 15 conceptuses using 
in situ hybridization analysis (Figure 4.4C). By Day 40, SLC2A2 mRNA was detected in 
areolae and this expression appeared to increase through Day 60. SLC2A2 mRNA was 
barely detectable in non-areolar regions of the chorion from Days 60 to 85 of pregnancy.  
There was no effect of E2 or P4 on expression of SLC2A2 mRNA in the 
pseudopregnancy or long-term P4 studies performed (data not shown). 
 
SLC2A3 mRNA Localizes Primarily to the Placenta Throughout Pregnancy 
Expression of SLC2A3 mRNA in endometria decreased from Days 9 to 13 
(p<0.001) in both pregnant and cycling gilts (Figure 4.5A; p>0.05). When expression of 
SLC2A3 mRNA in endometria from pregnant gilts was analyzed, there was no change in 
expression between Days 9 and 15 (r2=0.884; p>0.05) or Days 17 and 25 (r2=0.185; 
p>0.05) of pregnancy, but expression increased between Days 30 and 85 (r2=0.964; 
p<0.01). There was no change in expression of SLC2A3 mRNA in chorioallantois 
between Days 30 and 85 of pregnancy (Figure 4.5B; r2=0.04; p>0.05).  
SLC2A3 mRNA was barely detectable in the LE and GE of uteri from cycling 
and pregnant gilts, although expression was detected in the tips of the uterine villi on 
Day 60 (Figure 4.6). Expression of SLC2A3 mRNA by trophectoderm was detected as  
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Figure 4.4 Expression of SLC2A2 mRNA in endometria and placentae 
(A) Endometrial expression of SLC2A2 mRNA increased from Days 9 to 85 of 
pregnancy (r2=0.774; p<0.001); (B) Placental expression of SLC2A2 mRNA increased 
from Days 30 to 85 of pregnancy (r2=0.810; p<0.001); (C) Corresponding bright-field 
and dark-field images detected SLC2A2 mRNA in the trophectoderm at Day 15 and in 
the areolae, uterine LE, and CE on Days 60 to 85 of pregnancy. Values presented are 
means±SEM and p<0.05 is significant. Width of field is 870 µm except D15 Conceptus 
40X and Sense (580 µm) and D40P, D60P (1740 µm). The Day 40P Sense panel is the 
negative control. Legend: LE, luminal epithelium; Tr, trophectoderm; CE, chorion. 
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Figure 4.5 Expression of SLC2A3 mRNA in endometria and placentae 
(A) Endometrial expression of SLC2A3 mRNA was low during the estrous cycle and 
early pregnancy, and then increased between Days 30 and 85 of pregnancy (r2=0.964; 
p<0.01). (B) Placental expression of SLC2A3 mRNA was not different between Days 30 
and 85 (r2=0.04; p>0.05). (C) Endometrial expression of SLC2A3 mRNA decreased in 
response to E2 (p<0.05) and (D) was not affected by P4 (p>0.05). Values presented are 
means±SEM and p<0.05 is significant. 
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Figure 4.6 Cell-specific localization of SLC2A3 mRNA in endometria and placentae 
Corresponding bright-field and dark-field images revealed low endometrial expression of SLC2A3 mRNA in the endometrium 
during the estrous cycle and early pregnancy. However, there was abundant expression of SLC2A3 in the trophectoderm on 
Day 15 of pregnancy, which was maintained in the chorion and areolae through Day 85 of pregnancy. Width of field is 870 
µm. The D15 Conceptus Sense panel is the negative control. Legend: LE, luminal epithelium; GE, glandular epithelium; Tr, 
trophectoderm; CE, chorion.
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early as Day 15 and expression was maintained in the chorion through Day 85 of 
pregnancy. Chorion expression of SLC2A3 mRNA was greater in the areolae than in 
non-areolar regions of the chorion from Days 40 to 85 of pregnancy.  
Endometrial expression of SLC2A3 mRNA decreased in uterine LE and GE in 
response to E2 (p<0.05; Figure 4.5C and Figure 4.6), but there was no effect of P4 on 
expression of SLC2A3 mRNA in uterine LE (Figure 4.5D and Figure 4.6). 
 
SLC2A4 mRNA Is Expressed Lowly in Endometria and Localizes to the Uterine LE 
Endometrial expression of SLC2A4 mRNA was lower than for the other three 
SLC2A genes studied and was not affected by day, status, or the day by status interaction 
during the peri-implantation period of pregnancy (Figure 4.7A; p>0.05). Endometrial 
expression of SLC2A4 mRNA was not different between Days 9 and 85 of pregnancy 
(r2=0.005; p<0.05) and placental expression of SLC2A4 mRNA was not different 
between Days 30 and 85 of pregnancy (Figure 4.7B; r2=0.019; p<0.05). 
Endometrial expression of SLC2A4 mRNA was barely detectable by in situ 
hybridization analysis between Days 9 and 12, but was detectable in uterine LE by Day 
15 in cycling and pregnant gilts (Figure 4.8). Expression of SLC2A4 mRNA by uterine 
LE was maintained through Day 40 of gestation, and there was an increase in expression 
in uterine GE on Day 30. Placental expression of SLC2A4 mRNA was barely detectable 
by in situ hybridization analysis. 
Endometrial expression of SLC2A4 mRNA decreased in endometria of gilts in 
response to E2 (p<0.05; Figure 4.7C). Interestingly, localization of SLC2A4 mRNA
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Figure 4.7 Expression of SLC2A4 mRNA in endometria and placentae 
(A) Endometrial and (B) placental expression of SLC2A4 mRNA was not affected by 
day of the estrous cycle or pregnancy (p>0.05). (C,D) Endometrial expression of 
SLC2A4 mRNA increased in response to E2 and P4 (p<0.05). Values presented are 
means±SEM and p<0.05 is significant. 
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Figure 4.8 Cell-specific localization of SLC2A4 mRNA in endometria and placentae 
Corresponding bright-field and dark-field images detected SLC2A4 mRNA in uterine LE on Day 15 of the estrous cycle and 
pregnancy and in uterine LE through Day 50 of pregnancy. SLC2A4 mRNA localized to the uterine LE in response to both E2 
and P4. Width of field is 870 µm. The D15P Sense panel is the negative control. 
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suggested a decrease in abundance in uterine GE and an increase in expression in uterine 
LE (Figure 4.8). Since the uterine GE represents a greater percentage of cells in total 
endometrial tissue, the decrease seen in total endometrial tissue mRNA is not surprising. 
P4 also induced expression of SLC2A4 mRNA in uterine LE, although again, the 
abundance of SLC2A4 mRNA was greater in endometria from control gilts (p<0.05; 
Figure 4.7). 
 
SLC2A mRNAs Localize to Endometrial and Placental Endothelia During Pregnancy 
In addition to being expressed in epithelia at the uterine-placental interface, 
SLC2A transporter mRNAs were expressed in endothelia of blood vessels in both 
endometrial and placental tissues. The presence of SLC2A transporters in these 
endothelial cell layers is important for movement of glucose out of and into the 
endometrial and placental vasculatures. SLC2A1 mRNA was expressed in both 
endometrial and placental endothelia (Figure 4.9). SLC2A3 and SLC2A4 mRNAs were 
also present in endometrial and placental endothelia, although expression was lower than 
for SLC2A1. SLC2A4 mRNA appears to have higher expression in the placental 
endothelium than in the endometrial endothelium. 
 
SLC2A mRNAs Localize to Areolae and the Allantoic Epithelium During Pregnancy 
SLC2A1, SLC2A3, and SLC2A4 mRNAs were expressed in areolae, but SLC2A3 
appeared to have the greatest expression in areolae (Figure 4.10). The allantoic 
epithelium also expressed SLC2A1, SLC2A2, SLC2A3, and SLC2A4 mRNAs. 
 102 
 
 
Figure 4.9 SLC2A transporter mRNAs localize to the endometrial and placental 
endothelia during pregnancy 
Corresponding bright-field and dark-field images from in situ hybridization analysis show 
SLC2A1, SLC2A3, and SLC2A4 mRNAs in endothelia of endometrial and chorioallantoic blood 
vessels, which would allow movement of glucose out of and into the respective endometrial and 
placental vasculatures. Arrows indicate mRNA expression by blood vessels.  Height of field is 
870 µm. Legend: LE, luminal epithelium; GE, glandular epithelium. 
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Figure 4.10 SLC2A transporter mRNAs localize to areolae and the allantoic 
epithelium during pregnancy 
Corresponding bright-field and dark-field images from in situ hybridization analyis show 
SLC2A1, SLC2A3, and SLC2A4 mRNAs in the chorionic epithelium of areolae and in the 
allantoic epithelium. Expression of SLC2A3 mRNA was greater in areolar epithelia than in non-
areolar chorion. Arrows indicate areolae and allantoic epithelium.  Height of field is 870 µm.  
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Discussion 
Glucose is an essential nutrient for conceptus growth and development, but little 
is known about how glucose is transported in the pig endometrium and placenta. This 
study is the first to determine that: 1) SLC2A1, SLC2A2, SLC2A3, and SLC2A4 mRNAs 
are all expressed at the pig uterine-placental interface; 2) their individual temporal and 
spatial patterns of expression suggest that each has a unique role in glucose transport 
from the mother to the conceptus; and, 3) P4, the hormone of pregnancy secreted by the 
ovary, and E2, the maternal recognition of pregnancy signal secreted by the conceptus, 
likely act to increase SLC2A1 mRNA expression in the uterine epithelia. Figure 4.11 is a 
model depicting the multiple cell layers found at the pig uterine-placental interface and 
where transporters must be located, both by cell type and cell surface, to effectively 
transport glucose from mother to conceptus. The present results indicate that the 
endometrial endothelium expresses SLC2A1 and SLC2A3, which can transport glucose 
out of the maternal vasculature in pigs. The uterine LE expresses SLC2A1 and SLC2A4, 
although SLC2A1 expression is greatest. This is not surprising as SLC2A4 is insulin 
dependent. The conceptus removes glucose from the maternal blood continually, not just 
after meals, so having SLC2A1 as the prominent isoform would result in a more 
continuous movement of glucose into the conceptus. Early in pregnancy, the 
trophectoderm expresses SLC2A1, SLC2A2, and SLC2A3, but as pregnancy progresses, 
SLC2A3 becomes the most dominant isoform in the chorion. The allantoic epithelium 
expresses SLC2A1, SLC2A3, and SLC2A4 mRNAs, which would allow for movement of 
glucose either into or out of the glucose-rich allantoic fluid (Bazer et al., 1988). Finally,  
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Figure 4.11 A model for glucose transport from maternal to placental blood in pigs 
In an epitheliochorial placenta, glucose is transported from the maternal vasculature to 
the placental vasculature through multiple cell layers that comprise the uterine-placental 
interface. Movement of glucose requires GLUT transporters (ovals) on the apical (A) 
and basolateral (B) cell surfaces of each cell. Starting from the maternal blood, glucose 
is transported through an endothelium and into the uterine LE. The endothelial cells of 
the vasculature and the LE are in close proximity to facilitate this transport of glucose. 
Glucose is then transported out of the uterine LE and into the trophectoderm/chorion. 
Close proximity of the placental vasculature then facilitates movement of glucose from 
the trophectoderm/chorion, through the placental endothelium, and into the placental 
vasculature for use by the placenta and fetus. Glucose can also be transported into and 
out of the allantoic fluid through the allantoic epithelium. The arrows depict the 
direction of glucose movement. 
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the placental endothelium also expresses SLC2A1, SLC2A3, and SLC2A4 mRNAs for 
transport of glucose into the placental circulation.  
SLC2A1 and SLC2A3 are the prominent glucose transporters in the pig uterus and 
placenta, similar to what is observed in mice and humans (Jansson et al., 1995; Frolova 
and Moley, 2011a). Interestingly, SLC2A1 is the most abundant glucose transporter in 
the endometrium of most mammals studied, but the cell-specific localization of the 
transporter differs (Korgun et al., 2001; von Wolff et al., 2003; Gao et al., 2009a; 
Frolova and Moley, 2011b). In mice and humans, SLC2A1 is more abundant in the 
uterine stroma than epithelia, especially as decidualization progresses, while in the pig, 
SLC2A1 localizes to the uterine LE and GE. These differences in localization can be 
explained by major differences in type of implantation among species. The invading 
mouse and human blastocysts are supported by the decidualizing stromal cells 
immediately surrounding them, while the free-floating pig and sheep conceptuses must 
rely on molecules secreted or transported by uterine LE and GE into the uterine lumen 
during the peri-implantation period of pregnancy.  
The trophoblast cells of most mammalian species studied predominantly express 
the glucose transporter SLC2A3, although in mice and humans this expression is high in 
the first trimester, but decreases with advancing stage of gestation, while in the pig, 
SLC2A3 appears to be the prominent placental transporter in the trophectoderm/chorion 
through the beginning of the third trimester (Hahn et al., 2001; Ganguly et al., 2007; 
Brown et al., 2011). Similar to the endometrium, differences in expression of SLC2A3 
over time, and among species, can be attributed to utilization of different types of 
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implantation and placentation. SLC2A3 is a high-affinity transporter that will transport 
glucose efficiently even at low concentrations of glucose. During the first trimester in 
the mouse and human, the conceptus is in the process of establishing a connection with 
the maternal vasculature, but until this is firmly established, glucose has to be efficiently 
accrued from the surrounding decidualized stroma. In contrast, the pig conceptus never 
develops an intimate contact with the maternal vasculature since it develops an 
epitheliochorial placenta and, therefore, must continue to maximize the efficiency of 
glucose transport throughout pregnancy.   
Pig conceptuses remain free-floating within the uterine lumen for a protracted 
period of time prior to implantation as compared to humans or rodents. Pig embryos 
enter the uterus, develop into blastocysts, shed the zona pellucida, and then the 
presumptive placental membranes (trophectoderm and endoderm) elongate at a rate of 
30 to 40 mm/h from a 10 mm diameter sphere to a filamentous form that is 800-1,000 
mm in length by Day 16 of pregnancy. During this time, the free-floating conceptus is 
dependent upon the composition of uterine luminal fluid, including glucose, to support 
this extensive morphological remodeling of trophectoderm and endoderm during 
elongation. Glucose in the luminal fluid originates in the endometrium and has to be 
transported in through the uterine LE from the maternal vasculature in order to support 
this nutrient intensive process and allow the conceptus to survive and develop past this 
stage. The present data indicate that SLC2A1 is upregulated during this crucial period in 
the uterine LE and may be responsible for glucose transport into the uterine luminal 
fluid. Results of the present study also indicate that glucose in the uterine luminal fluid is 
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potentially transported into the conceptus through SLC2A2 and SLC2A3 transporters 
expressed by the trophectoderm. 
The maternal recognition of pregnancy signal in pigs is E2, which is secreted by 
the conceptus trophectoderm. In the pig, the corpora lutea can be maintained without any 
conceptuses present in the uterine horns when injections of exogenous E2 are 
administered daily between Days 11 to 14 of the estrous cycle, which mimics the 
maternal recognition of pregnancy signal. The present data clearly show that E2 
upregulates expression of SLC2A1 mRNA in uterine LE of pseudopregnant gilts, 
suggesting that estrogens secreted by the conceptus itself direct increased expression of 
this key glucose transporter in the endometrium. Previous studies have indicated that 
conceptus E2 upregulates gene expression of SPP1, STAT1, CD24, and FGF7 in the 
endometrium of pigs (White et al., 2005; Joyce et al., 2007; Ka et al., 2007; Ross et al., 
2007). These genes are specifically upregulated in the uterine LE between Days 12 and 
15 of pregnancy, which is also shown for SLC2A1 mRNA in this study. The 
psuedopregnant state provides an opportunity to determine the effects of E2 on the 
endometrium independent of other conceptus-secreted factors, but in an environment 
that is still under the influence of ovarian P4. Therefore, SLC2A1 mRNA can be 
upregulated by E2, independent of other conceptus-secreted factors, but may still rely on 
the presence of P4. 
When exogenous P4 was administered to ovariectomized gilts, there was 
upregulation of SLC2A1 mRNA in the uterine LE and GE. Therefore, it is reasonable to 
hypothesize that P4 induces SLC2A1 mRNA expression in uterine LE, while E2 
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amplifies this expression. A similar physiology has been demonstrated for the sheep 
where SLC2A1 mRNA is upregulated by P4, but enhanced by interferon tau (IFNT), the 
pregnancy recognition signal in sheep (Gao et al., 2009a). Both pigs and sheep enhance 
P4 induced SLC2A1 mRNA, and potentially glucose transport, with a conceptus-secreted 
signal. Regardless of whether a steroid hormone or a cytokine enhances expression of 
SLC2A1 mRNA, the observation that both species have this mechanism indicates that 
SLC2A1 is a particularly important glucose transporter for conceptus growth and 
development in species with a protracted period of development of the conceptus before 
implantation. 
Expression of SLC2A1 mRNA by GE was not upregulated by E2, but only by P4. 
This indicates a differential regulation of SLC2A1 expression by these two epithelia. The 
P4 nuclear receptor (PGR) is downregulated in the uterine LE by Day 10 and only 
partially downregulated in the GE by Day 12, although the endometrial stromal cells 
continue to express PGR (Geisert et al., 1994). Therefore, increased SLC2A1 mRNA 
expression in the uterine LE is potentially due to a downregulation of PGR, which 
allows E2 to have an effect through the estrogen receptor (ESR1). Alternatively, 
increased expression of SLC2A1 mRNA in uterine GE is potentially due to paracrine-
acting growth factors (progestamedins) being produced by the PGR-positive stromal 
cells in response to P4 (Johnson et al., 2000). This regulation of a glucose transporter in 
the uterine LE and GE illustrates the complex interactions that take place between the 
uterus, conceptus, and ovary to orchestrate successful conceptus development through 
the peri-implantation period of pregnancy in pigs. Further studies will be necessary to 
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determine if other SLC2A glucose transporters, and other nutrient transporters in 
general, can also be regulated by the steroid hormones, E2 and P4. 
The pig develops a diffuse, epitheliochorial type placenta to support the growth 
of each individual fetus. This placentation is characterized as superficial, non-invasive, 
and having a uterine LE that remains intact throughout pregnancy. By Day 24 of 
pregnancy, there is complete attachment between the uterine LE and the conceptus 
trophectoderm and these adhered epithelia begin to fold around Day 30 to increase 
surface area for nutrient transport (Friess et al., 1980). The trophectoderm expresses 
SLC2A3 mRNA from Day 15 when attachment is just beginning, and continues to be 
expressed in the chorion through Day 85 of pregnancy. SLC2A3 is also expressed in the 
tips of the uterine villi in the uterine LE at Day 60 of pregnancy (Figure 4.6), which is a 
site where the maternal and placental vasculatures are within 2 microns of each other, 
the closest they ever come together during pregnancy (Friess et al., 1980). Additionally, 
the maternal and fetal capillaries are arranged in a cross-countercurrent manner on 
opposite sides of the adhered, folded epithelia. If the fetal side of the placenta is “up”, 
then maternal blood enters at the top of the folds and exits at the bottom. In contrast, the 
placental blood enters at the bottom of the folds and exits at the top (Leiser and Dantzer, 
1988). This arrangement allows for optimum transport of nutrients, especially those 
dependent on concentration gradients, such as glucose, from mother to fetus. By 
localizing to the LE at the top of the uterine folds, SLC2A3, as a high-capacity and high-
affinity transporter, is in an optimal position for transporting the maximal amount of 
glucose across the uterine-placental interface at a period of pregnancy when placental 
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growth is slowing, but fetal growth is beginning to increase exponentially (Ullrey et al., 
1965; Knight et al., 1977).  
SLC2A1 mRNA also localized to the trophectoderm and chorion on all days of 
pregnancy studied, although with less abundance than in the endometrium. Our 
laboratory has not developed a model to explore the regulation of genes in the placenta, 
although the same molecules that regulate gene expression in the endometrium, E2 and 
P4, may also drive gene expression in the placenta. Tung et al. demonstrated that 
SLC2A1 protein was expressed in the chorion and placental endothelia of gilts at Day 50 
of pregnancy and that expression was upregulated by exogenous growth hormone (Tung 
et al., 2012). These findings suggest that there are a number of different regulators of 
expression of the glucose transporters at the uterine-placental interface and indicate an 
area where further study in necessary. 
In the pig, areolar structures form over the mouths of endometrial glands to 
transport large amounts of nutrients from the glandular epithelia into the specialized 
microvasculature on the placental side of areolar chorion cells (Renegar et al., 1982; 
Leiser and Dantzer, 1994). SLC2A2 and SLC2A3 are highly expressed in the areolae and 
this is an optimal location for these high capacity transporters to move glucose from the 
uterine GE to the placental vasculature. 
Once glucose is transported across the chorion by SLC2A3, it is necessary that 
transporters be strategically placed to move glucose both into the placental vasculature 
and into the allantoic cavity, which is filled with a hypotonic solution composed of 
electrolytes, sugars, proteins, and water that are of maternal and fetal origin, which 
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provide a nutrient reservoir for the fetus (Aherne et al., 1969; Wu et al., 1995). Glucose 
is found in substantial amounts in this fluid and, therefore, must be transported through 
the allantoic epithelium (Bazer et al., 1988). The present data indicate that SLC2A1, 
SLC2A3, and SLC2A4 mRNAs localize to the placental endothelium, although SLC2A1 
appears to be the most abundant transporter in this cell type. Further, SLC2A1, SLC2A3, 
and SLC2A4 mRNAs have the potential to transport glucose through the allantoic 
epithelium (see Figure 4.11).  
In summary, results of this study indicate differential temporal and spatial 
expression, localization, and hormonal regulation of the facilitative diffusion glucose 
transporters SLC2A1, SLC2A2, SLC2A3, and SLC2A4 at the uterine-placental interface 
of pigs during pregnancy (see Figure 4.11). The localization of these transporters 
indicates that glucose can be transported from the maternal endometrial blood by 
SLC2A1, and then through the chorioallantois to the placental blood by SLC2A3, which 
is clearly demonstrated by comparing the in situ hybrization panels at Day 20 of 
pregnancy in Figure 4.3 and Figure 4.6. The SLC2A transporters necessary to transport 
glucose, a nutrient necessary for survival and development of the conceptus, are 
upregulated by E2 from the conceptus trophectoderm, and P4 from the maternal ovary, 
indicating that glucose transport is dependent on steroid hormones during pregnancy in 
pigs. 
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CHAPTER V 
FRUCTOSE SYNTHESIS AND TRANSPORT AT THE UTERINE-PLACENTAL 
INTERFACE OF PIGS: CELL-SPECIFIC LOCALIZATION OF SLC2A5, SLC2A8, 
AND COMPONENTS OF THE POLYOL PATHWAY 
 
Introduction 
Glucose and fructose are abundant hexose sugars in porcine endometria and 
conceptuses (embryo/fetus and associated placenta), but little is known about the 
synthesis, transport, and metabolism of fructose at the uterine-placental interface. The 
presence of fructose in conceptuses is unique to species with epitheliochorial or 
synepitheliochorial placentae, indicating that fructose may be important for growth and 
development of fetuses supported by these types of placentation (Goodwin, 1956). 
Fructose plays a minor role as an energy source in the placenta and fetus, because 
fructose is oxidized to CO2 at only ~20% the rate of glucose (Meznarich et al., 1987).  
However, studies indicate that fructose can be used as a substrate in a number of 
metabolic pathways that could support conceptus development, including biosynthesis of 
glycosaminoglycans, phospholipids, and nucleic acids (White et al., 1982). Recently, in 
vitro studies demonstrated that porcine trophectoderm cells can metabolize fructose 
through the hexosamine biosynthetic pathway to stimulate the mechanistic target of 
rapamycin (mTOR) cell signaling and cell proliferation, and for the synthesis of 
hyaluronic acid, a significant glycosaminoglycan in the placenta (Kim et al., 2012).  
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Fructose is detected in uterine flushings of pregnant gilts as early as Day 12 and 
is present in greater quantities than glucose in allantoic fluid and fetal blood (Aherne et 
al., 1969; Zavy et al., 1982; Bazer et al., 1988). Additionally, fructose is undetectable in 
blood of pregnant gilts and sows (Pere, 1995). Studies by White et al. demonstrated that 
fructose injected intraperitoneally into an in utero fetus cannot cross the placenta or be 
converted into glucose, but glucose injected in the same manner can cross the placenta 
and be converted to fructose (White et al., 1979). Those results suggest the placenta is 
the site of fructose production, and it is hypothesized that fructose synthesis from 
glucose is a method for the conceptus to sequester a hexose sugar from the mother (Zavy 
et al., 1982).  
Glucose can be transported from maternal blood into pig endometrial luminal 
epithelium (LE), conceptus trophectoderm/chorion, and placental blood by solute carrier 
transporters SLC2A1, SLC2A3, and SLC2A4 (see Chapter IV). It is reasonable to 
hypothesize that fructose can then be synthesized from this glucose via the polyol 
pathway, through which glucose and NADPH are first converted to sorbitol and NADP+ 
by aldose reductase (AKR1B1), then sorbitol and NAD+ are converted to fructose and 
NADH, respectively, by sorbitol dehydrogenase (SORD). The intermediate, sorbitol, is 
found in high concentrations in ovine, bovine, and human placentae, especially during 
early pregnancy (Teng et al., 2002; Brusati et al., 2005; Jauniaux et al., 2005) and the 
enzyme that converts sorbitol to fructose, SORD, has been localized to the 
trophectoderm of bovine conceptuses (Rama et al., 1973), but there is nothing known 
about the polyol pathway or its components in pigs.   
 115 
 
After synthesis, fructose can be transported across cell membranes by members of 
the facilitative diffusion solute carrier 2A family of glucose transporters (SLC2A). Two 
members, SLC2A5 and SLC2A8, have an affinity for fructose. SLC2A8 is necessary for 
decidualization of the uterus in mice during implantation of blastocysts, most likely due 
to its ability to transport glucose into the differentiating stromal cells, but SLC2A5 has not 
been detected in human or rodent endometria or placentae (Kim and Moley, 2009; Frolova 
and Moley, 2011a; Adastra et al., 2012). Since humans and rodents, unlike pigs, do not 
have fructogenic placentae, differences would be expected in expression of these 
particular transporters. 
Once fructose enters into a cell, the first metabolic step is the addition of a 
phosphate group, which is catalyzed by ketohexokinase (KHK) to produce the metabolite 
fructose-1-phosphate (F-1-P). F-1-P can either be catalyzed into glyceraldehyde-3-
phosphate and dihydroxyacetone phosphate for entry into the glycolytic pathway or it can 
act as a signaling molecule to induce NFkB activation and subsequent production of 
cytokines (Feinman and Fine, 2013; Lanaspa et al., 2014). 
Our hypothesis is that specific cell types in the endometrium and chorioallantois 
utilize the polyol pathway to convert glucose to fructose to support growth and 
development of the conceptus.  This aims of this study were to determine the cellular 
localization of enzymes required for synthesis of fructose, the transport system for 
fructose, and the cells of the placenta and endometrium of pigs that use fructose.   
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Material and Methods 
 
Tissue Collection 
Sexually mature, 8-month-old crossbred gilts were observed daily for estrus (Day 
0) and exhibited at least two estrous cycles of normal duration (18 to 21 days) before 
being used in these studies.  All experimental and surgical procedures were in 
compliance with the Guide for Care and Use of Agricultural Animals in Teaching and 
Research and approved by the Institutional Animal Care and Use Committee of Texas 
A&M University.  
To evaluate the effects of pregnancy on expression of mRNAs and cell-specific 
localization of the proteins AKR1B1, SORD, KHK, SLC2A5, and SLC2A8, gilts were 
assigned randomly to either cyclic or pregnant status.  Cyclic gilts were 
ovariohysterectomized on either Day 5, 9, 11, 13, 15 or 17 of the estrous cycle. Gilts in 
the pregnant group were bred and ovariohysterectomized on either Day 9, 11, 13, 15, 17, 
20, 30, 40, 50, 60, or 85 of pregnancy (n = 3 or 4 gilts/day/status). The lumen of each 
uterine horn in each gilt was flushed with 20 ml physiological saline for those collected 
on Days 5 to 17 post-estrus. Pregnancy was confirmed in mated gilts by the presence of 
morphologically normal conceptuses in uterine flushings. The uterine flushings were 
frozen for storage at -80°C until analysis.  Tissue sections (~1 cm thick) from the middle 
of each uterine horn of all hysterectomized gilts were fixed in fresh 4% 
paraformaldehyde in PBS (pH 7.2) and embedded in Paraplast-Plus (Oxford Laboratory, 
St. Louis, MO). Additionally, endometrium was physically dissected from the 
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myometrium, snap-frozen in liquid nitrogen, and stored at -80°C for RNA extraction. 
Chorioallantoic tissue was physically dissected from endometrium and frozen in a 
similar manner. 
Progesterone and Estrogen Models 
To evaluate effects of estrogen (E2) and E2-induced pseudopregnancy on 
endometrial expression of AKR1B1, SORD, KHK, SLC2A5, and SLC2A8 mRNAs and 
cell-specific localization of their proteins, gilts were detected in estrus (Day 0) and 
assigned randomly to receive daily intramuscular injections of estradiol benzoate (E2; 5 
mg in corn oil; n = 4) or corn oil alone (CO; n = 4) on Days 11, 12, 13, and 14 of the 
estrous cycle (Joyce et al., 2007).  All gilts were ovariohysterectomized on Day 15 of 
pseudopregnancy. Tissues were collected as described previously. 
To evaluate effects of long-term progesterone (P4) treatment without ovarian 
hormones on endometrial expression of AKR1B1, SORD, KHK, SLC2A5, and SLC2A8 
mRNAs and cell-specific localization of their respective proteins, gilts were 
ovariectomized on Day 12 of the estrous cycle and assigned randomly to receive daily 
intramuscular injections of either CO (4 ml) or P4 (200 mg P4 in 4 ml CO) on Days 12 
through 39 post-estrus (n = 3/treatment) (Bailey et al., 2010c).  All gilts were 
hysterectomized on Day 40 post-estrus and tissues collected as previously noted. 
To evaluate effects of E2, P4, and their interaction independent of ovarian 
hormones on endometrial expression of AKR1B1, SORD, KHK, SLC2A5, and SLC2A8 
mRNAs and cell-specific localization of their respective proteins, gilts were 
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ovariectomized on Day 4 of the estrous cycle and assigned randomly to be treated daily 
from Day 4 through Day 12 as follows: 1) 200 mg P4 in CO (P4); 2) 5 mg E2 in CO 
(E2); 3) 200 mg P4 + 5 mg E2 in CO (P4+E2); or 4) CO alone (CO) (Ka et al., 2007). 
All gilts were hysterectomized on Day 12 and tissues collected as previously described. 
Total Recoverable Fructose 
Uterine flushings from Day 11 and Day 15 of the estrous cycle and pregnancy 
were analyzed for total recoverable fructose. The High Sensitivity Fructose Assay Kit 
(Sigma-Aldrich, St. Louis, MO) was used  to determine concentrations of fructose in 
uterine flushings according to the manufacturer’s instructions. Briefly, samples were 
deproteinated using a 10kDa MWCO spin filter (VWR) at 15,000 x g for 5 min. Sample 
Clean-up Mix was added to each sample to remove glucose. To account for high 
background levels, a sample blank without the Conversion Enzyme was run for each 
sample and subtracted from the sample readings during calculations. Total recoverable 
fructose was calculated by multiplying the concentration of fructose (determined with 
the kit) by total recoverable volume of uterine flushings (recorded at the time of sample 
collection). 
RNA Extraction and cDNA Synthesis 
Total RNA was extracted from endometrial and chorioallantoic tissue samples 
using Trizol reagent (Life Technologies, Carlsbad, CA) according to manufacturer’s 
recommendations.  First strand cDNA was synthesized using Superscript III First Strand 
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Kit (Life Technologies, Carlsbad, CA) according to the manufacturer’s instructions. First 
strand cDNA was diluted 10x before use in the qPCR reaction. 
Primers for qPCR and in situ hybridization were designed using NCBI Genbank 
sequences and Primer-BLAST (http://www.ncbi.nlm.nih.gov/). Primers were submitted 
to BLAST to test for specificity against the known porcine genome. Primer information 
can be found in Table 1. 
Quantitative PCR 
The qPCR assays were performed as described previously (Chapters III and IV 
of this dissertation). Briefly, PerfeCta SYBR Green Mastermix (Quanta) was used in 10 
µl reactions with 2.5 mM of each specific primer, on a Roche 480 Lightcycler (Roche) 
with approximately 60 ng of cDNA per reaction. The PCR program began with 5 min at 
95°C followed by 40 cycles of 95°C denaturation for 10 sec and 60°C 
annealing/extension for 30 sec. A melt curve was produced with every run to verify a 
single gene-specific peak. Standard curves with 2-fold serial dilutions were run to 
determine primer efficiencies. All primer correlation coefficients were greater than 0.95 
and efficiencies were 95-102%. The geometric mean of TBP, SDHA, and ACTB was 
used to normalize data from endometrial tissue, while the geometric mean of TBP, 
HPRT1, and TUBA1B used to normalize data from chorioallantoic tissue. The 2-ΔΔCt 
Method was used to normalize data and those fold changes were subjected to statistical 
analyses.
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Gene 
Name 
Method Gene ID Sequence Product 
Length 
AKR1B1 qPCR NM_001001539.2 F: 5'- CTGAACGCATTGCCGAGAAC -3'  
R: 5'- AGCTCATCAAGGCACAGACC -3' 
111 
KHK qPCR XM_003125300.3 F: 5'-GCTCTTGCTGCATCGTCAAC-3'  
R: 5'-TTCCGGCCCTCAATGTGGAT-3' 
139 
SLC2A5 qPCR XM_003361556.2 F: 5'-CGGCTCCTCCTTCCAGTATG-3'     
R: 5'-GGACACAGACACAGACCACA-3' 
151 
SLC2A5 ISH XM_003361556.2 F: 5'-AGACCAAAGATCTGGGCCAC-3' 
R: 5'-CGGCTCCTCCTTCCAGTATG-3' 
468 
SLC2A8 qPCR XM_003480608.2 F: 5'-GTCAGGTGTGGTCATGGTGT-3' 
R: 5'-TTGACGTGCAGAGGGAAGA-3' 
246 
SORD qPCR NM_001244162.1 F: 5'-TGGTGTCTGATCTGTCTGCG -3'  
R: 5'-GGCTCTCGTTGGAGATCTGG-3' 
84 
ACTB qPCR XM_003124280.3 F: 5'-TCCCTGGAGAAGAGCTACGA-3' 
 R: 5'-TGTTGGCGTAGAGGTCCTTC-3' 
187 
HPRT1 qPCR DQ845175 F: 5'-GGACTTGAATCATGTTTGTG-3' 
 R: 5'-CAGATGTTTCCAAACTCAAC-3' 
91 
SDHA qPCR XM_005659031.1 F: 5'-CTACAAGGGGCAGGTTCTGA-3'   
R: 5'-AAGACAACGAGGTCCAGGAG-3' 
141 
TBP qPCR DQ845178 F: 5’-AACAGTTCAGTAGTTATGAGCCAGA-3’ 
R: 5’-AGATGTTCTCAAACGCTTCG-3’ 
153 
TUBA1B qPCR NM_001044544.1 F: 5'-GCTGCCAATAACTATGCCCG-3'   
R: 5'-ACCAAGAAGCCCTGAAGACC-3' 
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Table 5.1 Primer information for genes of interest 
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In situ Hybridization 
Cell-specific expression of SLC2A5 mRNA in the porcine endometrium and 
placenta was determined by radioactive in situ hybridization analysis as described 
previously (Johnson et al., 1999). Briefly, a partial cDNA for porcine SLC2A5 mRNA 
was cloned from total RNA from Day 15 pregnant porcine endometrial tissue using 
specific primers (Table 5.1) and PCR amplification was conducted as follows: 1) 95°C 
for 5 min; 2) 95°C for 45 sec, 60°C for 30 sec, and 72°C for 1 min for 35 cycles; and 3) 
72°C for 10 min. The partial cDNA of the correct predicted size was cloned into a pCRII 
plasmid using a T/A Cloning Kit (Life Technologies) and the sequence verified using an 
ABI PRISM Dye Terminator Cycle Sequencing Kit and ABI PRISM automated DNA 
sequencer (Perkin-Elmer Applied Biosystems). 
Radiolabeled antisense or sense cRNA probes were generated by in vitro 
transcription using linearized plasmid templates, RNA polymerases, and [α-35S]-UTP. 
Deparaffinized, rehydrated, and deproteinated uterine tissue sections (5µm thick) were 
hybridized with radiolabeled antisense or sense cRNA probes.  After hybridization, 
washing, and ribonuclease A digestion, slides were dipped in NTB-2 liquid photographic 
emulsion (Kodak, Rochester, NY), and exposed at 4C for ten days.  Slides were 
developed in Kodak D-19 developer, counterstained with Harris modified hematoxylin 
(Fisher Scientific, Fairlawn, NJ), and then dehydrated through a graded series of alcohol 
to Citrosolv (Fisher Scientific). Coverslips were affixed with Permount (Fisher).  Slides 
were evaluated using an Axioplan 2 microscope (Carl Zeiss, Thornwood, NY) interfaced 
with an Axioplan HR digital camera and Axiovision 4.3 software, and digital images of 
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representative fields recorded under brightfield or darkfield illumination.  Photographic 
plates were assembled using Adobe Photoshop (version 6.0, Adobe Systems Inc., San 
Jose, CA). 
 
Immunohistochemistry 
AKR1B1, SORD, KHK, and SLC2A8 proteins were immunolocalized in porcine 
uterine and conceptus tissues as described previously (Joyce et al., 2005). A rabbit anti-
human AKR1B1 polyclonal immunoglobulin (IgG; catalog no. GTX113381; GeneTex, 
Inc., Irvine, CA), a rabbit anti-human SORD polyclonal IgG (catalog no. sc-366370; 
Santa Cruz Biotechnology, Inc., Dallas, TX), a rabbit anti-human KHK polyclonal IgG 
(catalog no. GTX109591; GeneTex, Inc.), and a rabbit anti-mouse SLC2A8 IgG (catalog 
no. GTX12394; GeneTex, Inc.) were used at 8.9 µg/ml, 5 µg/ml, 8.7 µg/ml, and 5 µg/ml, 
respectively. Antigen retrieval was performed using a boiling citrate buffer for anti-
SORD and anti-SLC2A8, protease for anti-AKR1B1, and no retrieval for anti-KHK. 
Additionally a rabbit anti-pig interferon gamma (IFNG) polyclonal IgG (catalog no. 
I7662-16N8; United States Biologicals, Salem, MA) was used at 5 µg/ml with the 
boiling citrate buffer antigen retrieval for identification of trophectoderm tissue. Purified 
non-relevant rabbit IgG, at the same concentration as the corresponding primary IgG, 
was used as the negative control. Immunoreactive protein was visualized in paraffin-
embedded sections (5µm thick) using the Vectastain ABC Kit (catalog no. PK-4001; 
Vector Laboratories, Inc., Burlingame, CA) according to kit instructions with 3,3'-
diaminobenzidine tetrahydrochloride (catalog no. D5637; Sigma-Aldrich, St. Louis, 
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MO) as the color substrate. Sections were counterstained with Harris modified 
hematoxylin (Fisher Scientific) and coverslips were affixed using Permount mounting 
medium (Fisher Scientific).  Digital images of representative fields of immune-stained 
tissue were recorded under bright-field illumination and photographic plates assembled 
as described for in situ hybridization. 
 
Statistical Analyses 
The qPCR data for normal tissues were analyzed for effects of day, pregnancy 
status, and their interaction for Days 9, 11, 13, 15 and 17 by 2-way ANOVA via the 
General Linear Models (GLM) procedures of the Statistical Analysis System (SAS 
Institute, Cary, NC) with the least significant difference (LSD) multiple testing method. 
The qPCR data were also subjected to a sliding time window linear regression analysis 
to determine if there was an effect of day of gestation on the gene expression for the 
genes of interest throughout pregnancy (Days 9 to 85). The sliding time windows of the 
analysis were designed to detect effect of day on gene expression during three 
biologically relevant periods of time: the beginning, the middle, and the end of the study 
period. Each window analyzed contained a minimum of three days. Some windows 
contained greater than three days as long as the regression model showed a non-
decreased performance in terms of the r2 and the p-value of the F-statistics. 
The data from the hormone therapy studies were analyzed using the Students t-
test. Data on total recoverable fructose in uterine flushing were analyzed for effects of 
day, pregnancy status, and their interaction for Days 11 and 15 by 2-way ANOVA via 
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the GLM procedures of SAS with the least significant difference (LSD) multiple testing 
method. All data are presented as mean±standard errors of the mean with significance at 
p<0.05. 
 
Results 
 
Total Recoverable Fructose Increases in Uterine Flushings From Pregnant Gilts  
 Total recoverable fructose in the uterine flushings from Days 11 and 15 of the 
estrous cycle and early pregnancy was determined (Figure 5.1). Total fructose was 
significantly higher in fluid from Day 15 pregnant compared to Day 11 or 15 cycling and 
Day 11 pregnant gilts (day x status p<0.01) indicating that the free-floating conceptus is 
exposed to increasing levels of fructose during the peri-implantation period of 
pregnancy. 
 
SLC2A8 Is Expressed in Uterine LE During the Peri-Implantation Period, and Is 
Expressed By the Placenta For the Majority of Pregnancy 
 SLC2A8 is a fructose and glucose transporter that is highly expressed during the 
estrous cycle and early pregnancy in pigs. Endometrial mRNA for SLC2A8 increased 
from Days 5 through 11, then decreased through Day 20 with no differences between 
cyclic and pregnant gilts (Figure 5.2a; day p<0.01). There was a decrease in expression 
of SLC2A8 mRNA in endometria from Days 9 to 85 of pregnancy (r2=0.198; p<0.01), 
but expression increased in the placenta from Days 30 to 50, and then decreased to Day
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Figure 5.1 Total recoverable fructose in uterine flushings from cyclic and pregnant 
gilts 
Fructose increased in the uterine flushings between Days 11 and 15 of pregnancy with no change 
during the estrous cycle (day x status p<0.01). Differing letters indicate significant differences. 
Values are presented as mean±SEM. 
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85 of pregnancy (Figure 5.2b; r2=0.909; p<0.05). In endometria from gilts treated with 
exogenous E2, expression of SLC2A8 mRNA was less than for control gilts (Figure 5.2c; 
p<0.05) and there was no effect of P4 on expression of SLC2A8 mRNA (Figure 5.2d; 
p>0.05). SLC2A8 protein was expressed in uterine GE of cyclic and pregnant gilts by 
Day 9 after onset of estrus.  SLC2A8 protein was first observed in uterine LE of 
pregnant gilts on Day 13, and was maintained though Day 15.  Expression of SLC2A8 
protein in uterine LE was limited to Day 15 in cyclic gilts (Figure 5.3). SLC2A8 was 
detected in uterine LE until Day 30 of pregnancy after which time expression 
transitioned from uterine LE to chorion, and specifically in the tall columnar cells at the 
top of the uterine folds. Expression of SLC2A8 protein in uterine GE decreased from 
Days 20 to 25 and remained detectable at very low abundance through Day 85 of 
pregnancy. Placental areolae and blood vessels in the placental stroma expressed 
SLC2A8 from Day 30 to Day 85. 
 Since SLC2A8 mRNA expression peaked on Day 11 of both the estrous cycle and 
early pregnancy, an additional hormone therapy model was utilized to elucidate 
regulation of expression of SLC2A8. In this model, ovariectomized gilts were given 
exogenous E2, P4, E2+P4, or neither, to mimic the normal exposure of the endometrium 
to these hormones during early pregnancy, then endometrium was collected on Day 12 
after onset of estrus. Endometrial expression of SLC2A8 mRNA was greatest in response 
to P4 treatment (Figure 5.4a). The effect of P4 to stimulate expression of SLC2A8 
mRNA decreased when administered in combination with E2, while treatment with CO 
or E2 alone decreased expression of SLC2A8 mRNA (p<0.05). Using 
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Figure 5.2 Expression of SLC2A8 mRNA in endometria and placentae 
Endometrial expression of SLC2A8 mRNA (A) increased from Day 5 to Day 11 during both the 
estrous cycle and pregnancy, then decreased through Day 20 of gestation (p<0.01). Placental 
expression of SLC2A8 mRNA (B) increased from Day 30 to Day 50, then decreased to Day 85 of 
pregnancy (r2=0.909; p<0.05). E2-treatment decreased SLC2A8 mRNA levels compared to 
controls (C; p<0.05), while there was no effect of P4 treatment (D; p>0.05). Values presented 
are mean±SEM with p<0.05 as significant. 
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Figure 5.3 Immunohistochemical localization of SLC2A8 at the uterine-placental 
interface 
SLC2A8 protein was detected by Day 9 in the GE of endometria from the estrous cycle and 
pregnancy, while LE expression was observed on Day 13 of pregnancy and Day 15 of the 
estrous cycle. SLC2A8 was detected in LE until Day 30 when the localization transitioned to the 
CE. SLC2A8 was observed in the smooth muscle surrounding the placental blood vessels at Day 
30. By Day 60, SLC2A8 was only detected in the areolae and placental blood vessels. Rabbit 
IgG was used as a negative control. Width of field is 890 µm. Legend: LE, luminal epithelium; 
GE, glandular epithelium; ST, stroma; CE, chorion; BV, blood vessel. 
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Figure 5.4 Regulation of expression of SLC2A8 by P4 and E2  
Endometrial expression of SLC2A8 mRNA (A) was greatest in endometria of P4-treated gilts, 
was suppressed in E2+P4-treated gilts as compared to P4-treatment alone, and was lowest in E2- 
and CO-treated gilts. Differing letters represent significant differences (p<0.05). Values are 
presented as means±SEM.  Immunostaining (B) detected SLC2A8 protein in the uterine LE and 
GE of P4-treated gilts and endometria from P4+E2-treated gilts had apical and basal cell surface 
staining in the uterine LE. In E2-treated gilts, immunostaining was observed in the smooth 
muscle surrounding blood vessels in the endometrium, while in CO-treated gilts immunostaining 
was barely detectable in uterine GE. Width of field is 870 µm except 63X (140 µm). Rabbit IgG 
was used as a negative control. Legend: LE, luminal epithelium; GE, glandular epithelium; BV, 
blood vessel. 
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Figure 5.5  Localization of SLC2A8 protein in the pig conceptus 
SLC2A8 protein was detected in the conceptus trophectoderm on Day 11 of pregnancy. At Day 
15 and 17, SLC2A8 was co-distributed with IFNG, indicating expression by trophectoderm, but 
not endoderm. Width of field is 5.45 mm (2.5X), 890 µm (10X), and 230 µm (40X). Legend: Tr, 
trophectoderm. 
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immunohistochemistry, SLC2A8 localized to the apical and basal cell surfaces of uterine 
LE and GE from gilts treated with P4 or P4+E2 (Figure 5.4b). The E2 treated gilts had a 
marked decrease in overall expression of SLC2A8 in the endometrium compared to that 
for gilts treated with P4, but there was detectable SLC2A8 protein in the smooth muscle 
surrounding the blood vessels. The CO treated gilts had no detectable SLC2A8 protein 
in uterine LE, sporadic protein in uterine GE, and no detectable protein in any other cell 
type. Results from this experiment suggest that P4, either directly or indirectly, is a 
positive regulator of expression of SLC2A8 in uterine LE and GE, while E2 may 
modulate induction of expression of SLC2A8 by P4 and increase expression of SLC2A8 
in the tunica media of blood vessels in the uterus. 
 SLC2A8 protein was detected in conceptuses beginning at Day 11 (Figure 5.5). 
At Day 15, SLC2A8 was detected in the same cells that express IFNG, which are has 
previously been reported to localize only to the trophectoderm, not the endoderm, cells  
(Lefèvre et al., 1998). The embryo at Day 15 also expressed SLC2A8 in what appears to 
be the somites. SLC2A8 continued to be expressed in the trophectoderm on Day 17 of 
pregnancy.  
 
Expression of SLC2A5 Increases in Uterine LE and GE,  
and Placental CE as Pregnancy Progresses 
 The abundance of endometrial mRNA for the fructose transporter SLC2A5 
increased from Day 25 to Day 85 of pregnancy (Figure 5.6a; r2=0.869; p<0.01). From 
Days 11 to 13, mRNA expression was higher in endometria from cycling gilts compared 
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Figure 5.6 Expression of SLC2A5 mRNA in endometria and placentae 
Endometrial expression of SLC2A5 mRNA (A) increased from Day 25 to Day 85 of pregnancy 
(r2=0.869; p<0.01). Expression of SLC2A5 mRNA in placentae (B) did not change from Days 30 
through 85 (p>0.05). E2-treatment of gilts had no effect (C; p>0.05), but P4-treatment increased 
SLC2A5 mRNA in endometria compared to control gilts (D; p<0.01). Values presented are 
mean±SEM with p<0.05 as significant. 
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Figure 5.7  Cell-specific localization of SLC2A5 mRNA by in situ hybridization at 
the uterine-placental interface 
Corresponding bright-field and dark-field images indicated that SLC2A5 mRNA was lowly 
expressed in uterine LE and GE during the estrous cycle and early pregnancy. By Day 25 of 
pregnancy, expression increased in uterine LE and continued to increase through Day 85 of 
pregnancy in both uterine LE and GE. SLC2A5 mRNA also localized to the chorion from Day 25 
through Day 85 of pregnancy. In endometria from the P4-treated gilts, SLC2A5 mRNA localized 
to the uterine LE and GE. The sense panels are the negative control. Width of field is 890 µm. 
Legend: LE, luminal epithelium; GE, glandular epithelium; ST, stroma; CE, chorion. 
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to the corresponding Days of pregnancy (day x status p<0.05). Placental expression of 
SLC2A5 mRNA did not change from Days 30 to 85 of pregnancy (Figure 5.6b; p>0.05).   
E2 had no effect on endometrial expression of SLC2A5 mRNA (p>0.05; Figure 5.6c), 
but P4 increased expression of SLC2A5 mRNA compared to CO treated gilts (p<0.01; 
Figure 5.6d). In situ hybridization analysis localized SLC2A5 mRNA to the uterine LE 
and GE at low levels during the estrous cycle and early pregnancy with increasing 
expression in those cells and the CE through Day 85 of pregnancy (Figure 5.7). 
Additionally, treatment with exogenous P4 increased the expression of SLC2A5 mRNA 
in uterine LE and GE. 
 
AKR1B1 Is Expressed in Uterine LE During the Peri-Implantation Period, and in 
Trophectoderm/Chorion For the Majority of Pregnancy 
 Aldose reductase (AKR1B1) catalyzes the conversion of glucose to sorbitol as 
the first step in the polyol pathway. Endometrial expression of AKR1B1 mRNA 
increased from Days 9 to 11, and then decreased through Day 15 with higher expression 
in endometria from pregnant gilts (Figure 5.8a; day x status, p<0.05). Endometrial 
expression of AKR1B1 mRNA did not change from Days 9 to 20 (p>0.05), but increased 
from Days 25 to Day 85 of pregnancy (r2=0.924; p<0.01). Placental expression of 
AKR1B1 mRNA was not different between Days 30 and 85 (Figure 5.8b; p>0.05). 
Treatment of gilts with E2 decreased endometrial expression of AKR1B1 mRNA 
compared to that for endometria from cycling control gilts (p<0.05; Figure 5.8c), and P4 
had no effect (p>0.05; Figure 5.8d).
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Figure 5.8 Expression of AKR1B1 mRNA in endometria and placentae 
Endometrial expression of AKR1B1 mRNA (A) increased from Day 9 to Day 11, decreased until 
Day 15 (day x status p<0.05), then increased from Day 25 to Day 85 of pregnancy (r2=0.924; 
p<0.01). Placental expression of AKR1B1 mRNA (B) did not change between Days 30 and 85 of 
gestation (p>0.05). E2-treatment of gilts decreased AKR1B1 mRNA compared to controls (C; 
p<0.05), while P4-treatment had no effect (D; p>0.05). Values presented are mean±SEM with 
p<0.05 as significant. 
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Figure 5.9 Immunohistochemical localization of AKR1B1 at the uterine-placental 
interface 
AKR1B1 localized to uterine LE from Day 13 through Day 15 of pregnancy and to the 
trophectoderm as early as Day 15. Expression of AKR1B1 continued in the chorion through Day 
85 of pregnancy. Rabbit IgG was used as a negative control. Width of field is: 890 µm for D5, 
D20P, D30P, D40P, D60P, D60P IgG; 445 µm for D9, D11, D13, D15; 572 µm for D15 
conceptus; 1208 µm for D85P. Legend: LE, luminal epithelium; GE, glandular epithelium; ST, 
stroma; Tr, trophectoderm; CE, chorion. 
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AKR1B1 protein was localized to the uterine LE of pregnant gilts and to 
placental trophectoderm/chorion.  AKR1B1 was first observed in uterine LE on Day 13 
of pregnancy, but not the estrous cycle (Figure 5.9). By Day 20, AKR1B1 was barely 
detectable in the endometrium, and was not observed in uterine LE through Day 85. In 
contrast, the conceptus trophectoderm expressed AKR1B1 as early as Day 15 and 
expression continued in the chorion through Day 85 of pregnancy. There was low 
abundance of AKR1B1 protein in the areolae at Day 40, but not at Day 85 of pregnancy. 
 
SORD Is Expressed in Uterine LE and GE During the Peri-Implantation Period, and Is 
Expressed in Trophectoderm/Chorion For the Majority of Pregnancy 
 Sorbitol is converted to fructose by the enzyme sorbitol dehydrogenase (SORD). 
Endometrial expression of SORD mRNA peaked on Day 5 of the estrous cycle and then 
decreased from Days 9 to 17 (Figure 5.10a; p<0.01), but there was no significant Day x 
Status interaction (p>0.05). When expression of SORD mRNA was analyzed across 
pregnancy, there were no significant changes from Days 9 to 13 (r2=0.858; p>0.05), but 
expression increased from Days 15 to 30 (r2=0.828; p<0.05). Placental expression of 
SORD mRNA increased from Day 30 to Day 40 (Figure 5.10b, r2=0.999; p<0.05). For 
E2- and P4-treated gilts, there was no effect on expression of SORD mRNA  (p>0.05; 
Figure 5.10c,d). SORD protein was expressed in the uterine GE at Day 5 through Day 17 
of both the estrous cycle and pregnancy (Figure 5.11). Uterine LE began to express 
SORD at Day 13 of the estrous cycle and pregnancy, and then expression decreased to 
low levels by Day 20 of pregnancy. The trophectoderm expressed SORD as early as  
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Figure 5.10 Expression of SORD mRNA in endometria and placentae 
Endometrial expression of SORD mRNA (A) peaked at Day 5 of gestation, then decreased 
through Day 15 (p<0.01). Placental expression of SORD mRNA (B) increased from Day 30 to 
Day 40 of gestation (r2=0.999; p<0.05). Treatment of gilts with E2 or P4 had no effect on 
endometrial expression of SORD mRNA compared to control gilts (C,D; p>0.05). Values 
presented are mean±SEM with p<0.05 as significant. 
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Figure 5.11 Immunohistochemical localization of SORD protein at the uterine-
placental interface 
SORD protein was detected in uterine GE by Day 5 and in uterine LE by Day 13 of both the 
estrous cycle and pregnancy. Trophectoderm expression of SORD protein was detected by Day 
15 and expression continued in trophectoderm/chorion through Day 85. Areolae also expressed 
SORD protein. Rabbit IgG was used as the negative control. Width of field is: 890 µm for D5, 
D20P, D30P, D40P, D60P, D85P, D60P IgG; 445 µm for D9, D13, D15 conceptus, D17; 286 
µm for D15C, D15P, D15 IgG.  Legend: LE, luminal epithelium; GE, glandular epithelium; ST, 
stroma; Tr, trophectoderm; CE, chorion; AE, allantoic epithelium. 
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Figure 5.12 Expression of KHK mRNA in endometria and placentae 
Endometrial expression of KHK mRNA (A) was greater in pregnant than cyclic gilts from Days 
9 through 17 (Day x Status p<0.01) and expression increased continually through Day 85 
(r2=0.478; p<0.05). Placental expression of KHK mRNA (B) did not change from Days 30 to 85 
of pregnancy (r2=0.433, p>0.05). Treatment of gilts with either E2 or P4 had no significant effect 
on expression of KHK mRNA compared to controls (C,D; p>0.05). Values presented are 
mean±SEM with p<0.05 as significant. 
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Figure 5.13 Immunohistochemical localization of KHK at the uterine-placental 
interface 
KHK protein was detected as early as Day 11 in conceptus trophectoderm and 
trophectoderm/chorion expression continued through Day 85 of pregnancy with areolae also 
expressing KHK. Endometrial expression was limited to uterine GE at Day 30 of gestation. 
Rabbit IgG was used as a negative control. Width of field is 890 µm for all images except D11, 
D15, D40, which are 445 µm. Legend: LE, luminal epithelium; GE, glandular epithelium; Tr, 
trophectoderm; CE, chorion. 
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Day 15 and the chorion, including the areolae, expressed SORD through Day 85 of 
gestation when uterine GE also had higher expression than during mid-pregnancy 
(Figure 5.11). 
 
KHK Is Expressed Primarily by the Trophectoderm/Chorion 
 Ketohexokinase (KHK) catalyzes the addition of a phosphate group to fructose to 
produce fructose-1-phosphate. Endometrial expression of KHK mRNA was higher in 
tissues from Days 9 through 17 of pregnancy compared to the corresponding Days of the 
estrous cycle (p<0.01; Figure 5.12a). There was an increase in expression throughout 
pregnancy with a peak at Day 30 (r2=0.478; p<0.05). Placental expression of KHK 
mRNA did not significantly change from Days 30 to 85 of pregnancy (p>0.05; Figure 
5.12b). Treatment of gilts with either E2 or P4 did not affect expression of KHK mRNA 
(p>0.05; Figure 5.12c,d). KHK protein was only detectable in GE of the endometrium at 
Day 30 of pregnancy (Figure 5.13). KHK protein was detected in the trophectoderm as 
early as Day 11 and in the chorion, including the areolae, at all stages of gestation 
studied through Day 85. There was stronger immunostaining in the tall columnar cells at 
the tops of the uterine-placental folds. 
 
Discussion 
There is an unusual abundance of fructose in pig fetal fluids and uterine flushings. 
Fructose has long been known to be synthesized in the placenta of ungulates and cetaceans 
during pregnancy, but the pathway by which fructose is synthesized, the transport 
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mechanisms involved, and the cells that may use fructose have not been described 
previously. Indeed, fructose has, for the most part, been ignored in research regarding 
ungulate species, possibly because fructose is not metabolized through the glycolytic 
pathway in the fetus or placenta (Battaglia and Meschia, 1978; McGowan et al., 1995; 
Bell and Ehrhardt, 2002). Results from this study indicate that fructose increases in uterine 
flushings of pregnant gilts from Days 11 to 15, that there are two transporters, SLC2A5 
and SLC2A8, which can transport fructose from the uterus to the conceptus, and that the 
components of the polyol pathway, by which fructose can be synthesized from glucose, 
are present at the uterine-placental interface during pregnancy in pigs (Figure 5.14). 
The transporters capable of transporting fructose from uterus to placenta localize 
to different cell types in a stage of pregnancy dependent manner. SLC2A8 localizes to 
uterine LE and GE during the peri-implantation period of pregnancy (Figure 5.14a), and 
to the chorion at Day 30 (Figure 5.14b). In contrast, SLC2A5 mRNA increases 
significantly by Day 30, and remains high through Day 85 of pregnancy in uterine LE and 
CE at the uterine-placental interface (Figure 5.14b). The results also indicated an 
interesting stage-dependent change in the cellular localization of the enzymes involved in 
the polyol pathway. From Day 13 through Day 17, AKR1B1 and SORD localize to the 
uterine LE (Figure 5.14a), but by Day 20, the proteins are undetectable in uterine LE, but 
are abundant in the chorion through Day 85 of pregnancy (Figure 5.14b). This intriguing 
shift in expression of the polyol enzymes from uterine LE to chorion during pregnancy 
suggests that the free-floating, elongating conceptuses are supported by fructose that is 
synthesized by the uterus. However, after implantation is initiated and placentation is  
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Figure 5.14 Current working model for fructose transport at the uterine-placental 
interface of pigs 
During the peri-implantation period of pregnancy (A), glucose is transported into uterine LE 
from the maternal vasculature by SLC2A1. The polyol pathway converts glucose to fructose in 
uterine LE, then fructose, and glucose, are transported into the uterine lumen by SLC2A8, 
SLC2A1, and SLC5A1. Fructose can be utilized in the trophectoderm after being transported in 
by SLC2A2 or SLC2A8, or be further transported to other extraembryonic tissues or the embryo 
proper, while glucose can be transported into trophectoderm by SLC2A3 or SLC2A8. As 
placentation progresses, during mid-pregnancy (B), glucose is transported into and through 
uterine LE by SLC2A1, but the polyol pathway enzymes do not localize to that cell type. Rather, 
glucose is transported into the chorion by SLC2A3 and SLC2A8 where conversion to fructose 
can occur. Fructose can either be used by the chorion or be transported by SLC2A5 to the 
placental vasculature in mid- to late-pregnancy. 
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established at the maternal/conceptus interface, the placenta becomes self-sufficient for 
synthesis and transport of fructose.    
 Pig embryos enter the uterus, develop into blastocysts, and then shed the zona 
pellucida. The presumptive placental membranes (trophectoderm and endoderm) elongate 
at a rate of 30-45 mm/h from a 10 mm blastocyst to a 150-200 mm long filamentous form, 
after which further elongation occurs until conceptuses are 800-1,000 mm in length by 
Day 16 of pregnancy.  This process provides maximum surface area for contact between 
trophectoderm and uterine LE to facilitate the uptake of nutrients from uterine LE and GE 
(Bazer and Johnson, 2014). Significant energy is required to drive these extreme 
morphological changes.  Glucose is essential to conceptus survival, growth, and 
development, and substantial amounts of glucose are transported across the placental 
membranes of pigs and mice (Goldstein et al., 1980). SLC2A8 is an outstanding candidate 
for fructose and glucose transport during these important events of early pregnancy 
because of its localization to both uterine LE and trophectoderm while the conceptus is 
free-floating.  
 SLC2A8 protein localizes to the apical and basal cell surfaces of hepatocytes and 
uterine epithelia as well as the endoplasmic reticulum and lysosomes in spermatocytes 
(Diril et al., 2009; Kim and Moley, 2009; DeBosch et al., 2014a). SLC2A8 can transport 
glucose and fructose into and out of cells when it is located in the apical or basal plasma 
membranes, but when SLC2A8 is located in the endoplasmic reticulum, it is hypothesized 
to be for transporting glucose into the endoplasmic reticulum to be used for glycosylation 
of new proteins, especially in cells with high secretory activity. In this study, SLC2A8 
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localized to the apical and basal surfaces of the plasma membrane in uterine LE, GE, and 
Day 11 trophectoderm, but it also localized intracellularly in Day 15 trophectoderm and 
in the embryo. The change of localization within the trophectoderm is interesting because 
the Day 15 trophectoderm is more active in secretion of molecules than the Day 11 
trophectoderm and SLC2A8 may help facilitate increased synthesis of proteins for 
secretion. 
Amongst the roles of the steroid hormones P4 and E2 in pregnancy, are their ability 
to regulate expression of multiple genes and proteins at the uterine-placental interface in 
mice, sheep, and pigs, including those involved in nutrient transport and metabolism (Gao 
et al., 2009a; Gao et al., 2009b; Kim and Moley, 2009). SLC2A8 protein expression is 
suppressed in uterine LE of ovariectomized mice treated with E2, while mice treated with 
P4 had an increase in expression of SLC2A8 protein in uterine LE (Kim and Moley, 2009). 
These results are similar to those from the ovariectomized pig model as E2 alone, or when 
administered with P4, suppressed endometrial expression of SLC2A8 mRNA compared to 
treatment with P4 alone, although the cellular localization of SLC2A8 to uterine LE and 
GE was not affected by hormone treatments. Interestingly, treatment of gilts with E2 alone 
resulted in endometrial expression of SLC2A8 mRNA equal to those of control 
endometria; however, expression was localized to smooth muscle surrounding the blood 
vessels. While this was not observed when E2 and P4 were administered together, 
SLC2A8 protein was expressed in the smooth muscle and endothelium of placental blood 
vessels from Days 30 to 85 of pregnancy. Since concentrations of E2 in both placental 
blood and the allantoic fluid increase as pregnancy progresses, E2 could be responsible 
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for the expression of SLC2A8 mRNA and protein in placental blood vessels (Knight et 
al., 1977). 
The high expression of SORD in uterine GE early in the estrous cycle may be 
attributed to one of two reasons. SORD may have a function other than converting sorbitol 
to fructose and fructose to sorbitol, or there is another aldose reductase family member 
that localizes to the GE to catalyze the first step in the polyol pathway. There are more 
than 190 known enzymes in the aldo/keto reductase family, each with their own 
specificities for different substrates, but most, especially those in the AKR1B family, are 
defined as NADPH-dependent oxidoreductases (Pastel et al., 2012; Penning, 2015). 
AKR1B1, specifically, has a high affinity for glucose and is active in the polyol pathway 
in other tissues (Pruneda et al., 2006; Alexiou et al., 2009). Additionally, AKR1B1 protein 
in the endometrium of pregnant pigs localizes to uterine LE beginning on Day 12 of 
pregnancy (Seo et al., 2014). We detected AKR1B1 protein in uterine LE from Days 13 
through 17 of gestation (Figure 5.9), but did not analyze uteri from Day 12 of pregnancy. 
This could account for the discrepancy as to when AKR1B1 is initially detected in uterine 
LE.  
The pig develops a diffuse, epitheliochorial type placenta to support the growth of 
each individual fetus. This placentation is characterized as being superficial, non-invasive, 
and having a uterine LE that remains intact. By Day 24 of pregnancy, there is complete 
attachment between the uterine LE and the conceptus trophectoderm and these adhered 
epithelia begin to fold around Day 30 to increase surface area for nutrient transport (Friess 
et al., 1980). Interestingly, the results of this study show that multiple proteins, SLC2A8, 
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AKR1B1, and SORD, are expressed in the uterine LE during early pregnancy, but 
expression by uterine LE begins to downregulate as folding commences and expression 
of those genes is limited to the placental chorion (see Figure 5.3 for an example of the 
temporal/spatial shift in the expression of SLC2A8). Additionally, the fructose transporter, 
SLC2A5, becomes highly expressed in uterine LE and chorion during the same period of 
gestation. As the placenta develops, there is a transition from uterine LE support of the 
conceptus to placental chorion support of the conceptus that is exemplified by changes in 
cell-specific expression of the proteins involved in synthesis and transport of fructose.  
P4 increased expression of SLC2A5 mRNA in uterine LE and GE of gilts treated 
with P4 from Day 12 to Day 40 post-estrus; therefore, P4 may induce the increase in 
expression of SLC2A5 at Day 30 of pregnancy. The receptor for P4, PGR, is not present 
in uterine LE and GE of the P4-treated gilts or in LE and GE of the pig uterus at Day 40 
of pregnancy (Figure A.5 and A.6). Therefore, the expression of SLC2A5 could increase 
due to removal of repression by PGR in uterine GE, or via actions of a paracrine-acting 
growth factor (progestamedin) produced by the PGR-positive stromal cells responding to 
P4 (Johnson et al., 2000).   
Another characteristic of the epitheliochorial placenta is the development of 
chorionic areola. Areolae form over the mouths of uterine glands and are comprised of 
folded chorion containing tall columnar cells with long microvilli that are optimal for 
transporting histotroph secreted from uterine GE (Renegar et al., 1982; Leiser and 
Dantzer, 1994). In addition to transporting histotroph, these cells may also play a role in 
synthesis of nutrients from precursor molecules in histotroph or from the placental 
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vasculature. SLC2A5 and SLC2A8 were detected in the areolae and could provide 
transport for glucose and fructose. Additionally, AKR1B1, SORD and KHK localized to 
areolae on Day 40, indicating that areolae are potential sites for synthesis and 
phosphorylation of fructose. The tall columnar cells at the tops of uterine folds in the inter-
areolar regions also are hypothesized to be highly active in transporting molecules as 
compared to the more cuboidal cells at the bottom of the uterine folds (Vallet et al., 2014). 
The localization of SLC2A8 to the tall columnar cells supports to this hypothesis, 
although, the localization of KHK to those cells, an enzyme that phosphorylates fructose 
to sequester it for use in the cell that KHK localizes to, raises questions regarding the role 
fructose may play at the uterine-placental interface.   
The polyol pathway is upregulated by hyperglycemia and, therefore, has been 
studied intensively in the pathological states of diabetes and cancer. In those states, 
activation of the pathway can result in: 1) accumulation of the intermediate sorbitol, which 
functions as an osmoregulator; 2) reduced ability to modulate oxidative stress due to 
consumption of NADPH; and, 3) production of fructose. Organ systems where the polyol 
pathway is normally active and functional include the liver, kidney, and male reproductive 
tract where fructose is produced in abundance by the seminal vesicles and the epididymis 
(Kobayashi et al., 2002; Pruneda et al., 2006). While the sow is not hyperglycemic during 
pregnancy, glucose accumulates at the uterine-placental interface in the pig due to the 
presence of both sodium-dependent (SGLT1; see Figure 3.3) and sodium-independent 
(SLC2A1, SLC2A4, SLC2A8; see Figures 4.2, 4.5, 5.10) glucose transporters and an 
appreciably lower concentration of glucose than that in the placental blood.  This 
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accumulation of glucose could activate the polyol pathway. Conversion of glucose to 
fructose would then not only sequester the sugar in the conceptus (fructose cannot be 
transported back to the maternal blood), but it would maintain the disparity in 
concentrations of glucose between maternal and fetal-placental blood to enhance transport 
of glucose to the conceptus. 
Shibutani et al. reported that KHK mRNA is present in parthenogenetic pig 
embryos as early as the 5- to 8-cell stage and that expression continues through the 
blastocyst stage (Shibutani et al., 2015). Those embryos are also unable to utilize fructose 
as the only carbohydrate source before the 5- to 8- cell stage of development. Results of 
the present study indicate that the pig conceptuses continue to express KHK protein to 
Day 11 in trophectoderm and to Day 85 of gestation in the chorion (Figure 5.6).   
 In the liver, fructose is used for glycogen and triglyceride synthesis, neither of 
which are synthesized in substantial amounts by the pig placenta (Ramsay et al., 1984; 
Feinman and Fine, 2013). Also, sperm use fructose as an energy source, but this too is 
minimal in the placenta (Aalbers et al., 1961). While recent in vitro data using porcine 
trophectoderm cells indicate that fructose activates the hexosamine biosynthetic pathway 
to stimulate  mechanistic target of rapamycin (mTOR) cell signaling and cell proliferation, 
and the synthesis of hyaluronic acid, a significant glycosaminoglycan in the placenta, there 
are still questions about the role of fructose in the placenta (Kim et al., 2012). Results of 
the present research indicate that the trophectoderm has the potential to utilize fructose 
due to the presence of KHK in those cells; however, the downstream molecules or 
regulatory targets will need to be determined in future studies.  
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  In conclusion, the components for the synthesis of fructose via the polyol pathway 
and for fructose transport are present at the uterine-placental interface during pregnancy 
in pigs (Figure 5.14). Additionally, those components are expressed in a temporal and 
spatial manner that is, at least in part, regulated by the steroid hormones progesterone and 
estrogen. Early in development, the free-floating conceptus can be supported by fructose 
synthesized by the uterine LE and transported into the uterine lumen. As pregnancy and 
placentation progress, the chorion takes over the synthesis of fructose, and the conceptus 
becomes self-sufficient for fructose production. Additionally, the localization of SLC2A8 
to uterine LE and trophectoderm during the peri-implantation period provides a 
mechanism for transport of fructose between the tissues synthesizing fructose and the 
tissues metabolizing fructose, particularly the conceptus trophectoderm and 
chorioallantois. 
 
 152 
 
CHAPTER VI 
SUMMARY AND CONCLUSION 
 
Summary 
Glucose and fructose are abundant hexose sugars in porcine endometria and 
conceptuses that play differing roles in supporting growth and development of the 
conceptus during pregnancy. Glucose is a major source of energy to the conceptus while 
fructose likely has a minor role as an energy source; however, fructose may be: 1) a 
precursor to other metabolites; 2) able to help establish concentration gradients for 
glucose between the maternal and fetal circulations; and 3) a regulator of non-metabolic 
cellular processes. The research for this dissertation has determined potential transport 
pathways for moving glucose and fructose to tissues where they can serve functional 
roles. Additionally, the localization of key enzymes involved in fructose synthesis has 
been determined, which is a major advancement because fructose is not supplied by the 
maternal blood to the conceptus. 
Before qPCR could be used as a tool for analysis of gene expression in the 
endometria and placentae of pigs, it was necessary to optimize the choice of reference 
genes. Analysis of mRNA expression is only possible when there is a stable expression 
of a reference gene with which to compare expression of the gene of interest. Therefore, 
in order to determine a set of three appropriate reference genes for endometrial and 
placental tissues, a group of 10 reference genes, selected due to their stability in other 
tissues, were analyzed by performing qPCR on endometrial and placental tissues from 
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time points throughout the estrous cycle and pregnancy. After analysis using the 
algorithms GeNorm and NormFinder, the geometric mean of TBP, HPRT1, and 
TUBA1B was determined to be appropriate for normalization of data from placental 
tissue while the geometric mean of TBP, ACTB, and SDHA was appropriate for 
normalization of data from endometrial tissue. YWHAZ, GAPDH, and B2M were not 
appropriately stable in those tissues for use as reference genes according to the 
algorithms. 
In order to determine that the chosen reference genes provided reliable results, 
qPCR analysis for two genes, SLC5A1 and SLC7A3, was compared to results from in 
situ hybridization analysis in which each mRNA was localized to specific cells within a 
tissue. Results of both the qPCR and the in situ hybridization analyses revealed that the 
sodium-dependent glucose transporter SLC5A1 was expressed predominantly early in 
pregnancy during the peri-implantation period and that expression was induced by 
trophectoderm-derived E2 (Figures 3.3 and 3.4). The amino acid transporter, SLC7A3, 
was expressed in the trophectoderm/chorion, expression increased from Days 30 to 40 of 
pregnancy, and the chorion was capable of transporting arginine (Figure 3.5).  
Quantification and localization of mRNAs for the glucose transporters SLC2A1, 
SLC2A2, SLC2A3, and SLC2A4 were performed using endometrial and placental tissues 
from the estrous cycle and pregnancy in pigs. Those four transporters are the most 
studied in other tissues and species and play major roles in whole body glucose 
homeostasis, insulin-driven glucose uptake, and rapid transport of glucose. SLC2A1 and 
SLC2A3 in particular have roles during pregnancy in other species. Indeed, this study 
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found SLC2A1 to be the prominent glucose transporter in the endometrium and SLC2A3 
to be prominent in the conceptus (Figure 4.2 and 4.4). Expression of SLC2A1 mRNA 
was also upregulated specifically in uterine LE of gilts treated with E2 or P4 (Figure 
4.2). Expression of SLC2A2 mRNA was only in trophectoderm and areolae, while 
SLC2A4 was lowly expressed in uterine LE and GE in a similar manner to SLC2A1 
(Figures 4.3 and 4.5). SLC2A1, SLC2A3, and SLC2A4 mRNAs were also localized to the 
endothelia of the endometrium and placenta as well as the areolae and the allantoic 
epithelium (Figures 4.6 and 4.7). These results indicate that glucose transporters are 
present in all cell types necessary for transport of glucose from maternal to placental 
blood (Figure 4.8). 
Two transporters that can transport fructose, SLC2A5 and SLC2A8, were 
examined.  SLC2A5 mRNA localized to uterine LE, GE, and chorion with expression 
increasing to Day 30 of pregnancy (Figure 5.7). In contrast, expression of SLC2A8 
mRNA peaked in endometria around Day 11 of the estrous cycle and pregnancy with the 
protein localizing to uterine GE by Day 9 and to uterine LE by Day 13 (Figures 5.2 and 
5.3). SLC2A8 protein was expressed in uterine LE until Day 30 of pregnancy, but then 
transitioned to being expressed in the chorion. In non-pregnant gilts, SLC2A8 protein 
was upregulated by P4 in uterine LE and GE, and by E2 in endometrial blood vessels 
(Figure 5.4).  
  After determining that glucose and fructose transporters were present in 
endometrial and placental tissues, the next step was to determine if the components 
necessary for fructose synthesis and metabolism were not only present, but where they 
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localized within uterine and placental tissues. The enzymes involved in the polyol 
pathway, AKR1B1 and SORD, were detected at both the mRNA and protein levels. 
AKR1B1 protein was expressed in uterine LE beginning at Day 13 of pregnancy, but 
expression was undetectable in uterine LE by Day 20, although the protein was 
expressed in the trophectoderm/chorion through Day 85 of pregnancy (Figure 5.9). 
SORD protein was also detectable at Day 13 of pregnancy in uterine LE and in uterine 
GE as early as Day 5, but expression transitioned to the chorion through Day 85 of 
pregnancy (Figure 5.11). KHK, the enzyme that adds a phosphate group to fructose, 
localized to conceptus tissue on each of the days of pregnancy studied, specifically to 
trophectoderm and the tall columnar cells of the chorion (Figure 5.13).  
 
Conclusion 
 These studies provide evidence that transporters necessary for the movement of 
glucose from maternal blood to placental blood are present at the uterine-placental 
interface in pigs throughout pregnancy. Additionally, the enzymes and transporters 
necessary to produce fructose via the polyol pathway, and to transport fructose, are 
present in a temporal and cell-type specific manner during pregnancy (Figure 5.14). The 
transport of glucose and fructose in the endometrium is regulated by progesterone and 
estrogen, which increase transcriptional or translational effects for expression of multiple 
transporters of the SLC2A and SLC5A families. This basic knowledge can be used to 
manipulate transport of hexose sugars for metabolism at the uterine-placental interface to 
increase birthweights of piglets, decrease variation among piglets within litters with 
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respect to growth and development, and improve survivability of piglets for increased 
efficiency and profitability of the swine industry. 
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APPENDIX A 
EXPRESSION OF PROGESTERONE RECEPTOR, PHOSPHATASE ACID TYPE 5 
TARTRATE-RESISTANT, AND SECRETED PHOSPOPROTEIN 1 PROTEINS IN 
THE UTERUS AND PLACENTA OF PIGS THROUGHOUT GESTATION 
 
Introduction 
 Progesterone (P4), the hormone of pregnancy, is produced by the corpus luteum 
and is required to maintain a successful pregnancy in the pig. P4 is a steroid hormone 
that exerts its actions on tissues through the progesterone receptor (PGR), which is 
encoded by a single gene, PGR, but has three isoforms (A, B, and C) with differing 
lengths and activities (Wetendorf and DeMayo, 2014). PGR is a classical nuclear 
receptor that binds P4, dimerizes, enters the nucleus, and binds DNA at progesterone 
response element domains to promote transcription of target genes, although P4 acting 
via its PGR can also inhibit transcription of some target genes (Mulac-Jericevic and 
Conneely, 2004). 
 Of the three PGR isoforms, B is the most transcriptionally active due to an 
additional activation domain (AF-3) in the amino terminus (Sartorius et al., 1994). 
PGRA has more inhibitory effects due to an active transcription inhibitory domain, 
which is blocked in PGRB (Giangrande et al., 1997). The third isoform, PGRC, is a 
truncated version of PGRA and PGRB with no amino terminus containing the main 
activation domain or the DNA binding domain. Therefore, PGRC cannot bind DNA 
directly, but can still bind P4 and dimerize, leading to the hypothesis that it has a role in 
sequestering ligand or the other isoforms to decrease P4 signaling (Wei et al., 1997). 
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Both PGRA and PGRB have been studied extensively in multiple species to determine 
their roles in the uterus during pregnancy, but the role of PGRC is still an enigma 
(Wetendorf and DeMayo, 2014).  
Previous studies have described PGR localization in pigs during the estrous cycle 
and early pregnancy, but not beyond Day 18 of pregnancy (Geisert et al., 1994; 
Sukjumlong et al., 2005).  Progesterone receptor B (PGRB) protein is expressed in the 
uterine LE, GE, stroma, and myometrium through Day 7 of the estrous cycle and 
pregnancy. During both the estrous cycle and pregnancy, prolonged exposure to P4 
downregulated PGRB in uterine LE by Day 10 and in uterine GE by Day 12 (Ka et al., 
2007). PGR is detected in the stroma and myometria through Day 18 of the estrous cycle 
and pregnancy. Progesterone receptor A (PGRA) protein has been detected by western 
blot in endometria from Days 0 to 10 of the estrous cycle and pregnancy (Geisert et al., 
1994).  
 In addition to inducing uterine quiescence and suppressing uterine immune 
responses during pregnancy, P4 stimulates the production and secretion of histotroph, a 
complex mixture of hormones, growth factors, nutrients, and other substances that are 
required for growth and development of the conceptus (Knight et al., 1974; Roberts and 
Bazer, 1988; Bailey et al., 2010a). Two major protein components of histotroph, acid 
phosphatase 5 tartrate resistant (ACP5; uteroferrin) and secreted phosphoprotein 1 
(SPP1; osteopontin), are produced and secreted by uterine GE during pregnancy in pigs 
(Renegar et al., 1982; Garlow et al., 2002). ACP5 is induced during the peri-
implantation period in uterine GE by P4, while SPP1 is induced in uterine LE by 
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estrogen during the peri-implantation period, but induction in the GE between Days 30 
and 40 is not solely dependent on P4 in pigs (Chen et al., 1973; Knight et al., 1973; 
Bailey et al., 2010a). P4 induces the production of histotroph through effects mediated 
via PGR; however, PGR are not expressed in uterine epithelia of mammals from just 
prior to implantation. At present, the mechanism of action of P4 to regulate functions of 
uterine epithelia is still unknown.  
Therefore, the aim of this study was to quantify total endometrial mRNA and 
localize PGR protein in cells of the uterus throughout the estrous cycle and pregnancy in 
pigs. In addition, two well-established proteins in histotroph, ACP5 and SPP1, were 
localized in porcine uterine and placental tissues throughout gestation to gain 
physiological insight into the relationship between the pattern of PGR expression during 
mid- to late-pregnancy and the patterns of expression of ACP5 and SPP1.  
 
Materials and Methods 
 
 Animals and Tissue Collection 
Sexually mature, 8-month-old crossbred gilts were observed daily for estrus (Day 
0) and exhibited at least two estrous cycles of normal duration (18 to 21 days) before 
being used in these studies.  All experimental and surgical procedures were in 
compliance with the Guide for Care and Use of Agricultural Animals in Teaching and 
Research and approved by the Institutional Animal Care and Use Committee of Texas 
A&M University.  
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To evaluate the effects of pregnancy on temporal and cell-specific expression of 
mRNAs and proteins for PGR, ACP5, and SPP1, gilts were assigned randomly to either 
cyclic or pregnant status.  Cyclic gilts were ovariohysterectomized on either Day 5, 9, 
11, 13, 15 or 17 of the estrous cycle. Gilts in the pregnant group were bred and 
ovariohysterectomized on either Day 9, 11, 12, 13, 15, 17, 20, 25, 30, 35, 40, 50, 60, or 
85 of pregnancy (n = 3 or 4 gilts/day/status). The lumen of each uterine horn of each gilt 
collected between Days 5 and 17 post-estrus was flushed with 20 ml physiological saline 
and flushings from mated gilts were examined for morphologically normal conceptuses.  
Tissue sections (~1cm thick) from the middle of each uterine horn of all hysterectomized 
gilts were fixed in fresh 4% paraformaldehyde in PBS (pH 7.2) and embedded in 
Paraplast-Plus (Oxford Laboratory, St. Louis, MO). Additionally, endometrium was 
physically dissected from the myometrium, snap-frozen in liquid nitrogen, and stored at 
-80°C for RNA extraction.  
 
Progesterone Model 
To evaluate effects of long-term P4 treatment without ovarian hormones on 
endometrial expression of PGR mRNA and localization of PGR protein, gilts were 
ovariectomized on Day 12 of the estrous cycle and assigned randomly to receive daily 
intramuscular injections of either corn oil (CO, 4 ml) or P4 (200 mg in 4 ml CO) on 
Days 12 through 39 post-estrus (n = 3/treatment) (Bailey et al., 2010c).  All gilts were 
hysterectomized on Day 40 post-estrus and tissues collected as previously described. 
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RNA Extraction, cDNA Synthesis, and Primer Design 
Total RNA was extracted from endometrial tissue samples using Trizol reagent 
(Life Technologies, Carlsbad, CA) according to manufacturer’s recommendations 
(Appendix B).  First strand cDNA was synthesized using Superscript III First Strand Kit 
(Life Technologies, Carlsbad, CA) according to manufacturer’s instructions (Appendix 
B). First strand cDNA was diluted 10x for the qPCR reaction. Primers for qPCR were 
designed using NCBI Genbank sequences and Primer-BLAST 
(http://www.ncbi.nlm.nih.gov/). Primers were submitted to BLAST to test for specificity 
against the known porcine genome. The PGR forward 5’-
GTGTCCTTACCTGTGGGAGC-3’ and reverse 5’- TTCTAAGGCGACAAGCTGGG-
3’ primers were developed from NCBI reference NM_001166488.1 and have a product 
length of 138 nucleotides. Primer information for reference genes can be found in Table 
5.1. 
Quantitative PCR 
Quantitative PCR assays were performed as previously described (Chapter III 
and Appendix B of this dissertation). Briefly, PerfeCta SYBR Green Mastermix 
(Quanta) was used in 10µl reactions with 2.5mM of each specific primer, on a Roche 
480 Lightcycler (Roche) with approximately 60ng of cDNA per reaction. The PCR 
program began with 5 min at 95°C followed by 40 cycles of 95°C denaturation for 10 
sec and 60°C annealing/extension for 30 sec. A melt curve was produced with every run 
to verify a single gene-specific peak. Standard curves with 2-fold serial dilutions were 
188 
run to determine primer efficiencies. All primer correlation coefficients were greater 
than 0.95 and efficiencies were 95-102%. The geometric mean of TBP, SDHA, and 
ACTB was used to normalize gene expression in endometrial tissue. 
Immunohistochemistry 
PGR, SPP1, and ACP5 proteins were immunolocalized in porcine uterine and 
conceptus tissues as described previously (Joyce et al., 2005)(Appendix B). A rabbit 
anti-human PGRA/PGRB polyclonal IgG (catalog no. RB-9017-P0; Thermo Fisher 
Scientific) was used at 5 µg/ml with a boiling citrate buffer antigen retrieval. A rabbit 
anti-bovine SPP1 affinity-purified polyclonal IgG was used at 25 µg/ml with a boiling 
citrate buffer antigen retrieval (Gabler et al., 2003). A rabbit anti-porcine ACP5 
polyclonal IgG was used at 5 µg/ml with a boiling citrate buffer antigen retrieval (Chen 
et al., 1975; Bailey et al., 2010a). Purified non-relevant rabbit IgG, at a concentration 
equal to that for the primary IgG, was used as the negative control. Immunoreactive 
protein was visualized in paraffin-embedded sections (5µm thick) using the Vectastain 
ABC Kit (catalog no. PK-4001; Vector Laboratories, Inc., Burlingame, CA) according to 
kit instructions with 3,3'-diaminobenzidine tetrahydrochloride (catalog no. D5637; 
Sigma-Aldrich, St. Louis, MO) as the color substrate. Sections immunostained for SPP1 
and ACP5 were counterstained with Harris modified hematoxylin (Fisher Scientific), 
whereas sections immunostained for PGRA/PGRB were not counterstained. Coverslips 
were affixed using Permount mounting medium (Fisher Scientific).  Digital images of 
representative fields of immune-stained tissue were examined and recorded under bright-
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field illumination using an Axioplan 2 microscope (Carl Zeiss, Thornwood, NY) 
interfaced with an Axioplan HR digital camera and Axiovision 4.3 software. 
Photographic plates were assembled using Adobe Photoshop (version 6.0, Adobe 
Systems Inc., San Jose, CA). 
Statistical Analyses 
The qPCR data for normal tissues were analyzed for effects of day, pregnancy 
status, and their interaction for Days 9, 11, 13, 15 and 17 by 2-way ANOVA via the 
General Linear Models (GLM) procedures of the Statistical Analysis System (SAS 
Institute, Cary, NC) with the least significant difference (LSD) multiple testing method. 
The qPCR data were also subjected to a sliding time window linear regression analysis 
to determine if there was an effect of day of gestation on the gene expression for the 
genes of interest throughout pregnancy (Days 9 to 85). The sliding time windows of the 
analysis were designed to detect effect of day on gene expression during three 
biologically relevant periods of time: the beginning, the middle, and the end of the study 
period. Each window analyzed contained a minimum of three days. Some windows 
contained greater than three days as long as the regression model showed a non-
decreased performance in terms of the r2 and the p-value of the F-statistics. 
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Endometrial Expression of PGR Throughout Gestation 
Endometrial expression of PGR mRNA was highest at Day 5 of the estrous 
cycle, decreased to Day 11, then increased again to Day 17 (Figure A.1; day x status 
p<0.01). Endometrial expression of PGR mRNA decreased from Days 13 to 40 of 
pregnancy (r2=0.847, p<0.01). Endometria from gilts treated with P4 for 28 days had 
lower expression of PGR mRNA than that for CO-treated gilts (Figure A.2; p<0.05). 
The antibody used to detect PGR in the present study was generated against both 
PGRA and PGRB antigens, but will be referred to as PGR. PGR protein was localized to 
uterine LE, GE, stroma, and myometrium on Day 5 of the estrous cycle and expression 
was maintained in those cells through Day 11 (Figure A.3). On Day 12, PGR protein 
was no longer detectable in uterine LE or superficial GE, but PGR protein was detected 
in the stroma, myometrium, and deep GE through Day 17 of the estrous cycle. 
PGR protein was localized to uterine LE, GE, stroma, and myometrium on Day 9 
of pregnancy with expression in LE being undetectable by Day 11 (Figure A.4), but 
expression of PGR was maintained in GE, stroma, and myometrium through Day 17 of 
pregnancy with deep GE appearing to have stronger immunostaining than superficial 
GE. 
At Day 25, PGR protein was detected in some, but not all uterine GE, and GE in 
close proximity to areolae had stronger expression of PGR protein (Figure A.5 and 
Figure A.8). At Day 40, the proportion of cells in the GE with detectable PGR decreased
Results 
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Figure A.1 Expression of PGR mRNA in endometrial tissue during the estrous cycle 
and pregnancy in pigs 
Expression of PGR mRNA was greatest at Day 5, decreased until Day 11 during the estrous 
cycle, then increased again to Day 17 (day x status p<0.01). PGR mRNA in pregnant endometria 
decreased from Days 13 to 40 (r2=0.847, p<0.01). Values are presented as mean±SEM.  
Figure A.2 PGR mRNA in endometria of P4-treated gilts 
Endometrial expression of PGR mRNA was significantly less in the P4-treated than CO-treated 
gilts (p<0.05). 
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and this continued through Day 85. The stroma and myometrium continued to express 
PGR through Day 85 of pregnancy. 
 In endometria from ovariectomized gilts administered exogenous P4, PGR was 
only detected in the stroma and myometrium (Figure A.6). In contrast, endometria from 
control gilts had detectable PGR in uterine LE, stromal cells, and myometrium. Neither 
treatment group of gilts had detectable PGR in uterine GE. 
 
ACP5 Protein Localizes to Uterine GE and Areolae For the Majority of Pregnancy 
 ACP5 protein was detected in uterine GE at Day 12 of pregnancy, the abundance 
increased by Day 25, and then remained in uterine GE to Day 85 (Figure A.6). At Day 
25, ACP5 protein localized to the lumen and CE of the areolae, and expression in the 
areolae continued through Day 85. ACP5 protein was not detectable in endometria from 
cyclic gilts (data not shown). 
 
SPP1 Protein Localizes to Uterine LE From Day 25, and Uterine GE From Day 35 to 
Day 85 of Pregnancy 
 SPP1 mRNA is induced in uterine LE by conceptus estrogens by Day 13 of 
gestation (Garlow et al., 2002). As expected, in the present study, SPP1 protein was 
detected in uterine LE at Day 25, and expression in uterine LE was maintained 
throughout gestation. Interestingly, SPP1 protein was only detectable in uterine LE in 
the interareolar region of the interface (Figure A.6). There was no detectable SPP1 in 
uterine LE proximal to areolae. On Day 35, SPP1 was barely detectable in uterine GE,
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Figure A.3 Immunohistochemical localization of PGR in uteri of gilts during the 
estrous cycle 
PGR protein localized to uterine LE, GE, stroma, and myometrium on Days 5 to 11 of the 
estrous cycle. At Day 12, protein was not detected in uterine LE, but was still detected in a few 
cells of the superficial GE, deep GE, stroma, and myometrium. At Day 17, PGR protein was 
detectable in uterine LE. Width of field is 570 µm. Asterisks represent area in magnified image 
below.  
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Figure A.4 Immunohistochemical localization of PGR in uteri of gilts during early 
pregnancy  
PGR localized to uterine LE, GE, stroma, and myometrium at Day 9. By Day 11, PGR was not 
detected in uterine LE or the superficial GE, but was detected in deep GE, stromal cells, and 
myometrium through Day 17 of pregnancy. Width of field is 570 µm. The D9 IgG panel is the 
negative control. Asterisks represent area in magnified image below. 
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Figure A.5 Immunohistochemical localization of PGR at the uterine-placental 
interface during mid- to late-pregnancy in pigs 
PGR localized to stromal cells and myometrium from Days 25 to 85 of pregnancy. Additionally, 
at Day 25, PGR localized to uterine GE, but not every GE cell. At Day 40, the proportion of GE 
with detectable PGR decreased and this continued through Day 85 of pregnancy. Width of field 
is 870 µm. The D50P IgG panel is the negative control. Legend: LE, luminal epithelium; GE, 
glandular epithelium; CE, chorion; ST, stroma; MYO, myometrium.  
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Figure A.6 Immunohistochemical localization of PGR in endometria of P4-treated 
gilts 
In endometria of P4-treated gilts, PGR was detected in stromal cells and myometrium, 
while in the CO-treated gilts, PGR was detected in uterine LE, stromal cells, and 
myometrium. Height of field is 570 µm. The IgG negative control panel is in Figure A.4. 
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Figure A.7 Immunohistochemical localization of ACP5 and SPP1 at the uterine-
placental interface during pregnancy 
ACP5 protein was detected in uterine GE at Day 12 of pregnancy and in areolae at Day 25 with 
expression maintained through Day 85 of pregnancy in both tissues. SPP1 protein localized to 
uterine LE on Day 25, but was not detected in uterine LE proximal to areolae. SPP1 was 
detected in uterine GE at Day 35 and expression in LE and GE was maintained through Day 85 
of pregnancy. Width of field is 870 µm. The rIgG negative control panel is in Figure A.8. 
Legend: LE, luminal epithelium; GE, glandular epithelium; CE, chorion. 
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but it was strongly expressed in uterine GE by Day 40. SPP1 was also detectable in the 
allantoic stromal cells at Day 40. GE and allantoic localization of SPP1 continued 
through Day 85. SPP1 was not detectable in endometria from cycling gilts (data not 
shown). 
 
PGR, But Not ACP5 or SPP1, Localized to Uterine GE That 
 Immediately Empty Into Areolae 
PGR was expressed in uterine GE immediately adjacent to areolae, specifically 
uterine GE that opens directly into the areola, but not in any other GE (Figure A.7). 
Additionally, two protein components of histotroph, ACP5 and SPP1, were not detected 
in the GE that expressed PGR in serial sections at Day 40 of pregnancy. ACP5 was 
detected in the lumen of the PGR-positive GE, indicating that it was connected to GE 
that did secrete ACP5. Indeed, GE less than 200 µm away in the histological section 
clearly expressed ACP5 and SPP1. 
 
Discussion 
 P4 is required for a successful pregnancy, yet the localization of PGR, an 
essential mediator for effects of P4, has not previously been evaluated beyond Day 18 of 
pregnancy in the pig. This study establishes that: 1) PGR expression in uterine LE 
returns by Day 17 of the estrous cycle; 2) PGR expression is maintained in the deep GE 
throughout the estrous cycle and early pregnancy; 3) PGR expression is maintained in 
the uterine stroma and myometrium through Day 85 of gestation; and, 4) PGR is 
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Figure A.8 Immunohistochemical localization of PGR, ACP5, and SPP1 in uterine 
GE proximal to areolae 
PGR is detected in uterine GE directly beneath an areola (*), which open directly into the areola 
at Day 40 of pregnancy. GE not directly adjacent the areola do not express PGR. ACP5 and 
SPP1 are not detected in uterine GE that contain PGR, but both proteins are observed in the 
lumen of the uterine glands and in GE distant from the areola. Width of field is 870 µm. The 
rIgG panel is the negative control. Legend: GE, glandular epithelia. 
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expressed in the necks of uterine GE that empty into the areolae, suggesting that these 
regions of GE are excretory ducts that are not involved in the synthesis of histotroph, but 
serve as conduits for the passage of histotroph into the areolar lumen. 
 During the estrous cycle, uterine expression of PGR mRNA was high on Days 5 
and 9, low on Days 11 and 13, and returned to high on Days 15 and 17. The protein 
localization for PGR confirmed that these changes are due to the loss of PGR from the 
LE and shallow GE by Day 11, which returned to LE and shallow GE by Day 17. The 
loss of PGR in uterine LE due to downregulation by its ligand, P4, has been described, 
but this is the first study to demonstrate the return of PGR protein in uterine LE late in 
the estrous cycle in the pig (Spencer et al., 2004; Mathew et al., 2011). This is expected 
due to decreasing concentrations of P4 as a result of luteolysis, and increasing 
concentrations of estrogen in blood during proestrus of the estrous cycle (Henricks et al., 
1972).  
 The pattern of PGR expression during early pregnancy is similar to that observed 
for the estrous cycle with the a loss of detectable PGR from uterine LE around Day 11, 
and a decrease in detectable PGR in the superficial GE after Day 12, resulting in only a 
few sporadic cells in the shallow GE expressing PGR by Day 17. As expected, PGR 
remained detectable in stromal cells and myometrium through Day 17 of pregnancy. 
These results are similar to those reported by Geisert et al. in terms of uterine LE, 
stromal cells, and myometrium; however, in the present study PGR was expressed in GE 
beyond Day 12, particularly in the deep GE, although not in every gland or every GE 
cell. This could be partly attributed to the use of an antibody against PGRA and PGRB 
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in this study, while previous reports on cell localization of PGR in uteri utilized 
antibodies generated against PGRB (Geisert et al., 1994). 
 This study, for the first time, localized PGR in the uteri of pregnant gilts to Day 
85 of gestation. At Day 25, some GE cells expressed PGR, but the proportion of cells 
expressing PGR decreased gradually until expression was undetectable at Day 50 and 
Day 85 of pregnancy. The loss of PGR in uterine GE from Days 25 to 50 corresponds to 
the stage in gestation when uterine GE is undergoing extensive hyperplasia and 
hypertrophy, which results in a dramatic increase in total uterine secretions after Day 30 
of pregnancy (Knight et al., 1974; Basha et al., 1980; Perry and Crombie, 1982). The 
concurrent timing of PGR downregulation in uterine GE and activation of uterinr GE to 
increase secretion of histotroph suggests that PGR downregulation may be necessary for 
maximal production of histotroph. The uterine stromal cells and myometrium continued 
to express PGR from Days 25 through 85.  
 As expected, ovariectomized gilts treated with P4 long term exposure had 
downregulated expression of PGR in uterine LE and GE. However, surprisingly, there 
was no detectable PGR in GE of endometria from either the P4-treated or control gilts, 
suggesting that downregulation of PGR in GE may not be completely P4-dependent 
since PGR protein was not observed in endometria that had not been exposed to ovarian 
or exogenous steroid hormones. Conversely, estrogen may be required to upregulate 
and/or maintain PGR expression in GE and the endometria of the ovariectomized gilts in 
this study were not exposed to estrogens (Ing and Tornesi, 1997). 
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 ACP5 and SPP1 protein had previously not been localized in porcine endometria 
throughout pregnancy. Immunohistochemistry was used previously to demonstrate that 
ACP5 is expressed by uterine GE of pigs at Day 60 of pregnancy, and is present in the 
areolae at Day 75 (Renegar et al., 1982). Results from the present study show that, in 
addition to expression of ACP5 in GE and areolae during mid-pregnancy, ACP5 is 
detected in uterine GE at Day 12 of pregnancy, in areolae by Day 25 when areolae are 
initially developing, and in uterine GE and areolae to Day 85 of pregnancy. In situ 
hybridization analysis demonstrated that estrogens secreted by the conceptus induce 
expression of SPP1 mRNA in discrete regions of uterine LE juxtaposed to the conceptus, 
and expression expands to the entire LE by Day 20, where expression is maintained 
through Day 85 (Garlow et al., 2002). Results from the present study provide further 
detail in that, unlike previously reported, SPP1 is not expressed in uterine LE adjacent to 
areolae. The physiological significance of this pattern of expression is not known, but 
SPP1 is proposed to attach uterine LE to chorion during implantation, and areolae are the 
only regions of the chorion that do not attach to uterine LE. The present results on 
localization of SPP1 protein are coordinate with results from in situ hybridization 
analyses showing that SPP1 is first detected in uterine GE at Day 35, increases through 
Day 40, and continues to be expressed in uterine GE through Day 85.  
 SPP1 is highly abundant in the allantoic stroma from Days 40 to 60 of pregnancy 
(Figure A.7). Although the exact cell type secreting SPP1 is unclear, the protein is 
located near the placental blood vessels. A similar pattern of SPP1 expression has also 
been observed in the allantoic stroma of the sheep. Interestingly, when ITGB3, an 
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integrin receptor for SPP1, was knocked down in sheep conceptuses, SPP1 mRNA was 
decreased in the placenta, and in those same conceptuses, fetal crown-rump length was 
decreased. These findings led to the hypothesis that SPP1 may enhance placental 
angiogenesis, which would allow for greater nutrient transport to the fetus (J.W. Frank 
and G.A. Johnson, unpublished results). The pattern of SPP1 expression in the allantoic 
stroma of the pig in this study suggests a similar role for SPP1 in angiogenesis. 
 Of interest is the observation that PGR was detected in the GE that directly open 
into the areolae. The epithelial cells that comprise the opening of the uterine glands have 
been hypothesized to have minimal secretory activity due to their cuboidal cytological 
form and small surface area (Friess et al., 1981; Leiser and Dantzer, 1994). Additionally, 
the capillary network that supplies the necks of the glands is a sparse, wide mesh of large 
capillaries, but as the gland tubule is followed down into the uterine stroma, toward the 
myometrium, the capillary bed becomes more intricate with smaller vessels indicative of 
transport occurring between the blood vessels and uterine GE (Leiser and Dantzer, 
1994). Further, we observed that two histotroph proteins, ACP5 and SPP1, are not 
detected in uterine GE that express PGR, although immunoreactive secretory product for 
these proteins are present in the lumens of the necks of the glands. We propose that the 
necks of the GE that directly open into the areolae are classic excretory ducts, similar to 
many other glands in the body, that do not produce histotroph, but serve only to transport 
histotroph into the lumens of the areolae. 
 The presence of PGR in the necks of glands that do not synthesize ACP5 and 
SPP1, juxtaposed to the lack of PGR in uterine GE that does synthesize ACP5 and SPP1, 
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highlights the conundrum that P4 regulates the expression of genes in cells that do not 
express PGR, and that the presence of PGR in GE cells appears to prevent the ability of 
P4 to induce protein expression in those cells (Chen et al., 1975; Bailey et al., 2010a). 
Indeed, the presence of PGR appears to have an inhibitory effect on ACP5 and SPP1. 
The paradox of having gene and protein upregulation by P4 in cells lacking PGR has 
been discussed extensively, but no definitive explanation has been put forward. One 
hypothesis is that effects of P4 on epithelial cells are mediated through PGR-positive 
stromal cells that can respond to P4 and produce paracrine-acting factors (termed 
progestamedins) that then act on epithelial cells (Johnson et al., 2000; Ka et al., 2007). If 
this is the case, then the presence of PGR may block the effects of progestamedins on 
expression of genes in uterine GE adjacent to areolae.    
In conclusion,  these results are the first to show that PGR is maintained in 
uterine stromal cells and myometrium through Day 85 of pregnancy, but PGR 
expression is not detectable in epithelia beyond Day 50 of pregnancy, except in the 
necks of uterine GE that empty into areolae. PGR expression in the necks of uterine GE 
appears to inhibit the ability of GE to produce ACP5 and SPP1, which suggests that 
these regions are uterine gland excretory ducts that serve as conduits for the passage of 
histotroph into the lumen of the areola.  
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APPENDIX B 
PROTOCOLS 
 
RNA Extraction 
An RNA extraction protocol for tissues. 
 
1. Place frozen tissue samples (~1g) directly into 10 ml Trizol reagent (Life   
Technologies, Carlsbad, CA, USA) in a 50 ml conical tube on ice.  
2. Homogenize the tissue using a Tissuemizer.  
3. Incubate the homogenized tissue at room temperature (RT) for 5 min. 
4. Centrifuge the samples at 12,000 x g for 10 min at 4°C. 
5. Keep the clear supernatant and add 2 ml chloroform. Vortex and centrifuge at 12,000 
x g for 10 min at 4°C. 
6. Keep the aqueous phase and add an equal volume of isopropanol. Vortex, incubate at 
RT for 10 min, then centrifuge at 12,000 x g for 10 min at 4°C.  
7. Aspirate off the liquid, wash the pellet with 10 ml 70% ethanol, and centrifuge at 
7,500 x g for 5 min at 4°C. 
8. Aspirate off the ethanol, let pellet dry, and re-suspend the pellet in 400 µl nuclease-
free water. Incubate at 70°C for 5 min to completely dissolve the pellet. 
 
 
DNase Treatment 
A protocol to remove contaminating DNA from RNA samples. 
 
For 1 reaction using DNase I (Qiagen):  
87.5µl RNA from Trizol extraction 
10µl RDD Buffer 
2.5µl DNase I  
 
Incubate for 15 min at RT and then 5 min at 70ºC. 
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cDNA Synthesis 
 
A protocol for synthesis of cDNA using the Superscript III First Strand Kit (Life 
Technologies). 
 
For 1 reaction: 5µg RNA  
1µl oligo(DT)20 
1µl 10mM dNTP 
Nuclease-free water up to 10µl  
 
Incubate for 5 min at 65ºC.  
 
Add: 
2µl 10x RT Buffer 
4µl 25mM MgCl2 
2µl 0.1M DTT 
1µl RNaseOUT 
1µl Superscript III Reverse Transcriptase  
 
Incubate at 50ºC for 50 min with the reaction being terminated at 85ºC for 
5min. Add 1µl RNase H and incubate for 20 min at 37ºC. 
 
 
Quantitative PCR 
A protocol for determining mRNA expression in tissues. 
 
1. Dilute cDNA from synthesis reaction 1:10 in nuclease-free water. 
2. Use the following reaction mix, repeated in triplicate for each sample: 
 5 µl PerfeCta SYBR Green Mastermix (Quanta Biosciences) 
 1.25 µl Primers (forward and reverse, 10 mM stock) 
 2.5 µl cDNA (~60ng) 
 1.25 µl Nuclease-free water 
 10 µl total 
3. Pipette reactions into a 96-well plate and seal the plate. 
4. Run the following PCR program: 
 A. 5 min at 95°C  
B. 95°C denaturation for 10 sec  
C. 60°C annealing/extension for 30 sec 
D. Repeat B and C for 40 cycles 
E. Run a dissociation curve after every run  
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Immunohistochemistry 
Immunohistochemistry is a tool for visualizing the cell localization of proteins in tissue 
sections. 
 
1. Cut 5 µm thick sections from paraffin-embedded tissue blocks using a microtome. 
Place cut sections on 42°C distilled water, then move sections onto glass slides. Leave 
the slides at 37ºC overnight to ensure adhesion of the tissue to the glass slide. 
 
2. Deparaffinize sections in Citrosolv, three washes for 4 min each, then rehydrate 
tissues through a series of ethanol washes (100% x3, 95% x2, 70% x2) for 30 sec each 
before placing slides in phosphate buffered saline (PBS pH 7.2). 
 
3. Antigen Recovery: 
A. Protease- Warm PBS to 37ºC, add Protease (0.5mg/ml), then submerge slides 
for 8 min. Rinse slides in distilled water and return them to PBS.  
B. Boiling Citrate Buffer- Make a solution of 41ml 0.1M Sodium Citrate, 9ml 
0.1M Citric Acid,  and 450ml distilled water, then bring to a boil. Submerge the 
slides for 10 min, then remove the buffer from the heat, but leave the slides in the 
buffer for another 20 min. Return the slides to PBS. 
C. No retrieval- Slides remain in PBS. 
D. Note- When testing antibodies, test all three retrievals to determine the 
optimal one for the tissue of interest. 
 
4. Quench the endogenous peroxidase activity by washing the slides in 1% H2O2 in 
methanol (6.7ml 30% H2O2 per 200ml methanol) for 15 min at room temperature. Rinse 
the slides in distilled water, then in PBS twice for 5 min. 
 
5. Circle sections with a PAP pen, then lay the slides flat before adding a blocking 
solution to block nonspecific reaction sites. When using the Vectastain ABC Kit (either 
the Mouse or Rabbit IgG kit), add 3 drops (or 100 µl) normal serum to 10 ml of PBS to 
prepare the blocking solution. Add 60 µl per section to the slides to fully cover each 
section with solution and incubate for 10 min at room temperature. Rinse slides in PBS 
twice for 5 min. 
 
6. The primary antibody will be diluted in a solution of PBS+1% BSA+0.1% Triton-X to 
1-5 µg/ml (for pig tissues, start with 5 µg/ml, but the concentration may need to be 
adjusted). Purified IgG from the species that is the antibody host will be used as a 
negative control and will be used at the same concentration as the primary antibody it 
corresponds with. A negative control will need to be run with every batch that 
corresponds with each antibody and retrieval method. Add 60 µl of primary antibody or 
IgG control per section to the slides to fully cover each section with solution and 
incubate overnight at 4°C in a humidified chamber (leave a small amount of PBS in the 
bottom of the container holding the slides). Rinse slides in PBS twice for 5 min. 
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7. Prepare the secondary antibody by adding 3 drops normal serum and 1 drop 
biotinylated secondary (from the Vectastain kit) antibody to 10 ml of PBS. Add 60 µl 
per section to slides to fully cover each section with solution and incubate for 60 min at 
37°C. Rinse slides in PBS twice for 5 min. 
 
8. Prepare the detector reagent at the beginning of the secondary antibody incubation so 
that it can stand at room temperature by adding 2 drops of A, then 2 drops of B (from the 
Vectastain kit) to 5 ml PBS. Add 60 µl per section to slides to fully cover each section 
with solution and incubate for 30 min at 37°C. Rinse slides in PBS twice for 5 min. 
 
9. Wash slides in 0.05M Tris-HCl (pH 8.8) for 5 min. Then, add 100mg 3,3’-
diaminobenzidine tetrahydrochloride (DAB) and 50µl H2O2 to 200 ml Tris-HCl before 
submerging the slides. As the slides are incubating in DAB at room temperature, monitor 
the sections under a microscope until the desired color intensity is reached (2-10 min). 
Stop the reaction by placing the slides in tap water.  
 
10. Counterstain slides with Harris modified hematoxylin (1-20 sec), rinse with distilled 
water until water is clear, then dehydrate sections through a series of alcohol washes 
(70% x2, 95% x2, 100% x3). Place slides in 3 washes of Citrosolv for 4 min each, then 
place coverslips on the slides with a drop of Permount mounting medium. 
 
11. Let slides dry overnight on a flat, dry surface that is protected from light. 
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Isotope In situ Hybridization 
In situ hybridization is a tool for visualizing the cell localization of a target mRNA in 
tissue sections. 
 
1. Design primers for the gene(s) of interest with primers of 20-24 bases and a product 
length of 400-600 bases using known sequences for the species of interest (available 
through NCBI).  
 
2. Generate partial cDNAs by RT-PCR using cDNA from a sample that will have an 
ample amount of the gene of interest. For each reaction: 
 2.5µl 10x PCR Buffer 
0.5µl 10mM dNTP 
0.75µl 50mM MgCl2 
1µl Forward Primer (10mM stock)  
1µl Reverse Primer (10mM stock) 
3µl cDNA from a 5µg total RNA reaction (~0.75 µg RNA) 
Nuclease-free water up to 25µl total for the reaction 
 
PCR amplification parameters are: 1) 95ºC for 5 min; 2) 95ºC for 45 sec, 60ºC 
for 30 sec, 72ºC for 1 min for 40 cycles; and, 3) 72ºC for 10 min.  
 
3. Amplified PCR products will then be subcloned in the pCRII cloning vector using a 
TOPO TA Cloning Kit (Life Technologies): 
A. Mix 4 µl of fresh PCR product with 1 µl salt solution and 1 µl TOPO vector, 
then incubate for 5 min at room temperature. 
B. Add 2 µl of the mixture in (A) to one vial of bacteria from the kit. Keep 
bacteria on ice from removal from freezer to heat shock. Incubate for 5 min on 
ice. 
C. Heat-shock the bacteria for 30 sec in a 42°C water bath without shaking, then 
transfer the vial back to the ice.  
D. Add 250 µl of room temperature S.O.C. medium. 
E. Shake the tube horizontally (200 rpm) at 37°C for 1 hr. 
F. Spread 10-50 µl from each vial on a prewarmed (37°C) agarose plate (see 
below for plate instructions) and incubate overnight at 37°C to grow colonies. 
G. Pick ~10 white colonies to transfer individually into glass tubes with 3 ml LB 
broth for propagation. 
 
4. Preparation of LB broth and agarose plates: 
 A. LB Broth-   10 g Tryptone 
     5 g Yeast Extract 
   5 g NaCl 
   1 ml 1M NaOH 
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   Up to 1L of ddH2O 
 B. LB Broth + Agar- 1L LB Broth 
    15 g Agar 
 C. Autoclave both LB Broth and LB Broth + Agar for 30 min.  
D. While still warm, pour LB Broth + Agar into 100mm polystyrene culture  
plates 
E. After LB Broth has cooled, add 1 ml Carbenicillin (100 µg/ml) to 1L LB 
Broth 
F. Before using plates, spread 40 µl X-gal (40 mg/ml) on each plate, then warm 
to 37°C 
 
5. Propagate colonies from Step 3G in 3 ml LB Broth in glass tubes in a shaker (200 
rpm) at 37°C overnight (tubes will a cloudy appearance have appropriate bacteria 
growth). 
 
6. Collect 1 ml of media containing bacteria and perform a DNA extraction using the 
DNA MiniPrep  (Macherey-Nagel, Germany) according to manufacturer’s instructions. 
The other portion will be stored at 4ºC until a colony is determined to contain the desired 
insertion.  
 
7. Purified DNA from the MiniPrep will be used for a restriction enzyme digest. For 1 
reaction: 
 12.3µl water 
2.0µl restriction enzyme buffer 
0.2µl acetylated BSA(10µg/µl) 
5µl DNA 
0.5µl EcoR1(10U/µl) 
20µl total 
 
After a 2 hr incubation at 37ºC, run the digest on a 2% agarose electrophoresis gel for 30 
min. Positive colonies will display a large vector band and a band at the product length 
of the primers used.  
 
8. Sequence the DNA from positive colonies in both directions using an ABI PRISM 
Dye Terminator Cycle Sequencing kit and an ABI PRISM automated DNA sequencer 
(Applied Biosystems, Foster City, CA) to confirm sequence identity.  
 
9. Propagate one clone for each gene with the correct sequence in 250 ml LB Broth at 
37°C overnight on a shaker (200 rpm). 
 
10. Collect the media containing the bacteria and extract the DNA plasmids using a 
MaxiPrep Kit (Macherey Nagel) according to manufacturer’s instructions. Keep 500 µl 
of bacteria culture and add it to 500µl 80% glycerol for a stock that can be frozen and 
stored at -80°C. 
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11. Linearize the DNA plasmids by digestion with an appropriate restriction enzyme. 
Choose restriction enzymes that will not cut the gene sequence, but will cut on the 
appropriate side of the insert to create both sense and anti-sense strands. Use the vector 
map to help with this. For 1 reaction: 
 20µg of DNA  
20µl Restriction Enzyme Buffer 
20U Restriction Enzyme 
Nuclease-free water up to 200µl  
 
Incubate for 2 h. The temperature will depend on the enzymes used. 
 
12. Purify the linearized DNA using the following Phenol:Chloroform Extraction: 
A. Add 200 µl PCI pH 8.0 to linearized DNA, then centrifuge at 20,000 x g for 
10 min. 
B. Retain the top phase, add 200 µl Chloroform, then centrifuge at 20,000 x g for 
10 min. 
C. Retain the top phase, add 3 vol 100% ethanol, 1/10 vol 3M NaOAc, and 5µl 
dextran T500 (10mg/ml), then place in -80ºC freezer for 15 min to precipitate 
DNA.  
D. Centrifuge the solution for 10 min at 20,000 x g at room temperature. 
E. Remove liquid, wash the pellet with 150 µl of 70% ethanol, and centrifuge 
again. 
F. Remove liquid and re-suspend the pellet in 40 µl nuclease-free water. 
 
13. Generate the isotope-labeled antisense or sense cRNA probes with an in vitro 
transcription reaction.  
 A. Perform the following reaction for each probe: 
1µg linearized DNA 
5µl 5x Transcription Buffer 
2.5µl 100 mM DTT 
2.5µl 2.5mM rGAC 
1µl RNasin 
2.5µl [α-35S]-UTP 
1.5µl T7 or SP6 RNA polymerase 
Nuclease-free water up to 25µl 
B. Incubate the probe reaction at 37ºC for 2 hr.  
C. Add 3µl RQ1-DNase I and 1.5µl RNasin, then incubate for 15min at 37ºC. 
D. Add 25µl yeast tRNA (10mg/ml) and 100µl PCI pH 4.5, then centrifuge at 
20,000 x g for 5 min.  
E. Aspirate the top layer and place it into a new tube to do a second extraction 
with 100µl chloroform:isoamyl alcohol (24:1), then centrifuge at 20,000 x g for 5 
min.  
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F. Place the top phase of the second extraction in the center of a NucAway 
(Ambion) gel column that was rehydrated with 650µl of nuclease-free water 30 
min earlier and centrifuge for 2 min at 750 x g. 
G. Add 60µl 3M NaOAc (pH 5), 2µl yeast tRNA, and 300µl 100% ethanol then 
place at -80ºC for 15min, followed by centrifugation for 10min at 20,000 xg at 
4ºC.  
H. Remove the supernatant, wash the pellet with 150 µl 70% ethanol, and 
centrifuge for 10 min at 20,000 x g at 4°C. 
I. Aspirate the liquid and re-suspend the pellet in 50µl of 100mM DTT 
J. Add 2 µl of the probe into a vial with 2 ml EcoLum and place the vial into a 
scintillation counter to determine the isotope count. 
 
14. Cut 5 µm thick sections from paraffin-embedded tissue blocks using a microtome. 
Place cut sections on 42°C ddH2O , then move sections onto glass slides. Leave the 
slides at 37ºC overnight to ensure adhesion of the tissue to the glass slide. 
 
15. Deparaffinize sections in Citrosolv, three washes for 4 min each, then rehydrate 
tissues through a series of ethanol washes (100% x3, 95% x2, 70% x2) for 30 sec each 
before placing slides in phosphate buffered saline (PBS pH 7.2; RNase-free) and 
following this series of washes: 
 A. PBS, 5 min, 2 washes 
 B. Fresh 4% Paraformaldehyde, 20 min, 1 wash 
 C. PBS, 5 min, 2 washes 
 D. Proteinase K (20 µg/ml) in 50mM Tris, 5mM EDTA, 7.5 min, 1 wash 
 E. Fresh 4% Paraformaldehyde, 5 min, 1 wash 
 F. DEPC-treated water, 1 min, 1 wash 
 G. PBS, 5 min, 2 washes 
 H. 70% Ethanol, 30 sec, 2 washes 
 I. 95% Ethanol, 30 sec, 2 washes 
 J. 100% Ethanol, 30 sec, 2 washes 
 K. Air dry the slides at room temperature 
 
16. Prepare the cRNA probe in hybridization solution containing 100 mM DTT 
calculating for 5x106 CPM/slide and 75 µl of solution per slide. Incubate for 10 min at 
70°C. 
 
17. Add the hybridization solution containing the probe to each slide and gently place a 
coverslip on top with no bubbles. Hybridize overnight in a humidified chamber at 55°C. 
 
18. After hybridization, the slides will be sent through a series of washes: 
 A. 5x SSC*/10mM βME, 30 min, 1 wash, 55°C 
 B. 50% Formamide/2x SSC/50mM βME, 20 min, 1 wash, 65°C 
 C. TEN (0.5M NaCl, 10mM Tris pH 8, 5mM EDTA), 10 min, 1 wash, RT 
 D. TEN, 10 min, 3 washes, 37°C 
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 E. RNase A (10 µg/ml) in TEN, 30 min, 1 wash, 37°C 
 F. TEN, 15 min, 1 wash, 37°C 
 G. 50% Formamide/2x SSC/50mM βME, 20 min, 1 wash, 65°C 
 H. 2x SSC, 15 min, 1 wash, RT 
 I. 0.1x SSC, 12 min, 1 wash, RT 
 J. 70% Ethanol/0.3M Ammonium Acetate, 5 min, 2 washes, RT 
 K. 95% Ethanol/0.3M Ammonium Acetate, 1 min, 1 wash, RT 
 L. 100% Ethanol, 1 min, 2 washes 
M. Air dry slides, then expose to Biomax film overnight in cassettes (16-18 hrs) 
to estimate emulsion exposure time 
*20x SSC contains 3M sodium chloride and 0.3M sodium citrate at pH 7  
 
19. All work with Kodak NTB2 emulsion must be done in the dark. Thaw emulsion at 
42°C in a light tight container. Mix emulsion 1:1 with 42°C water. In the dark, dip slides 
in emulsion mix, wipe excess emulsion off the back of the slide and place in a slide box 
containing dessicant. Leave slide boxes in a light tight box overnight to dry at RT, the 
wrap slide boxes in foil and place at 4°C for 5-14 days (depending on exposure on 
films). 
 
20. Develop slides in the dark, at RT, using the following series of washes: 
 A. Kodak D-19 Developer, 4 min, 1 wash 
 B. Water, 0.5 min, 1 wash 
 C. Kodak Rapid Fixer, 5 min, 1 wash 
 D. Water, 5 min, 2 washes (light can be turned on) 
 E. Hematoxylin, 20 sec, 1 wash 
 F. 50% Ethanol, 5 min, 1 wash 
 G. 70% Ethanol, 5 min, 1 wash 
 H. 95% Ethanol, 3 min, 2 washes 
 I. 100% Ethanol, 3 min, 3 washes 
 J. Citrisolv, 4 min, 3 washes 
 K. Affix coverslips with Permount, then allow slides to dry on a flat surface. 
 
21. View slides using bright-field and dark-field illumination microscopy.  
 
